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Abstract
Xanthine oxidase (EC 1.1.3.22) is a 300KDa molybdenum, flavin, iron-sulphur 
protein known for its hydroxylation reactions of purines with the final generation of 
uric acid. It has long been known that the redox reactions of purine turnover 
generate the one electron addition product superoxide radical and two electron 
addition product hydrogen peroxide in the presence of oxygen as an electron 
acceptor. Much work has focussed on this activity in terms of pathological 
implications following the hypoxia reperfusion hypothesis suggested by McCord in 
1985.
Owing to the similarity between xanthine oxidase and other molybdenum containing 
enzymes particularly nitrate reductase, the nitrate reductase activity of xanthine 
oxidase was assessed. This was found to occur under reduced oxygen 
concentrations and is thought to be due to oxidation of the enzyme via the loss of 
electrons to nitrate at the molybdenum site. It was then possible to generate nitric 
oxide from nitrite utilising an apparent nitrite reductase activity with a variety of 
substrates which was also molybdenum site dependent. The possibility of 
peroxynitrite generation at intermediate oxygen concentrations re-opened the 
discussion as to the function of xanthine oxidase.
The antibacterial action of peroxynitrite and a range of oxidants was assessed. 
The appearance of xanthine oxidase in high concentrations in human and bovine 
milk suggests this enzyme as a possible natural antibiotic.
The appearance of a circulating form of radical activity has also been suggested to 
be xanthine oxidase. In the light of the nitric oxide generating capacity of the 
enzyme, the binding of xanthine oxidase to live endothelial cells was assessed. In
Abstract
this thesis endothelial cells were shown to express, bind and upregulate xanthine 
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1.1.1 Importance of the environment
The human body contains mechanisms to deal with the everyday and not so every 
day aspects of living function. The seven basic modes of life: respiration, 
reproduction, nutrition, locomotion, excretion, growth (division) and irritability 
(response to stimulus), represent characteristics which are shared by most species 
on earth (exceptions include some of the most basic forms of “existence” known 
some of which carry out only a selection of these seven functions). To survive in a 
hostile environment, the ability to adapt has helped the present species on earth to 
exist at a point in time where others cannot. Taking the estimates for the age of our 
universe as 15 thousand million years and our own planets existence as around 
four and a half thousand million years, life apparently began some thousand million 
years following the formation of the planet. The particular environment found at 
that time is thought to have encouraged the conglomeration of organic molecules to 
form the very basis of the first forms of life (Pirie, 1985). Life in terms of the first 
chemical processes involving organic molecules which could somehow reproduce 
themselves by purely chemical processes. Experiments to replicate the early earth 
atmosphere using simple molecules such as ammonia, methane, hydrogen and 
water vapour reacted under a low oxygen conditions reveal the building blocks of 
life. Isomers of sugars were formed following discharges of electricity such as 
lightning; a phenomenon that we still see today on our own planet and on others in 
the solar system (Mason, 1989). These early life forms were never captured in 
fossil form, the fossil record that does exist, however, shows slow progress over the
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following two thousand million years. Before the Cambrian period (~ 500 million 
years ago) single celled organisms were joined by more complex multicellular 
organisms in what is referred to as the Cambrian explosion. A change in the 
environment has been suggested as the causation for this sudden change. 
According to recent research by Andrews in 1998, the suggestion is that a 
continental shift occurred, turning the continents through ninety degrees and 
causing a climate change. More precisely, it is believed that a movement of the 
Earth's lithosphere - the solid uppermost layer of the planet's crust - caused a 
climate change that propelled the evolution of new life forms. Analysis of rocks 
collected by the researchers suggest that all the major continents "experienced a 
burst of motion" at about the same time as the Cambrian explosion occurred in the 
geologic record. However, whether or not this phenomenon, known as "true polar 
wander", was enough to cause new life forms to emerge is an issue of great 
speculation (Andrews 1998).
Although the mechanism may still be under debate, it is clear that over the expanse 
of time, there have been great upheavals in the environment on earth that have had 
and are still having effects on life. Of particular interest is the change in the 
concentration of oxygen within the atmosphere. Oxygen, a gas first purified by 
Priestly in the 18th century, is essential to human life and to most other organisms. 
However, organisms exist to which oxygen is a poison, in that they cannot survive 
in an oxygen-enriched atmosphere. Presently the oxygen concentration in the 
Earth’s atmosphere is ~ 21%. This is kept fairly constant by the buffering effect of 
the oceans, the generation of oxygen from green algae, plants and other 
photosynthesising organisms. However, oxygen is used up by other species and 




The earliest known fossils are found to date to around 3,500 million years ago, 
during the Archaen period. These microbacteria are thought to have lived under a 
reducing atmosphere. During this time the oxygen concentration in the atmosphere 
was very low, -1%  of today’s values. About 2,200 million years ago iron oxides 
began to appear in paleosols (fossil soil) with the appearance of “red beds” 
containing metal oxides. Information collected from cosmic spherules -  
micrometeorites-submilimeter-sized particles derived from comets and asteroids -  
has been used to estimate oxygen concentration in the pre-Cambrian atmosphere. 
These cosmic spherules contain nickel-rich spinels that were crystallised and 
oxidised during atmospheric entry. This gives an estimate of the level of oxygen in 
the atmosphere at the time of arrival (Deutsch et al, 1998). This suggested a 
relatively rapid increase in oxygen concentration in the atmosphere at this time 
(Graham et al, 1995). The appearance of cyanobacteria 3,500 million years ago 
ties in with the rise in atmospheric oxygen and a change from a reducing 
atmosphere to one that was primarily oxidising. These photosynthetic organisms 
produced oxygen as a by-product of their metabolism and they became common 
and widespread in the Proterozoic era, 2,500 -  540 million years ago. This effect 
was so prolific as to raise the atmospheric oxygen content from 0 to 15% (Berner 
and Canfield, 1989, Holland, 1994 and Shields etal, 1997). It is possible that these 
cyanobacteria were the priming force for the explosion of species which occurred 
because of the change to oxygen utilisation for certain biochemical processes. The 
effect of the cyanobacteria on the ecology of the Earth reaches through to today in 
that the oil deposits are attributed to the activity of these organisms. They are also 
important providers of nitrogen fertilisers in rice cultivation as well as being the 




The increase in oxygen allowed for the formation of further plant species notably 
the vascular plants -  those containing xylem and phloem -  which caused another 
great rise in oxygen and a reduction in carbon dioxide. During the Carboniferous 
period, large amounts of carbon were fixed from the atmosphere as the fossil fuels 
were laid down. The resultant drop in carbon dioxide levels is shown in figure 1.1.
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Figure 1.1. The change in atmospheric oxygen and carbon dioxide concentrations 
over the past 600 million years. CA Cambrian, O Ordivician, S Silurian, D 
Devonian, C Carboniferous, P Permian, TR Triassic, J Jurassic, K Cretacious, 
T Tertiary (After Dudley, 1998).
Following this time the oxygen concentration fell dramatically, coinciding with the 
mass extinction seen during the Permian. Not only did the change in oxygen have 
effects but also the carbon dioxide levels had effects on regulating temperature by 
greenhouse warming. The overall density of the atmosphere and atmospheric 
pressure was also affected enabling the first flying species to become prevalent 
(Dudley, 1998). The biochemistry of these organisms can only be guessed at, but 
it is possible that they evolved to utilise the available substrates or to lessen their
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oxidative effects. This then shows the controlling effect of oxygen availability on life 
on earth.
1.1.2 Oxygen effects
On the switch from a reducing to an oxidising atmosphere, adaptations were 
required for survival. Oxygen itself had become a toxic entity, one that must be 
dealt with for the organisms to proliferate. The mechanisms by which this new 
oxidant was to be overcome must have evolved during the time of the rise in 
oxygen concentration, with those species able to adapt most quickly being the 
species to survive.
1.1.2.1 The mitochondrion and oxidative respiration
Oxygen plays a vital part in energy utilisation and metabolism. The mitochondrion 
is the organelle in eukaryotic organisms where energy is utilised. These organelles 
are thought to be the descendants of once free-living organisms that began a 
symbiotic relationship with other organisms as an energy provider (Margulis, 1970). 
Oxygen acts as the terminal electron acceptor in chains of enzyme-mediated 
reactions where electrons are taken from substrates during enzyme turnover. 
Glucose, a simple sugar, is broken down to pyruvate during glycolysis in the cell 
cytoplasm generating two molecules of energy-rich adenosine triphosphate (ATP) 
for each molecule of glucose under an oxygen-rich environment. The mitochondria 
house the pathways of energy generation from pyruvate. Pyruvate itself is fed into 
the Krebs cycle where a series of enzyme steps generates nicotinamide adenine 
dinucleotide reduced form (NADH) and carbon dioxide (C 02) as by-products. The 
final stage of ATP generation occurs by electron transporting reactions known as 
the respiratory chain. Hydrogen atoms from NADH generated in the Krebs cycle
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are converted to a proton and two electrons. These electrons are passed to the 
first of more than 15 different electron carriers in the respiratory chain. Each 
complex in the chain has a greater affinity for electrons than the previous complex 
and the electrons pass along this chain until they react with oxygen which has the 
greatest affinity of all for the electrons (Alberts et al, 1989). However, this system 
can be disrupted by the use of specific inhibitors of respiration such as cyanide or 
by the removal of oxygen. As oxygen is the terminal electron acceptor its levels in 
the cell will dictate the rate of ATP production. In fact, as oxygen concentrations 
are reduced the glycolytic pathway does not end with pyruvate but in the generation 
of lactate. Lactate acts as a storage product until the oxygen concentration is such 
that lactate can be converted to pyruvate and the cycle of ATP generation can 
restart. This system relies on oxygen availability for the smooth running of energy 
metabolism.
1.1.2.2 Adaptation to non-oxidative metabolism
Primitive organisms could generate ATP by the utilisation of organic molecules in a 
process probably similar to fermentation (Gest, 1980). The organic molecules are 
partly oxidised by the loss of a hydrogen molecule. In the reducing atmosphere of 
the time, hydrogen must have been transferred either by NADH or NADPH to a 
different organic molecule which thereby became more reduced. The products of 
fermentation are excreted into the media whereas others are retained in the cell for 
further biosynthesis.
The excreted products tend to be organic acids such as lactic, formic, acetic, 
butyric and succinic acids. The evolution of electron-storing transport chains 




Certain parasites are found under reduced oxygen atmospheres and their 
biochemical adaptations reflect their ability to survive the changing environments. 
The protozoan Trypanosomes utilise a variety of adaptations and certain species 
are more “aerotolerant” than others because of their biochemical pathways. 7. 
brucie generates pyruvate as its end product as they do not possess the enzymes 
involved in the Krebs cycle or an electron transport chain. Oxygen is utilised, when 
available, to directly oxidise NADH using the unique enzyme glycerophosphate 
oxidase (GPO). This system can be inhibited by the reduction of oxygen. 
However, this is not lethal as the organisms have two other energy metabolising 
activities one of which is anaerobic. This system, utilising an unknown oxidase, 
apparently accounts for 30-35% of the reducing power (Weimer et al, 1995).
The T. congolense group has pyruvate, acetate and succinate as end products of 
respiration. They do possess some Krebs cycle enzymes but function in the 
reverse direction. 7. cruzi have a fully functional Krebs cycle and generate C 02 
and succinate but here again the system works in reverse (Perie etal, 1993). 
However, other terminal electron acceptors are still used. Today, we still see 
adaptations to a reducing atmosphere. Free-living ciliates are generally regarded 
as aerobic and totally reliant on mitochondrial respiration for energy generation. 
However, several lineages have colonised anaerobic habitats where the role of the 
mitochondrion has been replaced by the hydrogenosome and obligate anaerobe 
ciliates now lack mitochondria (Brul and Stumm, 1994). These anaerobic ciliates 
are not phylogenetically related, implying that the process allowing their existence 
was not rare (difficult), and they have strong morphological ties to their aerobic 
relatives implying that the process was also recent (Frenchel, 1996).
The hydrogenosome is an organelle that produces hydrogen which can then go on 
to be used to replenish NADH levels following enzyme utilisation and ATP
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production (Biagini etal, 1997 and Diaz and De Souza, 1997). In Trichomonas sp, 
oxygen can be used as the terminal electron acceptor. However as the levels of 
oxygen are reduced the ratio of end products changes. In aerobic conditions no 
hydrogen is produced and more acetate is formed than succinate. In anaerobic 
conditions the reverse is seen. The aerobic metabolism generates greater 
amounts of ATP but the anaerobic system can still generate significant amounts; 
seven molecules ATP to five molecules ATP per 1 molecule glucose respectively 
(Benchimol et al, 1996).
A further adaptation to the varying oxygen concentration is the utilisation of a 
cytoplasmic NADH oxidase. This acts as an oxygen scavenger that mops up the 
extra oxygen protecting the hydrogenosome. In comparison to the relatively 
aerotolerant Tricomonas, Entamoeba sp. have no mitochondria and their NADH 
oxidase activity is not compartmentalised. T. foetus can tolerate up to 20% oxygen 
for short periods whereas E. histolitica can only tolerate ~ 5% oxygen.
Clostridium perfringens is the microbe responsible for gas gangrene in open 
wounds, an infection usually contracted from contaminated soil although 
commensal organisms can also survive in the gut. The bacterium itself cannot 
survive in an oxygen rich atmosphere and so generates hydrogen gas contained 
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Figure 1.2. Summary of the evolution of the mitochondria and the change in 
atmosphere and alternative energy metabolism (After Alberts et al, 1989).
1.1.3 Oxygen and physiology
Using oxygen as the terminal electron acceptor in the generation of energy-rich 
compounds means that the availability of oxygen will determine many reactions and 
rates of metabolism. In a normal physiological situation at sea level the 
concentration of inspired oxygen is equivalent to the atmospheric concentration ~ 
21% by saturation. Once inspired and bound to a transport protein, haemoglobin, 
myoglobin or haemolymph, which are iron based and copper based proteins 
respectively, the oxygen can then be transported to the tissues. Oxygen saturated 
transport proteins lose their oxygen in areas that are relatively low in oxygen for 
example respiring tissues. As the transport proteins move further away from their
9
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site of oxygen saturation, such as the lungs, gills and skin, their level of oxygen 
saturation is reduced as oxygen is lost to the tissues and carbon dioxide is 
exchanged. It is therefore possible that, in the tissues furthest from the transport 
protein oxygen saturation point, there will be less oxygen available for respiration. 
These tissues may then be termed relatively hypoxic. However, using this term 
suggests that this tissue is under some respiratory stress compared to tissue with a 
greater oxygen supply when the oxygen supply to the “hypoxic” tissue is the normal 
or normoxic supply that it would receive.
The supply of sufficient oxygen to the tissues has controlled the evolution of 
transport protein and respiratory systems. From diffusion limitation over body 
surfaces to removal of oxygen from water by gaseous exchange over gills to 
breathing in air, each environment poses problems that have to be overcome. The 
atmospheric, and therefore aquatic, oxygen concentration also controlled the 
respiratory system of organisms and led to the development of gigantism in the late 
Palaeozoic (Dudley 1998). Among terrestrial vertebrates at that time, large 
amphibians reached body lengths of up to 2 meters but were probably limited to 
that size by cutaneous respiration which is known to restrict maximum body size in 
modern urodeles (Ultsch 1974). By increasing the concentration of available 
oxygen the diffusive flux into the tracheal system is increased. The limits of body 
size can then also increase as the supply and demand ratio changes in favour of 
supply (Graham et al 1995).
For aquatic organisms the variation in temperature affects the oxygen saturation of 
water: oxygen saturation decreasing with increasing temperature. To counteract 
this, adaptations to the environment have evolved. Changes in the saturated lipid 
content of cell membranes helps to control membrane fluidity which is temperature 
dependent (Coussins and Prosser 1978) and the evolution of temperature sensitive
10
Chapter 1
and resistant enzymes allows function during dives where water temperature and 
therefore body temperature can change by over 20°C (Dunn et al 1983).
1.1.3.1 Hypobaric hypoxia
In humans, however, temperature is regulated to give a near constant core 
temperature of ~ 37°C. Oxygen availability however can become a problem at 
altitude. Although the percentage of oxygen in inspired air remains constant at 
varying altitudes, the fall in atmospheric pressure at higher altitudes decreases the 
partial pressure of inspired oxygen. This in turn decreases the driving pressure for 
gas exchange in the lungs. The atmospheric pressure and inspired oxygen 
pressure fall roughly linearly with altitude to be 50% of sea level value at 5,500m 
and 30% sea level value on the summit of Everest (~ 8,900m) (Peacock 1998).
To survive at these low oxygen partial pressures a range of physiological 
adaptations occur. At sea level, carbon dioxide is the main stimulus to ventilation. 
However, at altitude, the decrease in oxygen saturation of the blood is sensed by 
the carotid bodies, which stimulate an increase in ventilation to blow off carbon 
dioxide. By using a high-oxygen-sensitive potassium channel that is reversibly 
inhibited by low oxygen, the subsequent depolarisation stimulates calcium channels 
that mediate the signal in the nerves (Gonzalez eta11992 and Schoene 1997).
The heart at altitude responds with an initial increase in output compared to 
physical work but acclimatises to sea level values soon after. At all times however 
there is an increased heart rate and decreased stroke volume for any given level of 
work and the maximum obtainable heart rate falls as higher altitudes are reached 
(Monge and Leon-Velarde 1991).
The oxygen saturation of the haemoglobin is reduced on moving to altitude thereby 
reducing the amount available to the tissues. During acclimatisation, the oxygen
11
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saturation curve becomes left shifted. That is to say that the haemoglobin binds 
oxygen more avidly, increasing the blood oxygen saturation (Hsia 1997).
The blood volume also changes on a move to altitude with a two phase acute and 
acclimatisation response. The acute phase is caused by dehydration of blood 
plasma, which concentrates the haemoglobin and increases the amount of 
available protein able to carry oxygen per unit residence time in the lungs. The 
acclimatisation response is stimulated by the reduced oxygen concentration and 
the stimulation of the juxtaglomerula apparatus of the kidney and an increase in the 
production of erythropoietin (EPO) which in turn increases the haemoglobin 
concentration (Klausen et al 1996). The expression of vascular endothelial growth 
factor 1 (VEGF1) in the vasculature is linked with oxygen sensing and along with 
the expression of its receptor leads to angiogenesis especially in the heart and 
brain (Hochachka etal 1998).
1.1.3.2 Physiological hypoxia
During intense exercise the body can build up what is known as an oxygen debt. 
This occurs when the energy requirements outstrip their supply due to the loss of 
the terminal electron acceptor, oxygen. This reduces the electron cascades and 
the formation of high-energy metabolites. Glycolytic metabolism occurs in low 
oxygen to generate pyruvate which would normally go on to the Krebs cycle and be 
used for ATP generation. However, at times of oxygen debt, glycolysis switches to 
lactate production allowing turnover of the glycolytic enzymes. The lactate is stored 
until the oxygen concentration increases and Krebs cycle is initiated for the further, 
and more energetically efficient, generation of ATP. The measurement of the 
lactate-pyruvate ratio has been used by some as a marker of hypoxia or glycolytic 




The cellular response that leads to the macroscopic physiological response 
detailed above is mediated by environmental sensing systems. The carotid body 
initiates the hypoxic ventilatory response and pulmonary vascular oxygen sensors 
initiate the regulation of hypoxic pulmonary vasoconstrictor responses which 
matches lung and ventilation perfusion. Oxygen sensing in the vasculature causes 
VEGF1 expression with associated angiogenesis whilst oxygen sensors in the 
kidney and liver cause expression of EPO. Tissue specific oxygen sensing leads to 
metabolic reorganisation by altering the expression rates of hypoxia sensitive 
genes for metabolic enzymes and transporters (Hochachka et al 1998).
These adaptive responses to hypoxia feature the activation of genes for active 
proteins such as EPO, VEGF, endothelin, glucose transporters and glycolytic 
enzymes (Bunn and Poyton 1996). These genes share a common mechanism for 
oxygen-sensing and transcriptional activation. The key step in gene activation is 
the formation of the hypoxia-inducible factor-1 (HIF-1) protein complex and its 
binding to a DNA recognition sequence of the activatable gene (Wang and 
Semenza 1993). Semenza and Wang (1992) were able to show that a 50 
nucleotide enhancer sequence from the human EPO gene could mediate a 
sevenfold transcriptional induction of EPO protein expression in response to 
hypoxia. This sequence was able to bind a specific nuclear transcription factor 
which was induced by hypoxia via de novo protein synthesis.
This led to the description of the oxygen sensitivity of HIF-1 a expression and the 
constitutively expressed HIF-1 p. During low oxygen the HIF-1 a protein becomes 
stabilised as the ubiquitin-proteosome system is down regulated. HIF-1 a is able to 
bind to HIF-1 p to form a transcriptionally active complex (Salceda and Caro 1997)
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and this complex can then bind to specific nucleotide sequences of particular genes 
to cause their transcription and expression of protein (Srinivas et al 1998).
One such hypoxia-regulated protein is the inducible nitric oxide synthase (Melillo et 
al 1995). The induction of a nitric oxide generating enzyme during hypoxic 
episodes would allow the generation of NO on reperfusion and may enhance the 
relaxation of constricted vessels thus ensuring greater blood perfusion to the 
tissues.
This acute hypoxic response has been linked to certain disease states where blood 
supply is reduced to cause a hypoxic or ischaemic episode. Ischaemia of the 
heart, brain and other organs is resolved on reperfusion when blood flow is initiated 
and oxygen concentrations in the tissues are increased. It has been suggested 
that this reperfusion phase is associated with the injury caused by these episodes. 
In particular the role of oxygen and nitrogen radical species has come under certain 
scrutiny with regard to their involvement in pathology.
1.1.3.4 Hypoxia reperfusion injury
The role of superoxide and derived radical species in reperfusion injury is 
dependent upon their generation on the reintroduction of oxygen to previously 
hypoxic tissue. Famously, McCord in 1985 suggested that oxygen-derived free 
radicals were involved in post-ischaemic tissue injury in a range of diseases 
including Intestinal and myocardial ischaemia and in circulatory shock. This came 
from data relating to the protective effect of the enzyme superoxide dismutase 
(SOD) treatment during hypoxia reperfusion cycles in cats. It had previously been 
suggested (Meerson et al 1982) that superoxide had a role in the ischaemic heart 




The main protagonist in the generation of superoxide was suggested by McCord to 
be xanthine oxidase (XO). This enzyme was chosen because of its radical 
generating activity, its apparent wide tissue distribution and the availability of 
substrates that were thought to build up during the ischaemic episode. On 
reperfusion, oxygen would become available and with hypoxanthine present the 
generation of oxygen radicals could occur. The effects of allopurinol an inhibitor of 
XO was also shown to inhibit the effects of reperfusion on the permeability of cat 
intestine following local arterial hypotension and subsequent reperfusion (Granger 
et al 1981).
This hypothesis was taken up to explain many reperfusion injury pathologies. 
However, more recently the value of xanthine oxidase as the mediator of 
reperfusion injury especially in myocardial ischaemia has become less favoured 
due to reports suggesting that the heart did not contain active enzyme (Schaper 
1991). Further evidence was also suggested by using immunological detection 
methods that in humans did not show enzyme expression in the heart or brain 
(Linder et al 1999).
The recent discovery of a circulating form of xanthine oxidase however has led to 
the suggestion that injury to remote organs that did not contain measurable amount 
of active enzyme may be damaged due to the binding and generation of radical 
species of a circulating form released from the liver following an insult of some kind 
(Nielsen et al 1997). This debate remains unresolved so far and the evidence for 
the circulating form of the enzyme will be reviewed in a following section.
The role of xanthine oxidase as a generator of free radical species is therefore of 





From the first measurements of enzyme activity in milk by Shardinger in 1902, the 
specific activity of XO has been under investigation. XO itself belongs to a group of 
proteins known as oxidoreductases. This reflects the redox activity of the enzyme 
and the fact that the enzyme can function with a range of substrates to yield a 
range of products over a range of environmental conditions.
Fridovich and Handler (1961) showed that bovine milk and calf liver xanthine 
oxidase along with rabbit liver aldehyde oxidase were able to cause the oxidation of 
sulphite in the presence of their substrates, xanthine and N-methyl nicotinamide 
respectively. This was not the case however among other similar flavoprotein- 
containing oxidase and dehydrogenase enzymes including succinic 
dehydrogenase, glucose oxidase and alcohol dehydrogenase.
Previously, Weber et al (1956) had studied the reduction of iron and cytochrome c 
by xanthine oxidase and suggested that hydrogen peroxide formation during the 
oxidation of hypoxanthine was responsible for this activity. However, they also 
noted that free hydrogen peroxide could not reduce cytochrome c and therefore the 
reduction mechanisms for iron and cytochrome c must differ.
These speculations were possible as Morgan, Stewart and Hopkins (1922) 
produced evidence of hypoxanthine oxidation in the presence of oxygen. This was 
followed by observations made by Thurlow in 1925 that oxygen was reduced to 
hydrogen peroxide and by Horecker and Heppel in 1949 showing that the reduction 




It was also suggested that the activity reported by Totter et al (1960) of the 
hypoxanthine mediated oxidation of luminol or lucigenin followed by the emission of 
light was due to the same activity as that reported for the oxidation of sulphite. The 
reason for this apparent activity was the production of other oxygen derived radical 
species and in particular the one electron reduction of oxygen to yield superoxide 
radical.
This radical generating capacity led to the development of the idea for a role of XO 
in pathology.
1.2.2 Enzyme structure
1.2.2.1 Molybdenum and pterin cofactor
Further studies on the diet-dependent activity of rat liver xanthine oxidase enzyme 
identified a “liver residue factor” (LRF) which was not identified as a vitamin or other 
factor of known nutritional value at the time (Richert and Westerfeld 1951). The 
inclusion of the LFR increased the rat intestinal enzyme level 500-700 percent 
above the controls. By careful assay of intestinal and liver homogenates the LFR 
was suggested as being molybdenum and the inclusion of 0.1 mg of molybdenum 
per kilogram of diet produced saturation levels of the enzyme in the intestine 
(Richert and Westerfeld 1953).
Further studies using EPR spectroscopy confirmed the requirement for 
molybdenum for enzyme activity in purified enzyme and began to suggest the 
possible reaction mechanism of xanthine turnover (Bray and Meriwether 1966). 
Xanthine oxidase belongs to a group of mononuclear molybdenum enzymes that 
possess, at their active site, molybdopterin cofactor (Hille 1996). This has also 
been identified crystallographically in the similar enzymes, aldehyde oxidase and
17
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DMSO reductase from various bacterial sources. The discovery of this cofactor 
came from work by Pateman et al (1964) on the xanthine dehydrogenase and 
nitrate reductase enzymes of Aspergillus niger. The generation of mutations in this 
fungus produced non-functional enzymes, inferring that a common pathway of 
cofactor synthesis had been lost. Further study saw the discovery of particular 
control genes for pterin cofactor synthesis, molybdenum uptake from the 
environment and insertion of molybdenum into the cofactor (Johnson et al 1991). 
Hille (1996) proposed the reason for the possession of pterin cofactor to be the 
provision of a method by which electrons can be shuttled away from the 
molybdenum active site to allow a more rapid turnover and modulation of the 
molybdenum reduction potential.
The molybdenum cofactor may also be co-ordinated with molybdenum bound to 
oxygen or to sulphur, the oxo or sulphido ligands in the enzyme’s oxidised form. 
Both of these liganded forms are inhibited by cyanide causing the release of the 
sulphur that is replaced by oxygen to give the inactive desulpho form of the 
enzyme. This form of the enzyme can be found naturally occurring and can be 
resulphurated by using sulphide under turnover conditions (Huber et al 1996). The 
enzyme can also be isolated in a demolybdo form or without an intact pterin 
cofactor, both of which are inactive as xanthine oxidases (Gardlick et al and 
Ventom et al 1988).
The molybdopterin cofactor has thus been specified as the site at which the purine 
substrates xanthine and hypoxanthine are oxidised to urate and xanthine 




On further purification from the raw milk, it was found that the enzyme XO came as 
a brown solution. Visible spectrum analysis indicated the presence of a flavin 
moiety which was thought to be flavin adenine dinucleotide (FAD) (Ball, 1939 and 
Corran et al, 1939). The importance of the flavin has been shown in terms of 
enzyme turnover and the generation of superoxide. In the absence of oxygen and 
any other oxidising substrate the enzyme will gain electrons from hydroxylation of a 
purine substrate. This enzyme will now not be able to turnover as it is loaded with 
electrons and cannot return to the oxidised state without passing them on to an 
acceptor substrate. Oxygen has been shown to accept electrons from the electron 
rich enzyme with the formation of superoxide anion. This allows the turnover of the 
enzyme to carry out further hydroxylations of purine substrates.
Oxygen is supposed to bind and receive its electrons from the flavin thus allowing 
further turnover of the enzyme by utilising a second site removed from the 
molybdopterin.
The flavin is the apparent site at which NADH will donate electrons and cause the 
generation of NAD+. The electron-rich enzyme again in the presence of oxygen 
will give up its electrons to generate superoxide radical and allow further turnover of 
the enzyme. The flavin specific inhibitor Diphenyliodonium (DPI) has been shown 
to inhibit the oxidation of NADH to NAD+ by XO and also therefore to inhibit the 
production of superoxide radical by the same means of denying the enzyme 
electrons (Sanders et al 1997).
1.2.2.3 Iron sulphur
The requirement for iron in the activity of xanthine oxidation was described by 
Richert and Westerfeld (1954) using similar assays to those which showed the
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requirement for molybdenum. Using EPR techniques a paramagnetic signal from 
resting XO enzyme that was not attributable to Mo or FAD was shown by Bray and 
colleagues (1961). This signal was suggested as iron and confirmed in 1964 by 
Palmer et al who also suggested that the iron was reduced from a ferrous to a ferric 
state during enzyme turnover. The EPR signal occurred following those 
attributable to Mo and FAD and therefore suggested an involvement in electron 
transport mechanisms that followed this order. Following these observations, Lowe 
et al (1972) attributed this iron signal to an iron sulphur moiety (Fe-S) that was 
similar to a signal generated from spinach ferredoxin which also contains an iron 
sulphur moiety.
1.2.2.4 Structurally related enzyme systems
XO belongs to a group of enzymes that share a common reaction mechanism and 
structure. Such examples include aldehyde oxidase, carbon monoxide 
dehydrogenase and formate dehydrogenase (Hille 1996). They possess a 
molybdopterin cofactor and under go similar hydroxylation reaction of their specific 
substrates. Other molybdenum-based enzymes also exist and can be grouped into 
the sulphite oxidase and DMSO reductase like families. Such sulphite oxidase type 
enzymes are the assimilatory nitrate reductases of plant and fungal origin. These 
enzymes are responsible for the first step in assimilation of nitrogen in the form of 
nitrate for these organisms. They are similar to XO in that they possess FAD and 
molybdopterin cofactors but differ in that they contain a cytochrome with haem iron 
as a further cofactor (Kay et al 1990).
These enzymes catalyse the reduction of nitrate to nitrite in an NADH- or NADPH- 
dependent manner. Their catalytic activity is apparently under tight control in vitro 
with a nitrate reductase specific kinase responsible for the short term down
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regulation of nitrate reductase activity, which in plants follows the levels of 
photosynthesis generating the NADH and NADPH reducing equivalent. The control 
of nitrate reductase activity is also linked to light because of the generation of the 
nitrite, which can be toxic if not utilised by further enzyme systems (Ye et al 1994 
and Douglas etal 1998).
The dissimilatory nitrate reductases are similar in their molybdenum cofactor to the 
DMSO reductases of E. coli and couple the reduction of nitrate to nitrite with 
menaquinol to generate a transmembrane proton gradient. This protein has 
membrane spanning regions with the catalytic subunit on the periplasmic side 
(Jones et al 1980). The dissimilatory pathway is used in the absence of oxygen for 
the generation of proton gradients to allow ATP formation. This utilises nitrate as 
the terminal electron acceptor and allows respiration to continue.
E. coli possess three distinct nitrate reductases: A, Z and an, as yet, undesignated 
form. It is the A form that is induced by anaerobic conditions. A fourth protein 
product from the regulatory operon is not incorporated into the active enzyme but is 
required for maturation and function possibly due to stabilisation of the message 
coding for the enzyme (Dubourdieu and DeMoss 1992).
The product of nitrate reduction in both the assimilatory and dissimilatory pathways 
is nitrite. This nitrite can itself be reduced further to ammonium ion (NH4+) or to NO 
by a series of nitrite reductases (Ye et al 1994 and Cole 1996). In E. coli two such 
nitrite reductases (NiR) are expressed in low oxygen concentration, are induced by 
nitrite and appear to duplicate each other in their function as they both form 
ammonium ions. However, they are the products of two independent genes one of 
which codes for an NADH nitrite reductase (NADH NiR) the other coding for a 
formate nitrite reductase (FNiR). The NADH NiR is located in the cytoplasm and 
has a detoxification function where as FNiR is located in the periplasm generating a
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proton gradient, therefore having an energy conservation function. These two NiRs 
possess a different prosthetic group, NADH NiR having a sirohaem group to which 
the nitrite binds and the FNiR contains a cytochrome c haem moiety but both are 
based on iron.
Further types of NiRs exist such as the copper containing and the cytochrome cd1 
nitrite reductases. The copper containing enzymes possess two copper molecules 
at the active site, one of which, the type II copper, binds the nitrite before it is 
reduced (Godden et al 1991). The cytochrome cd1 NiR has been shown in -  65% 
of all denitrifying organisms but in fewer genera than the copper containing 
organisms. These enzymes consist of two identical subunits of 60KDa each with 
one haem prosthetic group per subunit.
Along with the reduction of N02' to NH4+ it has been suggested that nitrite could be 
reduced to nitrous oxide (N20 ) via NO by NiR and a NO reductase (Payne 1973). 
Following the proposal of several models, it was finally shown that nitrite 
reductases could generate NO from nitrite (Carr et al 1989) and that a specific NO 
reductase enzyme also existed to generate nitrous oxide (Carr and Ferguson 
1990).
From the data presented above the nitrite reductase enzymes show similar electron 
transfer reactions including a NADH activity and the utilisation of iron for activity but 
seem not to involve the use of molybdenum as the active site for substrate 
reduction.
1.2.3 Enzyme reactions
Xanthine oxidase mediates a range of reactions and is known for its part in purine 
metabolism. Equations (1) and (2) below detail the oxidation of hypoxanthine to
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xanthine and xanthine to uric acid by XO with the associated cofactors and 
products.
h2o + 0 2 o2-
Hypoxanthine Xanthine
h2o + o2 0 2-
U rM e m
These reactions are inhibited by blocking the molybdenum centre of the enzyme 
with purine analogues such as allopurinol and oxypurinol. This reaction occurs in 
the presence of oxygen as the electron acceptor and is rate dependent on its 
concentration (Fridovitch and Handler 1962). The Michaelis constant (Km) for 
xanthine and hypoxanthine are ~ 6pM under room air conditions and the Km for 
oxygen reduction was 21\M  and 800pM for the reduction of cytochrome c 
(Fridovich and Handler 1962).
The oxidation of NADH to NAD+ is shown in equation (3) with the electron again 
being given to oxygen to produce superoxide radical.
h2o 0 2 0 2-
NADH NAD +
(3)
It has been reported that this reaction is not affected by the molybdenum site 
inhibitors allopurinol and oxypurinol in the presence of oxygen but is inhibited by 
NAD+ and also by the FAD specific inhibitor diphenyliodonium (DPI) (Sanders et al 
1997). The Km for the oxidation of NADH in both bovine-derived and human milk 
enzymes was calculated by Sanders et al (1997) to be 1.23 and 0.597pM 
respectively. This reaction was dependent on the availability of oxygen in the 
absence of any other electron acceptor. The Km for oxygen utilisation in this
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system was not been calculated but it was suggested, by Sanders et al (1997) that 
NADH oxidation was linearly increased over the physiological range in the absence 








Figure 1.3. Diagrams to show the possible electron transfer through XO enzyme 
with the oxidation of xanthine or NADH with oxygen as the electron acceptor. 
A shows a generalised scheme of electron transport utilising the three redox 
centres of the enzyme Mo molybdopterin, FAD flavin centre and Fe-S the iron 
sulphur centres. B details the xanthine to urate reaction with the generation of 
superoxide anion. C shows the oxidation of NADH to NAD+ at the Flavin 
centre and the generation of superoxide radical.
More recently it has become clear that the XO enzyme isolated from a range of 
species and tissues show differences in the activities to certain substrates. The 
bovine milk enzyme is the most commonly studied and differs from certain sources
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of the human enzyme in the rate at which it catalyses purines (Parks and Granger 
1986 and DeJong et al 1990). These investigators showed that the human heart 
enzyme had reduced activity towards purines whereas the liver enzyme displayed 
similar activity to that of bovine milk.
It is clear, however, that a range of oxidation/reduction reactions can be mediated 
by this enzyme using a range of substrates, electron donors and acceptors.
1.2.4 Regulation
Xanthine oxidase is expressed in milk derived from both human and bovine 
sources. The protein is found associated with the milk-fat-globule membrane 
(Briley and Eisenthal 1975) during lactation and its expression and activity are 
regulated by a variety of mediators which is dependent on the cell type.
In the breast tissue during lactogenesis the process is characterised by a series of 
steps involving proliferation of the ductal buds and increased size and functional 
activity of the milk secreting alveolar myoepithelial cells. These phases are under 
the control of hormones and autocrine growth factors such as epidermal growth 
factor and prolactin. In the mouse the levels of XO mRNA and XO activity are 
relatively low until soon before the latter stages of pregnancy. This becomes 
elevated around the time of delivery and remains high until ~ ten days after the litter 
is removed from the mother after which it falls to pre-pregnant levels (Terao et al 
1997).
In kidney epithelial cells XO mRNA was induced by cytokine stimulation along with 
phorbol esters which suggests a role in the signalling cascade for phospholipase C. 
XO is the product of a single gene which has been located to chromosome 2 at 
band p22 where no other purine degrading or oxidase enzymes have yet been
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shown (Xu et al 1994). The human gene itself is composed of 36 exons which 
spans at least 60kb and is apparently similar to the mouse gene (Hoidal et al 1997). 
Of particular interest are the responsive elements (RE) which are found upstream 
from the start codon. They lie inside the promoter region and allow binding of 
specific transcription factors. Sequences for IL-6 and AP-1 have been identified 
along with a sequence homologous to the hypoxia inducible factor initiation site at -  
61 bases from the start codon. This leads to a transcriptional regulation sequence 
in the promoter which can turn on the gene using a range of stimuli.
So far sequence analysis has not shown response elements for gamma interferon, 
tumour necrosis factor or IL-1 which are all known to modulate enzyme activity 
(Hassoun et al 1998 and Page et al 1998). With all stimuli the modulation in 
enzyme protein is thought to be at the level of gene expression with activity being 
modulated in a post-translational manner.
1.2.5 Evolution
The xanthine oxidase sequence homology between species is high (>90%) for 
bovine and human milk but the enzyme can be found in diverse organisms such as 
Drosophila, Micrococcus bacteria and western palearctic water frogs (Smith et al 
1967, Hotz et al 1997 and Nishino et al 1997) where the sequence homology is 
reduced.
It is the similarity of XO to the enzyme aldehyde oxidase (AO) that suggests an 
ancient protein. This along with the single gene product and wide distribution in 
species expressing the protein has led to conservative estimates that the enzyme is 
older than 400 million years (Hotz et al 1997). It is also possible that the enzyme 
was primordial in that it was generated as the dehydrogenase form during the time 
before oxygen became abundant (Krenitsky 1978), the rise of AO being due to a
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duplication in the XO gene which underwent some rearrangement. The enzymes 
have similar sizes and substrate specificity but differ in their tissue expression 
(Terao et al 1997).
The generality of the enzyme may therefore have allowed its conservation over 
evolutionary time where both reducing and oxidising environments were prevalent.
It is for this reason that the xanthine oxidase enzyme may function with alternate 
substrates to generate reactive species of physiological and pathological 
importance.
1.3 Nitric oxide
Using the search criteria of “nitric oxide” the National library of Medicine Medline 
catalogue generated nearly 27000 hits (30/3/99). Voted as molecule of the year in 
1992, this gaseous molecule has become an area of heightened interest and of a 
great deal of research (Koshland 1992).
1.3.1 The historical background of NO and physiology
The initial interest in nitric oxide as a physiological mediator came in the mid-1970s 
from investigations into the role of cyclic nucleotides guanosine and adenosine 
mono phosphates (cGMP and cAMP) in smooth muscle relaxation. The levels of 
cGMP were elevated by a potent vasodilator, glyceryl tri nitrate (GTN) in arterial 
and other tissues (Diamond and Holmes 1975 and Diamond and Blisard 1976). It 
was hypothesised by Ignarro and co-workers that agents that activate soluble 
guanylate cyclase should cause smooth muscle relaxation if cGMP was involved. It 
was also noted that sodium nitroprusside which was unstable in aqueous solution 
released nitric oxide and was a potent activator of guanylate cyclase. This 
therefore suggested that nitric oxide should also be a vasodilator.
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Using nitric oxide gas and nitrosoguanidine compounds it was demonstrated that a 
marked relaxation occurred in preconstricted bovine coronary artery (Gruetter et al 
1979 and Gruetter et al 1980). Other chemical agents were also shown to give 
similar effects including the use of inorganic sodium nitrite (Gruetter et al 1981a,b). 
Furchgott and Zawadski (1980) demonstrated the requirement of the endothelium 
for relaxation responses in vascular tissues and suggested a humoral factor, a 
lipoxygenase-derived or free radical species to be the endothelium derived relaxing 
factor (EDRF). Griffith and co-workers (1984) confirmed the humoral and 
endothelium-dependent nature of EDRF, but showed evidence against a 
lipoxygenase-derived species and against EDRF as a free radical in rabbit aortic 
preparations.
Further to these and other experiments in 1986 both Furchgott and Ignarro 
independently suggested nitric oxide or a closely related species was responsible 
for the effects of EDRF (Furchgott 1988 and Ignarro et al 1988). The effects of 
EDRF and NO were compared by Palmer et al (1987) on vascular smooth muscle 
and platelet aggregations and observed that their actions were identical.
1.3.2 Nitric oxide synthase
Following the discovery of the endogenous nitrodilator substance as NO, the 
mechanism of its formation became and important aspect of research. From 
experiments on the activated macrophage it was noted that these cells could 
generate nitrite and nitrate on the addition of L-arginine (Iyengar et al 1987). 
Further to this, the nitrogen atoms in the nitrate and nitrite were shown to come 
from the terminal guanidino nitrogen atoms of l-arginine by gas chromatography 
and mass spectroscopy of labelled precursor. Then in 1989 Palmer and Moncada 
gave evidence of an enzyme-generated source of NO from L-arginine that required
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NADPH and calcium and generated L-citrulline as a by-product. The use of NG- 
monomethyl-L-arginine (L-NMMA) an analogue of L-arginine, caused a reduction in 
the stimulated release of NO from cultured endothelial cells (Palmer et al 1989) and 
caused an endothelial-dependent increase in vascular tone (Rees et al 1989). 
These data suggested that L-NMMA was an inhibitor of a nitric oxide synthase 
(NOS) and its effects on vascular tone were as a direct inhibition of NO generation.
1.3.2.1 NOS isotypes
NOS is a cytochrome P450 reductase-like haemoprotein and requires cofactors for 
the generation of NO. Flavin adenine dinucleotide (FAD), flavin mono nucleotide 
(FMN) tetrahydrobiopterin and calmodulin are all required and at least three distinct 
types that catalyse the production of NO have been described.
Type I NOS is a 168KDa protein found in the neurons which has been isolated and 
cloned (Bredt et al 1991). This enzyme is responsible for the calcium-dependent 
release of NO from neurones and non-adrenergic, non-colinergic nerves and also 
from skeletal muscle (Nakane et al 1993). The activity of type I and type III NOS 
enzymes is regulated by oestradiol which is a phenomenon observed during 
pregnancy (Weiner et al 1994).
Type II NOS has been shown to respond to bacterial endotoxin or inflammatory 
cytokines and is an inducible, calcium-independent, 130KDa protein. The rate of 
NO production is apparently raised over that of the previous two types mentioned 
and can be localised to macrophages (Lyons et al 1992). This isoform has 
associated with it a tightly bound calmodulin, which removes the requirement for 
calcium in stimulated NO formation. The induction of Type II NOS has been shown 




Type III NOS is endothelial cell-derived and is a 135KDa protein which is activated 
by the increase in intracellular calcium concentration within the physiological range 
(Sessa et al 1992). This isoform is unique in that it can be localised to the cell 
membrane as it contains a N-myristolation site (Sessa et al 1993).
1.3.2.2 NOS enzyme reactions
The evidence for NOS has steadily grown and the reaction of L-arginine to L- 
citrulline has been followed in a variety of tissues. The reaction is given by 
equation (4).
NADPH NADP+ 
l-arginine + 0 2 ^ l - c i t r u l l i n e  + NO
The substrates for NOS are L-arginine, oxygen and NADPH (Marietta 1994). L- 
arginine is synthesised as a product of the urea cycle and circulates in the blood at 
~ 100p.M (Boger et al 1997). In endothelial cells, however, the apparent 
concentration has been estimated to be in the millimolar range (Arnal et al 1995). 
The apparent binding constant, the Km for L-arginine and NOS has been calculated 
as -  5fxM (Venema et al 1996) which suggests that the availability of this substrate 
is not limiting under normal physiological conditions.
However, Meyer et al (1991) and Heinzel et al (1992) have described the 
generation of hydrogen peroxide by purified porcine neuronal NOS at low 
concentrations of L-arginine. This was followed by the measurement of superoxide 
anion from purified rat neuronal NOS in a NADPH and calcium calmodulin 
dependent manner (Pou et al 1992). This leads to the possibility of peroxynitrite 
generation under certain conditions as discussed by Xia and colleagues (1996). 
Using a kidney cell line and transfecting with a stable rat neuronal NOS with spin- 
trapping techniques, this group were able to show that a reduction in L-arginine
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resulted in the generation of superoxide anion. The simultaneous generation of NO 
and superoxide leading to the formation of peroxynitrite. It was also noted that 
under prolonged ischaemic conditions a lack of perfusion would lead to the 
depletion of L-arginine (Albina et al 1988) but the concentration of oxygen may 
control the rate of production for both products.
Recently the possible mechanism of superoxide generation by neuronal nitric oxide 
synthase has been suggested by Pou et al (1999). It was reported that superoxide 
could be measured in the presence of saturating levels of L-arginine. This leads to 
the relative competition for available electrons that can be donated to oxygen or to 
L-arginine.
The catalytic mechanism of NOS involves the flavin-mediated electron transport 
from NADPH to the terminal haem, where oxygen is bound and incorporated into 
NO and citrulline (Marietta et al 1988). The relative affinity of L-arginine (Km ~5jj,M) 
compared to oxygen may give clues as to the activity of the enzyme under 
ischaemic and reduced L-arginine conditions.
1.3.2.3 The effect of oxygen concentration on conventional NOS activity
As can be seen from reaction (4), oxygen is an integral part of the generation of NO 
from L-arginine. Experiments have been carried out into the effect of oxygen 
concentration on the rate of enzyme reaction.
In the lung of normal individuals, NO is generated and can be measured in the 
expired air. Consequently, it has been suggested that NO plays a central role in 
oxygen-induced vasodilation (Dillon et al 1996). The lung contains all three NOS 
isotypes (Gaston et al 1994) and in animal studies NO was suggested as the 
oxygen sensitive vasodilator (Nelin et al 1996). Kantrow et al (1997) gave evidence 
to suggest that hypoxia inhibited NO synthesis in the isolated rabbit lung and
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caused vasoconstriction which was reversed on the addition of oxygen to the 
perfusion system.
In human studies Dweik and colleagues (1998) measured the kinetics of purified 
NOS enzymes and from measurement of expired NO from subjects breathing a 
range of oxygen concentrations. They showed that the expired NO concentrations 
were dependent on the inspired oxygen concentration with a Km of 190^iM (~ 
17%sat). From purified NOS II the K,n02 was 135fiM (~ 10%sat) which, in the lung, 
covers the likely physiological range of oxygen concentrations. However, in tissues 
distant from the lung, the apparent oxygen concentration is reduced and this lung- 
derived NOS activity may therefore be limited.
The apparent activity of neuronal NOS was also studied in relation to oxygen 
concentration (Abu-Soud et al 1996). As discussed previously the NADPH- 
dependent reduction of bound oxygen will occur in the absence of L-arginine. The 
electrons donated from NADPH allow the NOS haem iron to bind oxygen which will 
then generate NO in the presence of L-arginine, or superoxide in its absence (Abu- 
Soud and Steur 1993). During NO generation, NOS apparently binds NO to the 
haem iron and generates an inactive ferrous-NO complex which decomposes in the 
presence of oxygen to ferric-NOS allowing the return of activity (Abou-Soud et al 
1995). In the absence of oxygen, however, the ferrous NOS is stable and activity is 
reduced. In the absence of L-arginine NOS catalysed the simple reduction of 
oxygen and gave an apparent Km02 of 40jiM which saturated at lOO i^M. In the 
presence of NO the oxygen concentration dependence showed Km02 values of 
400nM which saturated at ~ 800|iM. It was therefore suggested that the 
concentration of oxygen controlled the inactive ferrous-NOS, which in turn
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controlled the rate of NO generation by altering the affinity of the haem iron binding 
to oxygen. This may also be a method of self-regulation for NOS-I.
Rengasamy and Johns (1996) used bovine brain, cultured aortic endothelial cells 
and rat macrophages to generate Km02 values for NOS enzymes. They found a 
range of apparent values of -  25, 8 and 7pM respectively and suggested that 
pathophysiological conditions would decrease the NO production where oxygen 
concentrations were limiting.
The apparent difference between the results of Dweik et al (1996) and Rengasamy 
and Johns (1996) may reflect a tissue specific activity for NOS isoforms where 
adaptation to apparent oxygen concentration regulates the activity of the NOS 
enzymes.
1.3.3 NOS-independent NO generation
For many years the therapeutic application of nitrate drugs has given relief from 
angina pectoris by a mechanism which remains obscure. Formation of NO from 
glyceryl tri nitrate (GTN) has been demonstrated in intact bovine pulmonary and 
coronary artery and in cultured porcine aortic smooth muscle cells (Bennett et al 
1994). Both enzymic and non-enzymic methods have been proposed with an 
unidentified microsomal protein of 160-21 OKDa from bovine coronary artery 
mediating NO formation from GTN (Chung et al 1992) and the interaction with 
cysteine at high concentrations of GTN (Feelisch and Noak 1987). The location of 
nitrate reduction was investigated by Feelisch et al (1995). They showed the 
generation of NO from cultured endothelial cells using oxyhaemoglobin oxidation, 
cGMP accumulation and the inhibition of platelet aggregation; a bioassay of NO 
generation. The results suggested that human endothelial cells were capable of
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the bioactivation of organic nitrates and to some extent this was via an enzymic 
mechanism that had some requirement for thiols.
1.3.3.1 Organic nitrate reduction
The organic nitrate nitroglycerin or glyceryl tri nitrate (GTN) a polyol ester of nitric 
acid was first synthesised in 1846 by Sobrero as an explosive and reported as a 
therapeutic agent in 1879 by Murrell for the relief and prophylaxis of angina 
pectoris. This was preceded by the use of the organic nitrite, amylnitrite, in 1857 
for the treatment of angina and was the first described use of a nitrovasodilator. 
Their mechanism of action is proposed to be dependent on bioactivation once in 
the circulation, with consequent relaxation of the vessels to reduce the pressure on 
the heart during an attack of angina. Early work described the effect of nitrate 
drugs on dog and rabbit arteries (Bogaert and DeSchaepdryver 1968) and further 
evidence of a mechanism came with the description of the guanylate cyclase 
enzymes and the effects of azide and other NO donors by Kimura et al (1975).
In 1980 Ignarro and colleagues published a possible mechanism requiring the 
reduction of nitrates intracellularly by sulphydryl donors to form an S-nitrosothiol 
active intermediate that in turn directly, or by degrading to nitric oxide, activated 
guanylate cyclase. As discussed above, these and other experiments led to the 
description of the EDRF and NOS enzyme systems.
1.3.3.1.1 Glutathione S-transferase
Other methods of bioactivation have been suggested. Oberst and Snyder 
described the metabolism of GTN to inorganic nitrite by rabbit liver homogenates 
(1951). Using a pig liver enzyme Heppel and Hilmoe (1950) observed that GTN 
reacted with reduced glutathione to form oxidised glutathione and inorganic nitrite. 
This led to the suggestion by Needleman and Hunter (1965) that the major route for
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GTN transformation appeared to be denitration in the presence or reduced 
glutathione.
Using liver homogenates Pasodas del Rio (1970) gave apparent Km values for the 
reduction of GTN of 1.5x1 O'5 M but the reduction of the dinitrate and mononitrates 
occurred at much slower rates. The final end product of GTN denitration is glycerol 
but this was not measurable following incubation with readuced glutathione and 
liver homogenates (Needleman et al 1971). In terms of blood pressure 
depressants GTN was shown to be at least 10 times more potent than glyceryl di­
nitrate, 40 times more potent than inorganic nitrite and inorganic nitrate had no 
measurable effect (Needleman et al 1969).
More recently Simon et al (1996) measured an inhibition of response of cGMP 
production from nitrates by the addition of the glutathione S-transferase inhibitor 
Basilen Blue (BB) by electroporation into porcine epithelial kidney cells. Using an 
alternative inhibitor of GST, ethacrynic acid, Kenkare and Benet (1993) on rabbit 
aortic strips were able to inhibit relaxation responses to GTN treatment and also to 
inhibit the increase in cGMP generation. Nigam et al (1993) using the GST 
inhibitors Basilen Blue, bromosulphophthalein, Rose Bengal, haematin, 
chlorotriphenyltin and (octyloxy)benzoylvinylglutathione were able to show no 
inhibition of rabbit aortic strip relaxation by GTN when the strips were pre­
constricted by phenylephrine. In contrast, both Basilen Blue and 
bromosulfophthalein significantly inhibited GTN-induced relaxation of potassium- 
contracted aortic strips and Basilen Blue significantly inhibited GTN 
biotransformation in aortic strips pre-exposed to 25mM potassium. This was 
suggested to be due to a more favourable electrochemical gradient for entry of the 




Evidence for the role of NADPH-cytochrome P450 reductase (cyt P450) system in 
the biotransformation of organic nitrates has been obtained using hepatic 
microsomes (Servent et al 1989) to generate NO in the presence of NADPH and 
GTN. NADPH-dependent biotransformation of GTN in rat aortic microsomes was 
inhibited by SKF525A, carbon monoxide and oxygen (McDonald and Bennett 
1993). Furthermore, GTN-induced relaxation is enhanced under low oxygen 
conditions and in aortae from animals treated with inducers of cytochrome P450 
(Bennett et al 1992a). However, using inhibitors of cyt P450 in intact blood vessels, 
evidence has been shown to have both a positive and negative outcome. 
Treatment of blood vessels with the classical cyt P450 inhibitors SKF525A, 
metyrapone, cimetidine or carbon monoxide did not affect the GTN-induced 
relaxation or GTN biotransformation. This suggests that either cyt P450 is not 
involved in the mechanism of GTN biotransformation, or that isoforms not sensitive 
to the inhibitors used are present (Bennett et al 1992 and Liu et al 1993).
Using the cyt P450 substrate, 7-ethoxyresorufin (7-ER) and the flavoprotein 
inhibitor diphenyleneiodonium (DPI), it was reported that a substantial inhibition of 
GTN-induced relaxation occurred and these compounds also reduced cGMP 
accumulation and inhibited transformation of GTN to 1,2-GDN (Bennett eta11992b 
and Oyekan et al 1991).
DPI, however, is not specific for any one flavoprotein, it is also known to inhibit 
neutrophil NADPH oxidase (Hancock and Jones 1987) and the NADH oxidase 
activity of xanthine oxidase (Sanders et al 1997). It has additionally been reported 
to affect potassium and calcium currents in isolated pulmonary smooth muscle cells 




1.3.3.2 Nitrate and nitrite reduction in vivo
Over recent years it has become apparent that other mechanisms of NO generation 
exist under normal physiological and pathological conditions or through the 
utilisation of reducible, naturally occurring substrates. Nitrite is such a substrate 
that may be reduced to NO in the body.
Zweier et al (1995) pointed out the non-enzymic reduction of nitrite to NO in the 
ischaemic heart. It was shown that the acidotic nature of the ischaemic heart led to 
a reducing atmosphere that caused the reduction of nitrite to NO. This NO 
generation was independent of NOS and NOS inhibitors had only minimal effects 
on the NO generated. Using labelled nitrite ions they were able to demonstrate that 
nitrite can be reduced to NO in this model and was negatively correlated with 
intracellular pH and the production of NO with a threshold for NO detection at pH6. 
Human saliva contains both nitrate and nitrite. Dietary nitrates, which are derived 
from green leafy vegetables, are absorbed in the gastrointestinal tract 
(Tannenbaum et al 1976). Apparently nitrate is concentrated in the saliva up to 
25% of circulating levels and is secreted during salivation (Spiegelhalder et al 
1976). The reduction of salivary nitrate to nitrite by bacteria on the tongue has 
been described by Duncan and colleagues (1995) and this source of nitrite could 
be reduced to NO in the stomach following reduction in the acid conditions found in 
the adult (Lundberg et al 1994). Levels of nitrite in the stomach have been 
measured at 14ppm in the fasting subjects, which was increased to -  90ppm 
following the ingestion of nitrate (McKnight et al 1997). It was suggested then that 
the reduction of nitrate by commensal bacteria on the tongue generate nitrite which 
will then be reduced further to NO in the acidic environment of the stomach.
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This generation of NO was also described on the skin surface. Weller et al (1996) 
were able to increase the NO generated from skin by the topical addition of nitrite 
or by acidification of the skin. This was not inhibitable by classical NOS inhibitors 
and was suggested to follow a similar mechanism to the generation of NO in the 
stomach from nitrite utilising commensal nitrate reducing bacteria.
1.3.4 Reactions of nitric oxide
The accumulation of nitrate and nitrite in the body may be through ingestion but 
also from the reaction products of NO itself. Nitric oxide will react with a range of 
compounds, dependent on the particular environment and available reactants.
1.3.4.1 NO reaction with oxygen
The best known gas-phase reaction of NO is its conversion to nitrogen dioxide 
(N02) given in reaction (5).
2N0 + 0 2 -------- ►  2N02 w)
This reaction occurs rapidly at apparently high concentrations and forms 
characteristic brown fumes (Butler et al 1995). However in the aqueous phase, the 
reaction of NO and molecular oxygen is slow with a half-life of several hours (Wink 
et al 1993). The suggested physiological half-life of NO, -  3 to 50 seconds 
(Moncada et al 1988) in solution, rules out its oxidation by molecular oxygen 
(Kharitonov et al 1994).
N 02 reacts with water to give a mixture of nitrate and nitrite although it is suggested 
that nitrite is the major product obtained from this reaction (Wink et al 1993). The 
reaction of NO with N 02 is supposed to occur quite readily to produce N20 3, an 
anhydride of nitrous acid (Equations (6) and (7)).
N02 + N O -------- ►  N20 3
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N20 3+H 20  --------- ►  2HN02
The oxidation of N 02‘ to N 03‘ occurs readily especially in the presence of 
oxyhaemoglobin (Spagnuolo eta! 1987).
1.3.4.2 With nitrosothiols
These compounds contain NO and have received attention in discussions 
concerning EDRF and the physiological role of NO (Feelisch et al 1994). 
Nitrosothiols can occur in human plasma as the nitrosothiol of human serum 
albumin (Stamler et al 1992) but no particular function was assigned to them in this 
study. The biosynthetic generation of these nitrosothiols has also come under 
some scrutiny. It was suggested by Ignarro and Gruetter (1980) that NO reacts 
with thiol at -  pH7. However more recent evidence has suggested that the 
required species is the nitrosonium ion (NO+) but this also has its problems in that 
it is reported as a transient species in solution at pH7. Pryor et al (1982) were able 
to use N 02 as the reactant with thiol to produce nitrosothiols. However, this is also 
an unlikely biosynthetic mechanism due to the slow rate of N 02 formation from NO 
and molecular oxygen in solution (Lewis and Deen 1994).
More recently the possible interaction of peroxynitrite with excess NO may cause 
the production of the nitrosonium ion, as peroxynitrite can cause one electron 
oxidations, which may then go on to form nitrosothiols by a nitrosation reaction 
(Pryor et al 1994). Peroxynitrite itself is apparently not capable of this nitrosation 
reaction but in the presence of metal catalysts it can act as a nitrating agent 
(Beckman et al 1992).
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1.3.4.3 With iron to form iron-nitrosyls
The reaction of NO with iron is possibly the most significant in terms of biological 
activity. It is the reaction of NO with iron in guanylate cyclase that allows its 
activation (Craven and DeRubertis 1978). The related reaction is the binding of NO 
to haemoglobin to form nitrosylhaem and this has been extensively studied due to 
the electron paramagnetic spectrum that is generated (DeRubertis et al 1978). As 
the switch for guanylate cyclase activation, NO binding to haem must be reversible 
and this is apparently the case (Henry et al 1991). This is important with respect to 
the active site of many haem-containing oxidase enzymes, including NOS.
The binding of NO to biological non-haem iron has also been reported. The 
inhibition of nitrogen fixation has been observed by the binding of NO with iron- 
sulphur (Fe-S) clusters of nitrogenase enzymes using electron paramagnetic 
resonance spectroscopy (EPR) (Meyer 1981 and Henry et al 1993). The binding of 
NO to Fe-S to form the Fe-S-NO adduct contrasts with NO-haem binding in that it 
usually causes the destruction of the Fe-S cluster. This method has been 
suggested as the cytotoxic mechanism for NO action on key enzymes, especially 
the inhibition of cytoplasmic aconitase (Gardner et al 1997).
1.3.4.4 With superoxide to form peroxynitrite
In recent years it has become apparent that the reaction of NO with superoxide 
radical is possibly the most likely reaction to occur in vivo. Peroxynitrite is a strong 
oxidant and the cytotoxicity previously ascribed to NO or superoxide alone may 
actually be due to their reaction and degradation products. The reactions are 
shown below
N0 + 0 2- --------- ►  ONOO-
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The reaction occurs at a rate constant near the diffusion-controlled limit (Huie and 
Padmaja 1993). The rate constant for peroxynitrite formation has been calculated 
by a variety of methods and the most recent figure was measured by Kissner et al 
(1997) using laser flash photolysis. By subjecting peroxynitrite to a burst of laser 
energy superoxide and nitric oxide is formed. By measuring the rate of 
recombination to form peroxynitrite the rate of reaction has been calculated as 1.9 
±0.2 x 1010 M'1 s'1. This is important when assessing the reaction characteristics of 
nitric oxide and superoxide when other reactions may occur. The reaction of 
superoxide with superoxide dismutase would reduce the production of ONOO- but 
the rate constant for superoxide with SOD is given as 2x 109 M'1 s'1 (Huie and 
Padmaja 1993). The rate of reaction of NO with haem compounds varies 
depending on the nature of the haem. For example myoglobin has a rate constant 
ranging from 103 to 107 M'1 s'1 depending on the source of the myoglobin. The rate 
constant also varies with the type of haem, ie ferrous or ferric in nature, with ferrous 
compounds having rate constants -  2x 107 M'1 s'1. The relative reactions are 
therefore dependent on the concentrations of NO, superoxide, SOD and haem 
compounds in the general milieu (Pryor and Squadrito 1995).
Peroxynitrite itself, apparently exists in equilibrium with its conjugate acid 
peroxynitrous acid (ONOOH) at pH 7.2. The decomposition of ONOO- is 
complicated (Pfeiffer et al 1997), as the anion is stable in alkaline conditions but 
decays rapidly to ONOOH at physiological pH with a pKa 6.8 (Radi et al 1991 and 
Koppenol et al 1992). Three pathways of ONOOH decomposition have been 
proposed. It was suggested by Beckman et al (1990) that ONOOH decomposes to 
form hydroxyl and N 02 radicals based on the sensitivity of peroxynitrite induced 
reactions to hydroxyl radical scavengers. This was independently supported by 
EPR data suggesting evidence of free hydroxyl radicals on decomposition of
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peroxynitrite (Pou et al 1995). However Koppenol et al (1992) concluded from 
molecular dynamic calculations that homolytic cleavage of ONOOH was 
improbable. This led to the hypothesis by Pryor et al (1996) of a caged radical form 
of ONOOH - ONOOH* which decomposes to radical species that rapidly react 
again due to the viscosity of the surrounding media and the diffusion limited 
reaction. They also suggested that -  99% of the caged radicals [HO’ ‘NOJ would 
return to reform ONOOH and just ~ 1% would form nitrate, the isomer of ONOO-.
A third decomposition mechanism was suggested by Pfeiffer et al (1997) 
suggesting that the decomposition of authentic peroxynitrite prepared by two 
different methods produced nitrite and oxygen in a 2:1 stoichiometry at pH7.5. It 
was suggested that this mechanism was due to the reaction with ONOO- to form 
biologically active metabolites which may contribute to physiology and/or pathology 
of NO and superoxide.
The metabolic generation and fate of peroxynitrite remains an area of intense study 
with many complex reactions and interactions occurring. The physiological actions 
of nitric oxide and superoxide or peroxynitrite are leading to a reassessment of their 
individual and combined activities.
1.3.5 NO in physiology and pathology
The physiological role of NO has been studied since the mid-1970s due to its 
effects on guanylate cyclase and on smooth muscle relaxation. The pathological 
role of NO has been noted previously as a toxic gas and a constituent of smog 
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Figure 1.4. Summary of the possible reaction products of nitric oxide and 
superoxide with some of the breakdown products and metabolising enzymes. 
Sir Humphry Davy in 1800 showed the toxicity of NO during experiments on the 
effectiveness of inhaled gases for relief of asthma in his work on nitrous oxide. The 
paradoxical actions of nitric oxide may come down to the particular concentration 
and duration of production and also on the availability of molecular targets and 
reactions with other available substrates (Laurent et al 1996).
The concentration of NO that causes a physiological or pathological effect in vivo 
has been difficult to elucidate. The apparent Km for NO binding to guanylate 
cyclase enzyme is in the nanomolar range and the steady state concentration of 
NO of ~ 4-5pM can be reached in the immediate vicinity of a cell monolayer 
(Laurent et al 1996). The diffusion distance of NO secreted by a single cell has 
been calculated to be 150 -  300pm in 4 -  15 seconds but the concentration over 
the larger distances will be diluted (Lancaster 1994). The focal nature of cellular
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toxicity was demonstrated by Steiner et al (1997) using activated macrophages or 
islet endothelial cells to cause the lysis of syngeneic islet cells within 15 hours with 
~ 15 -  40 i^M NO over that time. It is therefore possible that the nature of NO 
actions is dependent on the relative concentrations of the NO produced, with higher 
concentrations responsible for pathological actions.
1.3.5.1 Regulatory role
The regulation of vascular tone has been dealt with previously in this chapter as it 
was the first description of NO generation in a physiological role. The generation of 
continuous amounts of NO from endothelial cells allows relaxation of the vessels 
and the control of both local and systemic blood pressure.
Penile erection is apparently regulated by the oxygen sensitivity of NOS enzyme in 
the corpus cavernosum. On stimulation the oxygen tension in the corpus 
cavernosum is increased from a near venous level to an arterial level of saturation 
(Azadzoi et al 1995). The trabecular smooth muscle of the corpus cavernosum is 
stimulated by NO and relaxation of smooth muscle occurs. Endogenous NO 
generation is regulated by the oxygen concentration -  25mmHg in the flaccid penis 
compared to the relaxation induced by the addition of endogenous nitric oxide 
which was oxygen concentration independent -  100mmHg (Kim et al 1993). 
Previously in this chapter the use of organic nitrates was discussed in terms of their 
bioactivation to NO in vivo. These drugs are used in a clinical setting for the relief 
of angina pectoris. The major effect of the organic nitrates is in the modulation of 
blood pressure to reduce the load on the heart itself. Their action tends to be 
greatest in the venous circulation followed by the coronary arteries and at high 
concentrations they have effects in the arterial system (Ghio et al 1992). Their 
combined response is to cause a reduction in venous return and an augmentation
44
Chapter 1
in coronary flow and these effects are most pronounced in the poststenotic 
collateral vessels (Abrams 1980 and Brown et al 1981). The net result of 
venodilation and coronary vasodilation is a decrease in ventricular filling pressure 
and in wall tension and an augmentation in coronary flow. The oxygen demand is 
reduced and improved oxygen delivery occurs particularly in ischaemic regions 
(Vatner et al 1972).
The organic nitrates also appear to have antithrombotic properties. Loscalzo 
(1992) was able to demonstrate the inhibition of platelet aggregation with GTN. 
GTN, or a metabolite of it, causes the activation of guanylate cyclase in the platelet 
and increases cyclic guanosine monophosphate (cGMP). This is accompanied by 
inhibition of agonist-mediated calcium flux and reduction of fibrinogen binding to the 
glycoprotein llb/llla receptor. This system was also seen to reduce platelet 
adhesion to damaged intimal linings (Lam et al 1988) and can possibly dissolve 
platelet aggregates (Stamler et al 1989).
1.3.5.2 Protective role
The antioxidant role of NO comes from its reaction with oxygen, carbon and 
nitrogen centred radicals and can be seen to have a scavenger role under a range 
of conditions (Grisham et al 1999). This is because of the unpaired electrons of NO 
which react rapidly with alkoxyl and alkyl hydroperoxyl radicals at near diffusion 
reaction rates (2x109 M'1s‘1 Padjama and Huie 1993). It is these reactions that 
have been suggested to have a modulatory role in enzyme- or metal-catalysed lipid 
peroxidation (Rubbo et al 1994).
Peroxidation of polyunsaturated lipids is thought to be an important pathological 
event involved in the development of tissue damage and dysfunction. In recent 
studies, Rubbo and colleagues (1994) demonstrated that NO inhibits lipid
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peroxidation and therefore may be important in the modulation of the inflammatory 
response by inhibiting the formation of proinflammatory lipids.
The iron or haemoprotein catalysed oxidative reactions may mediate the responses 
associated with acute and chronic inflammation. In the post-ischaemic, reperfused 
heart the role of oxidant stress has been linked with increases in leucocyte 
adhesion and transendothelial cell migration from oxidant production within the 
microcirculation (Grisham et al 1998). This is probably caused by an increased 
expression in adhesion molecules or the fixation of transiently expressed adhesion 
molecules by the peroxidation of membrane lipids which reduces membrane fluidity 
(Beaudeux et al 1997 and Kurose et al 1997). This oxidant stress may also lead to 
apoptosis induction, DNA damage, inflammatory mediator synthesis and regulate 
gene expression (Granger and Kubes 1996, Grisham et al 1998 and Wink and 
Mitchell 1998).
NO was shown by Kanner et al (1991) to inhibit iron-catalysed oxidation reactions 
by binding to ferrous complexes. It was also shown (Miles et al 1996) that NO 
inhibited the superoxide driven Fenton reaction which, in the presence of iron, 
generates hydroxyl radical (OH) in vitro. By adding varying amounts of NO to a 
Fenton reaction process the hydroxylation of benzoic acid was reduced. This 
demonstrates that depending on the fluxes of the different reactive species, NO 
may have an antioxidant capability.
1.3.5.3 Deleterious role
In an almost reverse manner to those mentioned above, the reaction of NO with 
oxidants may lead to the generation of toxic compounds that may cause cellular 
damage. NO itself has been suggested as an enzyme inhibitor. This has been 
suggested as having a direct effect by binding to enzymes or by inhibition of
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enzyme assembly processes. The pig neutrophil NADPH oxidase is one such 
system where the assembly process is inhibited by NO. Fujii and colleagues 
(1997) were able to demonstrate neutrophil NADPH oxidase inhibition which was 
not due to direct interaction of NO and enzyme nor to the reaction of peroxynitrite 
with the enzyme, but was greatly enhanced during the assembly process.
Direct reaction of NO with enzymes has been shown for cytochrome c oxidase (cyt 
c oxidase). The reaction of NO with the binuclear metal centre of cyt c oxidase 
apparently leads to the formation of nitrite at the active site (Torres et al 1998) the 
mechanism of which was described as the opposite of nitrite reduction to NO by 
non-haem nitrite reductases (Averill and Vincent 1993). The inhibition was caused 
by the binding of NO to the reduced copper centre of the enzyme rather than the 
expected reaction with Fe2+.
Nitric oxide binding to the aconitases and specifically the four iron - four sulphur 
(4Fe-4S) domain of mammalian cytoplasmic and mitochondrial enzymes has been 
suggested to be part of pathology (Gardner et al 1997). These are inorganic 
prosthetic groups whose iron atoms are co-ordinated to inorganic sulphides and 
usually liganded to protein by cysteine thiolates (Drapier 1997). By co-culturing 
L10 hepatoma cells with NO producing mouse macrophages, Drapier and Hibbs 
(1986) were able to show that there was a hierarchy in sensitivity of the 
mitochondrial Fe-S-containing enzymes. Aconitase was most sensitive to NO, 
followed by complex I and complex II, with complex III unresponsive to NO 
treatment. This gradation in sensitivity to NO was suggested as being caused by 
access to the cluster, or by the interaction of NO with the ligands that anchor the 
cluster to the protein.
The reaction of NO with iron, Fe-S and haem proteins leads to the possibility that 
there may be regulation of certain protein activities due to the binding of NO. NO
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generation itself relies on the binding of oxygen and nitrogen to the haem moiety of 
NOS enzymes. NOS activity has been linked to the binding of NO to haem iron of 
neuronal NOS in both the ferrous and ferric states under anaerobic conditions to 
generate a stable NOS haem iron-NO complex (Abu-Soud et al 1995). This 
binding caused an inhibition in NO generation from NOS and may therefore be a 
method of NO regulation. In fact, the same group (Abu-Soud et al 1996) has also 
suggested this in the case of oxygen availability as a regulator of NOS activity. In 
this case the rate of the ferrous NO complex breakdown in neuronal NOS was 
dependent on oxygen concentration. It is this complex breakdown that is vital for 
enzymic turnover with the ferrous NO complex remaining stable at low oxygen 
concentrations.
Over production of NO can lead to mutagenesis and cell death and has been 
shown to be mutagenic in a variety of systems (Burney et al 1999). These range 
from mutations in E. coli and human cell lines (Routledge et al 1993) to an In vivo 
mouse model (Gal and Wogan 1996). Using cell lines as an in vitro model of NO 
toxicity, a range of pathways have been identified from inhibition of DNA synthesis, 
mitochondrial damage, apoptosis, cell cycle distribution changes and DNA strand 
breaks (Burney et al 1997). An effect on ribonuclease reductase activity has also 
been shown, which seemed only to be temporary in nature and the activation of 
poly(adenosine 5’-di-phosphoribose) synthetase has also been attributed to both 
NO and ONOO- (Burney et al 1999).
The formation of the anhydride (N20 3) from equation (6) can lead to both direct and 
indirect DNA damage. Direct action results from nitrosation of primary amines on 
DNA bases which leads to deamination and at physiological pH, N20 3 has been 
demonstrated to be the most important species (Lewis et al 1995). Indirect actions 
are due to mutations that can arise from the deamination of bases where guanine
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deaminates to xanthine, mispairing of which can cause a G:C to A:T transition 
which will ultimately lead to single strand breaks (Lindahl and Andersson 1972).
The action of ONOO- on DNA rather than deamination is oxidative and ONOO- 
addition leads to more damage than treatment with an equivalent amount of NO. 
The spectrum of ONOO- damage is also increased over NO, which is probably 
accounted for by their relative reactivity. The addition of ONOO- to naked plasmid 
DNA can cause strand breaks using as little as 2-5jiM compared to no detectable 
strand breaks in NO treated plasmids at millimolar concentrations (Kennedy et al 
1997 and Tamir et al 1996).
(The effect of ONOO- on DNA damage will be discussed further in chapter 3 and is
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Figure 1.5. Summary of the possible physiological and pathological effects of NO 
generation. After Grisham et al 1999.
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1.4 Bacterial infections, enteritis and scours
1.4.1 Bacterial infections and their diseases
1.4.1.1 Introduction
In 1990 it was estimated that 4,123 million of the greater than 5,000 million global 
population (-78%) lived in developing countries. Of the 40 million deaths in these 
countries -  9 million were estimated to be caused by infectious and parasitic 
disease; diarrhoeal infections being the fourth most common cause of death 
worldwide. Apparently, 98% of deaths in children occur in the developing countries 
and most of those as a result of some form of infection (Murray and Lopez 1997). 
Diarrhoeal disease is a major cause of mortality and morbidity in developing 
countries (Turnidge 1998). Rotavirus infections are an important cause of the 
disease in infants, whereas bacteria are the most common pathogens in older 
children and adults (Cunliffe et al 1998).
1.4.2 Disease-causing pathogenic bacteria
1.4.2.1 E. coli
E. coli are Gram-negative, rod-shaped bacteria belonging to the family 
Enterobacteriaceae. There are currently four classes of enterovirulent E. coli that 
cause gastroenteritis in humans. These are the enterotoxigenic, enteropathogenic, 
enterohaemorrhagic and the enteroinvasive E.coli. While all cause a similar type of 
disease on infection in humans it is the enteropathogenic (EPEC) strains which are 
most prevalent. These bacteria cause their infection using mechanisms separate 
to the generation of toxins as compared to the enterotoxigenic strains.
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Infections are sporadic in nature and therefore the source of infection is often 
difficult to identify. Human, bovine and swine can be infected by this group of 
bacteria but all contain commensal strains in their gut flora that may prevent further 
infection by pathogenic organisms
The disease most often associated with this type of infection is infantile diarrhoea. 
EPEC cause either a watery or bloody diarrhoea, the former associated with the 
attachment to, and physical alteration of, the integrity of the intestine (Donnenberg 
and Kaper 1992, Donnenberg et al 1995). Bloody diarrhoea is associated with 
attachment of the bacteria and an acute tissue-destructive process, apparently 
caused by a toxin similar to that of Shigella dysenteriae, also called verotoxin. In 
most of these strains the shiga-like toxin is cell-associated rather than excreted 
(Frankel et al 1998).
The infective dose is presumed to be low in infants under 6 months old as the 
infectivity of these bacteria is high. The infectivity, however, is reduced as the host 
ages and adults are only infected with high doses following stomach acid 
neutralisation with bicarbonate (Levine et al 1978). Common causes of outbreaks 
include infected beef and chicken, although any food associated with faecal to oral 
contamination may harbour these strains. The passage of bacteria from infected 
infants can be through contaminated bed linen, toys and towels and was suggested 
to be present in dust and transmitted by aerosols (Rogers 1951). Infected but 
asymptomatic mothers and carers have been implicated in the continuation and 
spread of a particular outbreak in hospitals and nurseries from a single infected 
infant (Bower et al 1989, and Wu and Peng 1992). However, vehicles of 
contamination are often weaning foods and formulas.
In the developed countries, the frequency of EPEC infection has apparently 
dropped since the 1940s and 50s, where mortality rates of up to 50% were
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common in explosive community acquired outbreaks (Robins-Browne 1987). 
However, in developing countries EPEC is still a major cause of infant diarrhoea 
and particularly in the 0-6 month age group. Up to 40% of infant diarrhoea has 
been attributed to EPEC infections in a variety of countries (Brazil, Mexico and 
South Africa) and settings (hospitals and rural environments) (Nataro and Kaper 
1998).
It has also been noted that breast-feeding is protective against diarrhoea caused by 
EPEC (Rothbaum et al 1982 and Blake et al 1993). Both colostrum and milk 
strongly inhibit the adhesion of EPEC to an epithelial cell line HEp-2 in vitro with 
activity being found in both slgA and oligosaccharide fractions (Cravioto et al 1991 
and Camara et al 1994). Also a variety of antibiotics have been used to treat EPEC 
and have reduced the severity of infection, however, multi-antibiotic-resistant 
strains are becoming more common (Mietens 1997).
1.4.2.2 Salmonella species
Salmonella is a rod-shaped, motile bacterium -  non-motile exceptions are S. 
gallinarum and S. pullorum, nonsporeforming, stains negative in Gram stain and of 
the genus bacteriaceae. There is a widespread occurrence in animals, especially 
in poultry and swine. Environmental sources of the organism include water, soil, 
insects, factory surfaces, kitchen surfaces, animal faeces, raw meats, raw poultry, 
and raw seafoods, to name only a few (Tauxe 1998).
The acute symptoms of infection include nausea, vomiting, abdominal cramps, 
diarrhoea, fever, and headache. Chronic consequences may show arthritic 
symptoms up to 3-4 weeks after the onset of acute symptoms. The onset time from 
ingestion is 6-48 hours and the infective dose can be as low as 15-20 cells; 
depending on the age and health of the host and strain differences among the
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members of the genus. The duration of acute symptoms may be 1 to 2 days or 
may be prolonged, again depending on host factors, ingested dose, and strain 
characteristics. All age groups are susceptible, but symptoms are most severe in 
the elderly, infants and the infirm. AIDS patients suffer salmonellosis frequently 
(estimated 20-fold more than general population) and suffer from recurrent 
episodes (Mathews et al 1998).
The actual cause of these symptoms and disease are due to the penetration and 
passage of Salmonella organisms from the gut lumen into the epithelium of the 
small intestine where inflammation occurs. There is evidence that an enterotoxin 
may be produced, perhaps within the enterocyte (Hamzaoui and Pringault 1998 
and Raupach etal 1999).
It is estimated that from 2 to 4 million cases of salmonellosis occur in the United 
States (U.S.) annually. The incidence of salmonellosis is apparently rising both in 
the U.S. and in other industrialised nations. S. enteritidls isolations from humans 
have shown a dramatic rise in the past decade, particularly in the northeast United 
States (6-fold or more) and the increase in human infections is apparently 
spreading south and west, with sporadic outbreaks in other regions (Djuretic 1997).
1.4.3 Resistance to treatment
Since the isolation of antibiotics in the 1930s and ‘40s, the first line of treatment for 
bacterial infections has been through their administration for a variety of infectious 
diseases. So much so that soon after their introduction the first signs of resistance 
began to emerge (Moellering 1995). Since that time, further antibiotics have been 
developed by modifications of the original penicillin and the generation of other 
molecules but resistance has also become a problem with these forms as well 
(Harrison and Svec 1998).
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Resistance develops from an interplay of micro-organisms, infected people or 
livestock and the particular environment including antibiotic use and infection 
control procedures in which the two are found (Struelens 1998). Hospitals and 
particularly intensive care units are an important environment for the development 
and spread of resistant bacteria. The reason for this is the high doses of antibiotics 
in use in conjunction with a high concentration of people including attendant staff 
giving an enhanced potential for cross infection (Gold and Moellering 1996).
The molecular basis of resistance relies on four basic mechanisms: Antibiotic 
modification, blocking antibiotic entry or removal at a rate higher than uptake, 
alterations to the target rendering the antibiotic less efficient and by the production 
of an alternative target (Hawkey 1998). Resistance can be intrinsic or acquired. 
This may arise by spontaneous mutation of the genome in the presence or absence 
of antibiotic to leave a particular bacterium with an advantage over non-mutant 
types. DNA can also be acquired from resistant bacteria in the form of plasmids. 
These are pieces of DNA outside of the host genome that can confer resistance on 
the recipient that was once sensitive to a particular antibiotic. The overuse of 
antibiotics forces this bacterial evolution by selecting out those individuals that are 
resistant to the strategy in use.
1.4.4 Use in animals
The first use of antibiotics in the veterinary field was to treat mastitis (Foley et al 
1946). In the United Kingdom (U.K.), antibiotics have been used in the livestock 
industry as veterinary medicinal products to treat or prevent animal disease or as 
zootechnical feed additives to aid feed conversion. Diseases most often requiring 
anti-microbial drugs are respiratory and enteric diseases in pigs and cattle and 
mastitis in dairy cattle (Johnston 1998). In the U.K. in 1997, there were a total of
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1,900 drugs under licence for use in animals with a market value of £379 million. 
Anti-microbial agents, both for farm and pet animals, totalled some £80 million with 
growth promoters for foodstuffs valued at £12 million (Johnston 1998).
The prophylactic use of antibiotics had raised questions as to their efficacy, their 
concentration in the food chain and the possibility of the development of antibiotic 
resistance in the animal, in turn causing resistance in human borne diseases. The 
Swan report of 1969 was the first inquiry into these problems by the Joint 
Committee on the Use of Antibiotics in Animal Husbandry and Veterinary Medicine 
(MAFF 1998). This issue was raised again with the banning of several antibiotics, 
for use as growth promoters, by the European Community including Avoparcin in 
1997.
Avoparcin was used as a growth promoter when added to feed to increase its 
utilisation in animals. In 1995, Denmark and then Germany in 1996 banned the 
use of avoparcin. This was due to concerns that avoparcin overuse was not only 
leading to an increase in resistance against itself as an anti-microbial but also to a 
similar antibiotic vancomycin which is still used in human medicine. As vancomycin 
is used as an antibiotic of “last resort” in humans for a number of pathogenic 
bacteria the loss of its efficacy due to resistance would be an important factor 
(Woodford 1998).
1.4.5 Measures to counteract resistance
To overcome resistant strains of bacteria, a range of strategies have been 
introduced. It has been suggested (Murray 1994) that a prime aim is to reduce the 
use of antibiotics by greater education on their effectiveness, regulatory measures 




The apparent fitness of bacterial strains may also be an area for exploitation by 
using a particular treatment that may combat resistance. It has been noted that in 
the absence of antibiotic, some resistant strains of bacteria are not as fit as the wild 
type, non-resistant strains (Levy 1994). By the removal of the antibiotic, the 
resistant strains will be out-competed by the non-resistant strains until the main 
infectious agents will consist of the antibiotic-sensitive bacteria. The antibiotic can 
then be reintroduced and the drug regains its efficacy. However, the above set of 
experimental observations apparently did not take into account the effect of multiple 
generations and “forced evolution” (Lenski 1997). Cells which are transfected with 
a resistance plasmid do not compare well with the wild-type in the absence of the 
antibiotic to which it now has resistance to. Over time however, the resistant strain 
begins to evolve a strategy to overcome this short fall and over -  500 generations 
will compete with the wild-type as effectively without the antibiotic present (Spratt 
1996 and Schrag et al 1997).
The reduction in drug usage over time may still mediate an effect in a mixed 
population with reversions back to the resistant wild type but at a much slower rate 
than was previously thought. Work by Levin et al (1997) using mathematical 
models of population growth shows an increased likely hood of reversion only if the 
sensitive strains have some advantage. This may be in the form of reduced drug 
concentrations and helped by the relative proportions of sensitive and resistant 
strains in the population.
Therefore, along with the education and surveillance strategies suggested above, 
alternative treatments are required.
With the growing calls for a reduction in the use of antibiotics, other strategies need 
to be sought. Education and surveillance strategies will work in the medium to long
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term, but it is what to do in the meantime to combat infection whilst the long-term 
measures begin to show their effects.
1.5 Effectiveness of human milk
As was described above, infantile diarrhoea is a major cause of illness in the 0-6 
month age group. The prevalence of disease has been linked to the use of formula 
feeds made up with contaminated water (Hart and Cunliffe 1997).
Previously, up until the mid 20th century, human infants were routinely fed human 
milk with greater than 90% of children aged 0-6 months receiving at least partial 
breast-feeding (Grulee et al 1934). The benefits of breast-feeding were apparent at 
the time, with some estimates suggesting that mortality in non-breast-fed infants 
was greater than 50-fold higher than in those infants receiving human milk 
(Stevenson 1947). Epidemiological studies have been important in demonstrating 
that breast-feeding clearly protects infants against respiratory and gastointestinal 
infections, or at least decreases the severity of these infections (Welsh and May 
1979, Martinez etal  1981, May 1988 and Beaudry etal  1995).
The primary protective factors in breast milk are thought to be the presence of 
specific antibody and anti-adhesion factors. However, a variety of antimicrobial 
factors have been detected in human milk over the years and most of these factors 
are not destroyed by pasteurisation (62.5°C for 30 minutes) (May 1994). At 
present, provision of the bioactive components contained within human milk to the 
infant, rather than just its value as a source of essential nutrients, is apparently one 
of the strongest indications for breast-feeding the human infant.
Initial experimentation to characterise human milk components focused on the 
antibody titre, cells and non-immunoglobulin factors with potential protective effects 
such as lactoferrin and lysozyme! In viiro experiments suggested that many of
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these components had beneficial effects in mediating antimicrobial actions in the 
broad protection against infection given by human milk (Welsh and May 1979).
By the examination of epidemiological data, the protective attributes of 
immunoglobulins in milk achieve less prominence since infants were shown to 
develop infections despite “protective” levels of immunoglobulin in the milk they 
were fed (Ruiz-Palacios et al 1990). Indeed, in a study of Gambian mothers, where 
the levels of immunoglobulins were measured there was no change in secretion of 
immunoglobulins in infection and in particular during diarrhoeal infections (Prentice 
et al 1984). A non-immunoglobulin defence component lactoferrin was also 
studied. The in vitro effect of its anti-microbial actions were apparent but were not 
shown in vivo (Sanchez 1992).
Human colostrum contains large numbers of neutrophils (Pickering et al 1983), 
which are replaced by lower numbers of mononuclear phagocytes as milk 
production matures (Ho et al 1979). The ability of these cell types to mediate 
immunity by removing infectious material suggests that their presence in human 
milk is for that specific task. However, using mixed and separated populations of 
leucocyte, a range of results have been generated that conflict on one hand but 
support an alternative hypothesis for their inclusion as useful mediators. The 
leucocytes are inflammatory cells which when tested were shown to be 
hyporesponsive; have reduced adherence, aggregation and microbicidal activity 
compared to blood-derived cells (Prentice et al 1987 and Buescher and Mcllhern 
1993). It was suggested therefore that colostrum exposure suppressed the usual 
inflammatory responses of the milk-derived cells. The alternative hypothesis 
suggested milk as being anti-inflammatory, preventing maternal inflammation- 
related leucocytes from causing damage to the infant (Goldman et al 1986 and 
Buescher and Mcllhern 1993).
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Scouring calves are those that show either overeating or infective diarrhoea like 
disease. In the case of over eating scours, the effect on the fourth stomach, the 
abomasum, is such that the Lactobacillus bacteria cannot form curd from the 
ingested milk or formula feed by acidification which leads to low digestion and loss 
of non fermented feed by excretion. This can lead to further infective scours and 
dehydration as the calves can becomes weak and compromised.
Infective scours are similar to those seen in the human infant, with bacterial: E. coli 
and Salmonella species and viral: Rotavirus causing an inflammation and diarrhoea 
like disease.
As compared to the human infants, calves are removed from the mother’s milk 
soon after birth. Calves are then given a “replacer” formula feed which is a mixture 
of nutrients that are similar to human infant formula feeds and contain dried milk 
powder. The incidence of scouring due to infection arising from bacteria is 
increased in calves fed on replacer compared to those fed cow’s milk or colostrum 
(Nocek et al 19984).
In the light of our earlier findings and the fact that both human and bovine milk is 
rich in XO protein, it was hypothesised that active XO could be exploited to 
generate reactive nitrogen and oxygen species. In the presence of infective 
organisms, the formation of the strong oxidant peroxynitrite may cause a reduction 
in viability and reduce their numbers to such an extent as to reduce the severity of 
disease in both human and bovine enteritis.
1.6 Circulating Xanthine oxidase
The possibility effectiveness of XO as a generator of superoxide, nitric oxide and or 
peroxynitrite may be enhanced by the release of the enzyme from protein rich 
stores and its relocation to sites low in or devoid of enzymic activity. Pathological
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conditions which exhibit enhanced plasma XO include hepatitis, acute viral 
infection, ischaemia reperfusion and hypercholesterolaemia (Radi et al 1997). 
Other pathological conditions show radical generating systems in plasma that are 
not seen in normal controls. Rheumatoid arthritis is one such disease that shows a 
circulating plasma radical generating activity which has been associated with flares 
in the disease. In the presence of NADH rheumatoid plasma shows superoxide 
generation as measured by lucigenin enhanced chemiluminescence (Blake et al 
1997). The presence of elevated XO was also shown in patients with inflammatory 
and autoimmune rheumatic diseases (Miesel and Zuber 1993). This same study 
was also able to show that cortisone treatment of these patients caused a 
normalisation of the serum XO levels to that of the healthy controls.
A circulating enzyme can therefore have systemic effects which may out-weigh the 
localised effects in protein rich tissues.
The binding of XO to endothelial cells was described by Tan et al (1993) and was 
said to bind in a partially heparin-reversible manner. Further evidence suggested 
heparin as an inhibitor of cell damage by XO derived oxidants by a mechanism not 
related to the scavenging of oxidants (Lapenna et al 1992). Proteoglycan synthesis 
was also enhanced by low level radical generation from XO and inhibited at high 
levels of radical generation suggesting a link between proteoglycan synthesis and 
oxidant production (Panasyuk etal 1994).
Heparin is a polyanionic glycosaminoglycan and has been shown to dissociate 
proteins from cells by competition for protein binding to anionic cell surface 
proteoglycans (Kjellen and Lindahl 1992). XO itself is known to bind to heparin 
above heparan sulphate and chondroitin sulphate
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A mechanism of binding at sites distant to the site of generation is therefore 
suggested and has been investigated in this thesis by in vitro methods with cultured 
endothelial cells.
The existence of a circulating anti-trypanosome activity in the Cape buffalo has also 
been described and shown to be xanthine oxidase (Muranjan et at 1997). It is 
therefore possible that a circulating enzyme may have effects on systemic 
infections or can be directed to points of infection via the circulation.
In the light of the above discussion, xanthine oxidase enzyme from a variety of 
sources was assessed for its ability to generate nitric oxide from nitrogen 
containing compounds under conditions of hypoxia and with increasing oxygen 
concentrations. The possible oxidants derived from this enzyme may suggest a 
role in the cytotoxicity of human and bovine milk on infective micro-organisms. The 
fact that the enzyme circulates in a range of disease states suggests that a NO and 
superoxide generating and circulating enzyme may mediate pathology and 
therefore the binding of XO enzyme to endothelial cells was assessed in relation to 





The nitrate and nitrite reductase activity of xanthine oxidase
Chapter 2
Chapter 2
This chapter deals with the activity of xanthine oxidase in terms of its ability to 
generate nitric oxide from a range of substrates.
2.1 Introduction
2.1.1 Known xanthine oxidase reactions
The classically known activities of xanthine oxidase involve the oxidation of 
hypoxanthine to xanthine and the subsequent oxidation of xanthine to uric acid. 
During this process, in order for the hypoxanthine and xanthine to be oxidised, the 
enzyme itself must be reduced. Xanthine oxidase has long been associated with 
the mechanism of gaining and losing electrons in an apparent electron shuttling 
capacity. The specificity of the enzyme for substrates or electron donor substrates 
derives from its multi-centre structure. The limited substrate specificity was shown 
early on in the history of XO enzymic analysis by Dixon in 1926. In his report he 
described the need for a donor of electrons and an acceptor of electrons to be 
present for reactions to occur. He studied the specificity for electron donors 
compared to hypoxanthine using oxygen or methylene blue as the electron 
acceptor. Then in the reverse of this protocol, the specificity of the enzyme for 
electron acceptors in the presence of hypoxanthine as electron donor was shown.
It was noted that xanthine and hypoxanthine were oxidised by purified milk enzyme 
in the presence of methylene blue which followed work by Morgan et al (1922). 
Also the oxidation of aldehydes was measured and led to the discussion of a 
possible separate aldehyde oxidase enzyme from the milk preparation (although 
Dixon pointed out that the oxidation of aldehydes was possible without a specific 
catalyst). Out of 35 electron donor substances used, including caffeine, uracil and
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amino acids, only three, hypoxanthine, xanthine and aldehydes, were oxidised by 
the milk enzyme.
In the case of electron acceptors, the specificity was said to be “immaterial”. 
Oxidising substances were used in the presence of enzyme and hypoxanthine. 
Oxygen, methylene blue, iodine and picric acid were all capable or oxidising the 
enzyme. Dixon also repeated the experiments of Dixon and Thurlow (1924) and 
showed that nitrate could oxidise hypoxanthine and xanthine in the presence of XO 
and itself becoming reduced to nitrite. This followed on from the work of Bach 
(1911) where aldehydes were able to reduce nitrates in milk preparations.
The reduction of nitrates by xanthine oxidase then became almost lost as its 
importance was not noted to any great extent.
Fridovich and Handler, in a series of papers on xanthine oxidase, refer to 
experiments using nitrate as an electron acceptor in the absence of oxygen. In 
1962 they followed the reduction of nitrate by measuring the accumulation of nitrite 
under “rigorously anaerobic conditions”. They noted that nitrate reduction was not 
observed in the presence of oxygen and confirmed this by recovery studies of the 
nitrate suggesting that the lack of nitrite accumulation was not due to the aerobic 
reduction of nitrite by xanthine oxidase.
The next references to the nitrate reductase activity of XO include German and 
Russian titles on the inhibition of nitrate reductase activity (Hackenthal and 
Hackenthal 1966), nitrate and nitrite reductase activity of XO (Alikulov et al 1980) 
and the nitrate reductase activity of milk xanthine oxidase (Sergeev et al 1985). 
These studies link with the growing background of information on the similar 
structures found in xanthine oxidase and assimilatory nitrate reductase and the 
nitrogen fixing enzyme nitrogenase, the common active site being a molybdopterin 
co-factor. In fact the molybdenum cofactors had been isolated and transferred from
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XO enzyme to a non-active nitrate reductase enzyme from Neurospora crassa to 
produce an enzyme capable of the aerobic reduction of nitrate to nitrite (Hawkes 
and Bray 1984).
Experiments describing the formation of urate under hypoxic conditions also led to 
a re-evaluation of the mechanism and reactions of XO. Reinke et al (1987) were 
able to measure increased 1-methyl urate production in plasma and brain effusate 
after intra-peritoneal injection of 1-methyl xanthine to hypoxic rats. They presented 
data that suggested the presence of oxidising substrates other than oxygen and 
NAD+ which were capable of maintaining XO activity during hypoxia. Elsayed et al 
(1993) used isolated perfused rat lungs to show uric acid as a marker of oxygen 
tension. Comparing 95, 21 and 0% oxygen concentrations the urate levels 
generated were far greater in the 0% oxygen perfused lungs than in the normoxic 
and hyperoxic lungs. Serum urate levels have also been measured in chronic heart 
failure and show an inverse correlation between serum urate and functional 
capacity in patients with cardiac failure compared to controls (Leyva et al 1997).
2.1.2 Determination of nitric oxide
Various methods for the detection of nitric oxide exist. They range from the 
detection of nitric oxide gas directly (Glover 1975 and Menon et al 1989) to assays 
of the known effects of nitric oxide. These include the oxidation of oxyhaemoglobin 
to met-haemoglobin (Kelm et al 1988), relaxation responses in isolated blood 
vessels (Palmer etal 1987), anti-aggregation responses of platelets (Moncada et al 
1988) or the measurement of cGMP generation in NO treated cells (Radomski et al 
1987).
In experiments on the generation of NO in aerobic conditions the measurement of 
nitrite has been used. Nitric oxide reacts with oxygen to produce a variety of stable
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end products including nitrite and nitrate (Beckman et al 1990). The routine 
measurement of nitrite is to follow the diazotisation of sulphanilamide and N-1(- 
naphthyl)ethylenediamine dihydrochloride (NED) in the presence of nitrite, the so- 
called Griess reaction.
Many basic scientific and clinical studies have used this assay system to determine 
the effect of NOS inhibitors or the prevalence of NO in diseases such as 
hypertension (Marzinzig et al 1997). Many biological fluids can be tested including 
plasma, serum and urine and also culture medium from cells expressing nitric oxide 
generating systems (Granger et al 1999).
However, to measure nitric oxide under reduced oxygen conditions, this approach 
is not applicable due to the lack of available oxygen and therefore the generation of 
nitrite.
Spectrophotometric assays are also used for the measurement of NO reactions 
with oxyhaemoglobin. This is based on the stoichiometric conversion by NO of 
oxyhaemoglobin to methaemoglobin. With this assay the formation of NO can be 
continuously monitored by time dependent recording of the absorbance changes in 
the Soret band associated with oxyhaemoglobin oxidation at 411nm (Kelm et al 
1997).
Biological assays of NO release and action can also be used (Moncada et al 1989). 
Blood vessels or vascular beds are excised and prepared for pressure 
measurements induced by various treatments. The vessels are constricted by the 
addition of an agonist and the pressure change noted. The effect of NO on these 
constricted vessels can be seen as a decrease in pressure as the vessels relax. In 
this thesis, preliminary experiments were run to assess the effectiveness of 
preparations under reduced oxygen as classically all preparations have been run in 
media flushed with 95% oxygen. Their response to various treatments including
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XO, organic and inorganic nitrate addition and the effect of allopurinol on the 
response to various NO donors was also measured.
The use of a membrane-covered amperometric NO sensor (World Precision 
Instruments, WPI) was also investigated. The basic principle of the sensor is that 
NO diffuses through the gas permeable membrane and is then oxidised by an 
electric current in the probe. The magnitude of the current created by the NO 
oxidation can be related to the concentration of NO in the sample because the rate 
of oxidation is dependent on the rate of diffusion of the NO to the electrode surface. 
The rate of diffusion is directly dependent on the partial pressure of NO in the 
sample.
Initial experiments using this probe allowed for the measurement of NO in solution 
by forming NO from acidified nitrite in the presence of potassium iodide (Kl). This 
probe, however, had a high signal to noise ratio and slow response times 
compared to other methods and was not used further in this study. A WPI electro­
chemical NO probe has since been used to show NO generation in the presence of 
xanthine oxidase (Trujillo et al 1998).
For the determination of NOS activity, substrate depletion or product accumulation 
assays have been used. These include L-citrulline production as the by-product of 
L-arginine breakdown. Also used was the rate of reduction in NADPH absorbance 
at 340nm, which is also relative to the rate of enzyme turnover. The rate of NADH 
depletion in the presence of nitrates and nitrites was assessed for xanthine oxidase 
in the light of its previously described NADH oxidising activity (Sanders et al 1997). 
For experiments where NADH was replaced by another electron donor, an 
alternative assay was required.
To allow the determination of specific activity a real time NO assay was used. For 
many years the measurement of NO in the gas phase has been performed in
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studies on NO as a pollutant in the atmosphere from industrial output and from car 
exhausts (Fontijn et al 1970). A sensitive method of analysing the volatile gas NO 
was developed around the reaction of ozone with NO. This reaction follows the 
equations (9) and (10) below.
NO + 0 3 --------------- ► N 0 2* + 0 2
N02* --------------- ►  N02 + hv (10)
The formation of electronically excited nitrogen dioxide leads to the decay of that 
species and the emission of light. The specific emission wavelength is in the red 
and near infra red wavelengths and is detected by a photomultiplier tube (PMT) 
through a 600nm band pass filter.
For the determination of NO concentration in the gas phase a calibration gas of 
known NO content can be purged through the analyser. The signal strength is then 
used to prepare a standard curve of signal to NO concentration and unknown NO 
gas concentrations can be calculated. The sensitivity of the instrument in use for 
these experiments was reported to be below 1ppb (10'9) for NO in the gas phase. 
The generation of superoxide and hydrogen peroxide from XO is well known from 
both purine substrates and NADH. The effect of oxygen on the NO generating 
capacity of this enzyme is important from the fact that previous studies show a 
need for strict anaerobic reaction for the reduction of nitrates to nitrite (Fridovich 
and Handler 1962 and Sergeev et al 1985). The possibility exists that this enzyme 
may generate both reactive oxygen and nitrogen intermediates the reaction of 
which may lead to the formation of peroxynitrite.
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2.2 Methods and materials
2.2.1 Nitrate reductase assay
The activity of nitrate reductase was assessed by following the rate of reduction in 
absorbance at 340nm of NADPH in a spectrophotometer. The reaction followed 
the basic principle outlined in equation (11) below.
B-NADPH + Nitrate------- — — ►  p-NADP + Nitrite + H ,0 ..Z (11)
Using a final volume of 1ml the reagents were added in the following order (shown 
as final concentrations, all chemicals used were purchased from SIGMA, UK unless 
otherwise stated). Buffer - 50mM PBS at pH 7.2, FAD 5pM, p-NADPH 200jiM, 
potassium nitrate 10mM and NR (NAD[P]H: Nitrate oxidoreductase; EC 1.6.6.2 
from Aspergillus sp, SIGMA, UK) or XO (Xanthine oxidoreductase, EC 1.1.3.22 
from bovine buttermilk, Biozyme, UK) enzyme. Two sets of blanks were used, 
Blank A was made up without the addition of enzyme which was replaced by an 
equal volume of buffer and Blank B was made up with enzyme but without 
potassium nitrate which was replaced by buffer. All solutions were freshly 
dissolved in PBS and remained on ice until required. The reaction was carried out 
in air-saturated buffer at 25°C and followed in a spectrophotometer (Kontron) with a 
1cm light path in 1ml plastic cuvettes at 340nm.
The initial rate of reaction was measured as the linear slope of the absorbance 





Nitrite was assayed by a modification of Griess assay (Bredt and Snyder 1994). 
The principle behind the assay relies on a diazotization reaction in the presence on 
nitrite to give a purple magenta colour, the absorbance of which is proportional to 
the nitrite concentration (See equation (12) below).
Solutions of unknown nitrite content were reacted with an equal volume of a 1 % 
solution of sulphanilamide made up in the respective buffer and acidified with 1M 
HCI at pH1. This mixture was allowed to stand at room temperature protected from 
light for 10 minutes. To this mixture was added an equal volume of 0.1% N-1(- 
naphthyl)ethylenediamine dihydrochloride (NED) and the mixture allowed to stand 
at room temperature protected from light for a further 10 minutes. Following 
incubation, the absorbance at 550nm was measured in a spectrophotometer with a 
1cm light path or in a 96-well plate-reading spectrophotometer.
For each nitrite determination a standard curve of known nitrite concentrations was 
generated using a serial dilution of a 1 mM sodium nitrite stock solution made fresh 
daily in diluent media. The absorbance of unknown nitrite solutions was related to
n o 2- h 2o
h 2n o 2s ► h 2n o 2s
Sulphanilamid






the absorbance of the standard nitrite curve using a linear regression equation and 
a graphical data fitting program (Prism™, GraphPad Software, USA).
The Greiss assay was used in both 1 ml and 1 50jliI assay formats. The sensitivity 
for both assays was -  1jaM nitrite.
2.2.3 The measurement of oxygen saturation
As the concentration of oxygen is important in the response of cells to their 
environment, a suitable method of measuring oxygen saturation was required. For 
all of the experiments recorded in this thesis, requiring oxygen saturation 
measurements, a Clark type oxygen micro-electrode was used. This type of probe 
has a small diameter cathode and as a result its consumption of oxygen is low. 
The resulting oxygen tension gradient is located beneath a membrane which 
reduces the effect of stirring on the readings. The electrode consists of two 
platinum wires embedded in glass which form the cathode with the anode being 
formed by a silver band wrapped around the glass. During use, a voltage is applied 
across the anode and cathode. This causes the oxygen in the media adjacent to 
the cathode to be reduced which results in electron flow. It is this flow of electrons 
that produces a current which is read on the oxygen meter. Diffusion of oxygen 
occurs into the membrane of the electrode to replenish that lost by reduction. The 
amount and rate of diffusion is low for this type of electrode and therefore the 
replenishment of oxygen on the outside of the membrane takes place at normal 




2.2.3.1 Calibrating the oxygen electrode
The electrode must be calibrated to yield reproducible results. Using media 
saturated with gases of known oxygen concentration compared to a zero oxygen 
saturated media, the relative oxygen saturation of a particular unknown media can 
be determined.
After long storage the electrode was allowed to equilibrate in media for 2 hours 
prior to calibration. Calibration was carried out using media at the same 
temperature as that of experimental conditions, typically 37°C. Fist, the zero 
setting was calibrated using a solution of sodium borate (10mM) to which was 
added a pinch of sodium sulphite. This drives off the oxygen for 5 to 10 minutes, 
dependent on stirring velocity, allowing the zero oxygen saturation to be set.
The electrode was then washed in PBS and the 100% oxygen saturation was 
measured using media gassed with pure oxygen for -  20 minutes (All gases were 
purchased from BOC). Once the readings had stabilised a final calibration check 
was made by mixing media vigorously to cause air saturation. This should read 
-21% oxygen saturation. If the readings were far from those expected, the zero 
and 100% calibration points were repeated until the air-saturated media was -  21% 
saturation. This occurred on numerous occasions however once calibrated the 
readings were free from drift for up to 12 hours. Gasses for calibration and in all 
experiments were prewarmed by passing through heated water at 37°C.
In all experiments the level of zero calibration by the chemical method described 
above was similar to (± 0.1%O2sat) the oxygen saturation measured after gassing 
with 5% C 02 balanced nitrogen (n = 6). This was the detection limit although this 
type of nitrogen gas apparently carries some oxygen.
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2.2.4. Experimental reaction vials
2.2.4.1 Glove box experiments.
Experiments including cellular incubation and 96-well plate determinations were 
carried out in a sealable glove box. This chamber allowed for the delivery of a 
range of gas mixtures and the manipulation of a large number of reactions at one 
oxygen concentration. The glove box could also be environmentally controlled 
including temperature and humidity adjustments.
The efficiency of gassing media inside the glove box was assessed in a range of 
plastic plates at a range of media surface areas and volumes. Figure 2.1 shows 
the effect of gassing on the oxygen saturation of air-saturated media exposed to 
5% C 02 balanced nitrogen in the glove box.
2 0 i 6-well 1 ml
12-well 1ml 
24-well 1ml
n k 48-well 0 .2ml
** 96-well 0.2ml




Figure 2.1. The effect of gassing on the oxygen saturation of PBS in a range of 
plastic vessels. The glove box was gassed - 5% C 02 balanced nitrogen was 
allowed to flow through the cabinet displacing atmospheric air - for 10 minutes 
prior to the introduction of 5 different tissue culture plates with air-saturated 
PBS at a range of volumes. The oxygen saturation of each well was 
measured using an oxygen microelectrode (Strathkelvin Instruments,
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Glasgow) calibrated as previously described within the glove box every ten 
minutes. Once the oxygen saturation had stabilised the cabinet was purged 
with 5% C 02 balanced nitrogen for a further ten minutes-*. This protocol was 
repeated and the results of readings taken in triplicate are expressed as 
means ± SD (n = 1).
The oxygen saturation of each type of plastic vessel is shown to fall over time. The 
rate of fall is dependent on the amount of oxygen in the glove box, the air-saturated 
media and the surface area to volume ratio (SAVR) of the respective vessels. The 
SAVR of 1ml PBS in a 6 well dish is such that the levels of oxygen saturation fall 
more quickly than in the 96-well plates. As 96-well plates were to be used in 
experiments the volume was kept at 200pl but the glove box was purged 
continually for 1 hour prior to starting experiments.
2.2.4.2 The use of sealable 7ml plastic bijou bottles
Further experiments required the use of a reaction vial to allow oxygen variations, 
temperature control, mixing and ease of access. For single reaction experiments, 
plastic disposable bijou bottles were used. The oxygen saturation of media within 
these vessels was measured whilst the media was gassed. Figure 2.2 shows a 
representative graph of the effect of 5% C 02 balanced nitrogen gassing on the 
oxygen saturation of 1ml of PBS at 37°C. The rate of degassing meant that 
experiments requiring zero oxygen saturation were gassed with 5% C 02 balanced 
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Figure 2.2. The effect of gassing with 5% C 02 balanced nitrogen on the oxygen 
saturation of 1ml PBS at 37°C in a 7ml bijou bottle. Measurements were 
made with a microelectrode as described above and a representative trace is 
shown.
2.2.5 Xanthine oxidase-mediated generation of nitrite from nitrate 
Experiments to determine the nitrate reductase activity of xanthine oxidase were 
carried out using a 96-well plate format with a final volume of 200^1. All buffers 
were subjected to gas purging in a glove box at 37°C for 1 hour to remove oxygen. 
Experiments were set up in situ without the introduction of atmospheric air, all 
manipulations being carried out within the glove box. Reactants were mixed by 
pipetting before the introduction of enzyme that had been gassed separately 
outside of the glove box. Experiments were terminated by the addition of 1% 
sulphanilamide inside the glove box which was then assessed for the formation of 
nitrite by following the nitrite assay protocol detailed in 2.2.2.
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2.2.6 The measurement of nitric oxide generation
2.2.6.1 The relaxation response of perfused mesentery
This assay involves the perfusion, via the superior mesenteric artery (SMA), of an 
excised rat mesenteric vascular bed with Krebs-Henseleit solution (KHS) gassed 
with known gas mixtures. By perfusing at a constant flow of 5ml min'1 and 
monitoring the perfusion pressure changes it is possible to record alterations in 
vascular resistance. In order to examine the relaxation response, the tissue must 
be first constricted using phenylephrine at a final concentration of 10nM in the 
perfusion buffer. The protocol was carried out as follows:
Rats, female Wistar (~ 250g) from the University of Bath animal house were 
euthanised by a single injection of Sodium pentobarbitone BP (Euthatal, Rhone 
Merieux, France) at 200mg kg-1 into the peritoneal cavity followed by cervical 
dislocation. The rat was then dissected by opening along the abdominal midline. 
The SMA was located by its relationship to the position of the left renal vein, which 
becomes visible after moving the intestine to the right of the animal. The 
connective tissue was removed to the right of the renal vein to expose the 
descending abdominal aorta. The colic artery was identified at the base of the 
colon and tied off using suture thread. A thread was tied loosely around the SMA 
close to its origin and an incision made into the descending abdominal aorta 
opposite to the origin of the SMA. The SMA was then cannulated via the incision 
using a portex cannula of ~ 2cm with a Luer fitting which attached to the perfusion 
system. When the cannula was in place it was secured by tying a double knot with 
suture thread.
Once the mesentery was cannulated, the intestine was removed from the fine 
branches of the SMA. This was achieved by cutting small blood vessels away from
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the colon end of the intestine. The intestine was then gently pulled to remove it 
from the mesentery all the way to the stomach. The mesentery was then cut free of 
the stomach and aorta and immediately placed into the perfusion system shown in 
figure 2.3.
f  Pump








Figure 2.3. The apparatus set up for the determination of relaxation responses of 
constricted rat mesentery. Inj = injection port, PT = pressure transducer.
Blood was initially removed from the mesentery by perfusion of KHS at 37°C and 
the preparation left to stabilise for 20 minutes. The mesenteric arteries were then 
constricted by the addition of phenylephrine to the perfusion media and the change 
in perfusion pressure was recorded on the chart recorder. This was then left for 20 
minutes to stabilise.
Following the experiments each mesentery was fixed in formal saline and prepared 
for histological section by dehydration in ethanol and xylene and embedded in wax.
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Sections, 5pm, were cut using a sledge microtome and the tissue attached to 
polished glass slides before being baked at 50°C. These sections were then stored 
at room temperature until processed (see appendix I)
2.2.6.2 The chemiiuminescence reaction of NO with ozone
NO release from various enzyme reactions was monitored in the gas phase using 
an ozone-enhanced chemiluminescence (OEC) analyser. The apparatus was set 
up as described in figure 2.4. A carrier gas of known oxygen content was purged 
through the apparatus to gas the reaction cell and to carry the generated NO to the 
analyser. This gas was first bubbled through water containing activated charcoal in 
a water bath at 37°C. The OEC analyser (NOA 280, Sievers, USA) required a 
continual flow rate of gas equal to 200ml min'1. The flow rate of the carrier gas 
equalled the required uptake rate of the analyser in this sealed system. The 
reaction cell consisted of a 7ml sterile plastic bijou bottle (Sterilin, UK) which was 
capped and housed a stirring bar. The cap of the reaction vessel had three holes 
cut into it to allow the carrier gas in, the gas out to the analyser and a third hole for 
the injection of substrate and enzyme. This third port was also used for the 
determination of oxygen saturation using the oxygen micro electrode.
The reaction cell was housed within a water bath with circulating water at 38°C. 
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Figure 2.4. The apparatus set up for the detection of NO from various reaction
NO was measured continually by the reaction with ozone described above and the 
results recorded using proprietary software on a personal computer.
The NO analyser was calibrated using gas of 90ppm NO and the internal 
calibration software of the analyser.
2.2.7 The measurement of peroxynitrite generation
To assess the generation of ONOO- in various systems and the effectiveness of 
ONOO- scavengers, two assays were employed.
2.2.7.1 Oxidation of Dihydrorhodamine to rhodamine
From the work of Kooy et al (1994) and Crow et al (1995) it was evident that 
authentic ONOO- could cause the oxidation of dihydrorhodamine (DHR -  Molecular 




molar extinction coefficient (74500 M'1 cm'1). This enabled this process to be 
followed spectrophotometrically. In experiments on the generation of ONOO- by 
XO the following assay procedure was used.
Reaction solutions were made up fresh from frozen DHR solutions to give final 
concentrations of 50fxM DHR, 0.1 mM Diethylenetriaminepentaacetic acid (DTPA) in 
1 ml of 50mM PBS. This was then placed into a spectrophotometer at 37°C and the 
absorbance at 500nm was measured over time with a 1cm light path.
This assay was also modified for use in a 96 well plate format. All final 
concentrations remained the same only the volume was reduced to 200|jJ. The 
absorbance was read through a 492nm GG filter over time at 37°C.
2.2.7.2 The peroxynitrite-mediated luminol and lucigenein 
chemiluminescence
Following the work of Radi et al (1993), the use of luminol (5-amino-2,3-dihydro- 
1,4-phthalazinedione) chemiluminescence with peroxynitrite made for an assay of 
the ONOO- scavenging effect of various compounds. It was suggested that the 
reaction of ONOO- with luminol lead to the excitation of aminophthalate as the 
emitting species. As the formation of aminophthalate is dependent on 
decomposition of the luminol endoperoxide it is thought that the reaction of ONOO- 
with luminol must generate this unstable intermediate which then follows the light 
emitting pathway.
The following protocol was used:
Luminol was dissolved in 1M NaOH and diluted in PBS before the pH was adjusted 
to 7.3 and then used at a final concentration of 500|nM, was injected in to the wells 
of a black walled 96-well plate. Chemically generated peroxynitrite (See appendix 
I), at a range of concentrations, was then injected in to the same wells of a 96-well
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plate. The resultant chemiluminescence reaction was followed using a plate 
reading chemiluminescence analyser measuring light emission above 405nm.
The addition of possible scavenging compounds was carried out before the 
injection of the ONOO- at a range of concentrations in PBS buffer at pH 7.2. The 
light emission data were relayed to a computer and the maximal light emitted in 
arbitrary light units (ALU) was taken as the fastest reaction rate.
The effect of peroxynitrite on the chemiluminescence derived from lucigenin (bis-N- 
methylacridinium nitrate) was also assessed in the same manner using 500pM 
lucigenin.
2.3 Results
2.3.1 The nitrate and nitrite reductase activity of xanthine oxidase
2.3.1.1 Comparison to Nitrate reductase enzyme
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Figure 2.5. The oxidation of NADPH by xanthine oxidase and nitrate reductase in 
the presence and absence of 10mM potassium nitrate under aerobic
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conditions. Experiments were carried out in duplicate cuvettes and the mean 
± SEM of three independent experiments is shown.
Both enzymes showed significant reduction of NADPH in the absence of nitrate 
compared to the auto oxidation of NADPH in the control cuvettes. The addition of 
nitrate to the reaction was also shown to increase the rate of NADPH reduction. 
XO enzyme showed a smaller increase in reduction rate compared to NR on the 
addition of nitrate but similar reduction rates were seen in the absence of added 
nitrate. Following the reduction of NADPH, the levels of generated nitrite were 









Figure 2.6. The nitrite generated by the aerobic reduction of inorganic nitrate by 
XO and NR in the presence of NADPH as measured by the Greiss assay. The 
conditions were as described for figure 2.5. The reactions in the cuvettes 
were allowed to run for 1 hour to remove excess NADPH and an aliquot was 
taken from each cuvette and run against a standard curve of known nitrite 
concentrations.
The apparent nitrite generation by NR in the presence of nitrate is shown to be ~ 
70pM. In the case of XO there was no detectable nitrite above the control values 
by this assay method.
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2.3.1.2 The generation of nitrite under reduced oxygen conditions
Following the information given by Fridovich and Handler (1962) and Segeev et al 
(1985) the reaction of XO with nitrate was carried out under reduced oxygen 
conditions in the presence of xanthine. Experiments were set up in the glove box 
under 5% C 02 balanced nitrogen so that the assay was run in reverse by initiating 
the reaction by the addition of enzyme to the longest time point. The termination of 
each reaction therefore occurred at the same time and nitrite concentration was 
then assayed. Figure 2.7 shows the effect of time and nitrate concentration on the 







Figure 2.7. The time-resolved generation of nitrite from XO, 53.2jig in the presence 
of xanthine, 100|nM at a range of KN03 concentrations in a reduced oxygen 
atmosphere. The experiments were carried out inside a temperature- 
regulated (37°C) glove box which was gassed with 5% C 02 balanced nitrogen. 
All reagents were allowed to equilibrate inside the glove box for one hour 
before the initiation of reaction by the addition of XO enzyme. Assay 
conditions were as follows: Using 50mM PBS pH 7.2 throughout, 100pM 
xanthine, 1, 5 and TOmM KN03 and 53.2pg XO in a humidified atmosphere
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under 5% C 02 balanced nitrogen. A blank without enzyme or without xanthine 
was also run and gave no measurable nitrite. Graph shows the mean ± SEM 
(n = 3) in triplicate.
From the graph, the generation of nitrite increases over the fist 30 minutes followed 
by a reduction in the amount of nitrite assayed. The peak height for each 
concentration of nitrate was after 30 minutes incubation ~ 5, 15 and 25|liM nitrite 1, 
5 and 10mM nitrate respectively by this assay method.
2.3.1.3 The effect of pH on nitrite generation
The optimal pH for the reduction of nitrate to nitrite by this system was assessed. 
Figure 2.8 shows the effect of buffer pH on the generation of nitrite from inorganic 
nitrate
Figure 2.8. The effect of pH on the generation of nitrite from nitrate in the presence 
of XO and xanthine. Buffer solutions of potassium phosphate buffered saline 
were generated to give a range of pH values. Using 1mM nitrate, lOO^M 
xanthine and 53.2^ig enzyme the reaction was carried out under the conditions 
previously described for 30 minutes after which the levels of generated nitrite 












The effect of lowering the pH was to enhance the generation of nitrite in this 
system. The pH optimum for this reaction lies between pH 5.5 and 4.5 which is in 
good accord with Segeev et al (1985) who gave a pH optima of 5.2 and similar to 
Fridovich and Handler (1962) who gave a pH value of 4.6.
2.3.1.4 The effect of known XO inhibitors on the nitrate reductase activity of 
XO
The effect of known specific XO inhibitors, oxypurinol and BOF-4272 was assayed 
against a positive control reaction. In Figure 2.9 the effect of both inhibitors is to 
reduce the measurable nitrite formed compared to uninhibited controls. The 
inhibitory dose that caused 50% inhibition of the control (IC50) is for BOF-4272, 
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Figure 2.9. The effect of the xanthine oxidase inhibitors oxypurinol and BOF-4272 
on the generation of nitrite from nitrate by XO in the presence of xanthine. 
Experiments were carried out as described in figure 2.3 with the following 
additions. Oxypurinol or BOF-4272 at a range of concentrations (100^iM- 
0.03fiM) were added to the reaction mixture. The reaction was initiated by the 
addition of XO and followed for 30 minutes after which the levels of nitrite
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generated were assayed. The graph shows the percentage nitrite of each 
treatment compared to a positive control reaction. Results are ± SEM (n = 3) 
carried out in triplicate.
Diphenyliodonium (DPI) has been used as an inhibitor of NADPH oxidase activity in 
neutrophils and to inhibit the NADH activity of xanthine oxidase. Its effect on the 
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Figure 2.10. The effect of DPI on the nitrate reductase activity of bovine xanthine 
oxidase. Experiments were as described in figure 2.9. Results are the mean 
± SEM of 5 individual experiments carried out in triplicate.
The effect of DPI in this system was not to inhibit but to enhance the measurable 
nitrite. This was not due to the DPI itself containing nitrite as a control of DPI at all 
concentrations with enzyme in the absence of xanthine showed no measurable 
nitrite formed under the same conditions.
This experiment was repeated under 5% C 02 balanced air conditions with DPI and 
the results shown as total nitrite generated under the conditions described in figure 
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Figure 2.11. The effect of DPI on the nitrate reductase activity of xanthine oxidase 
under 5% C 02 balanced air. Experimental protocol as for Figure 2.9. Results 
are shown as ± SEM (n = 3) in triplicate.
The effect of the DPI is to enhance the XO nitrate reductase activity to generate 
measurable nitrite under saturated air conditions.
2.3.1.5 The use of organic nitrate substrates
The medicinal use of organic nitrates makes them of particular interest in the study 
of the nitrate reductase activity of XO. Using commercially available medicinal 
preparations of both glyceryl trinitrate (GTN) and isosorbide dinitrate (ISDN) (David 
Bull Laboratories, UK), their effectiveness as substrates for reduction to nitrite by 
XO was assessed using the protocols previously described for inorganic nitrate. 
Figure 2.12 shows the initial experiments on the reduction of organic and inorganic 
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Figure 2.12. The generation of nitrite from the organic nitrates, glyceryl tri nitrate 
(GTN) and isosorbide dinitrate (ISDN). Experiments were carried out as 
previously described in figure 2.5 using 1mM nitrate for 30 minutes under 
reduced oxygen conditions. Results are expressed as mean ± SEM (n = 3) in 
triplicate.
The generation of nitrite from both organic and inorganic nitrates was observed 
above control values. Both GTN and ISDN at equimolar concentrations gave 
significantly more nitrite formation under the conditions described than inorganic 
nitrate (p<0.01 by students t-test comparing ISDN and GTN to inorganic nitrate and 
p<0.05 comparing GTN to ISDN).
2.3.1.6 The effect of XO inhibitors on the reduction of organic nitrates to 
nitrite by XO
The effect of oxypurinol and DPI on the nitrate reductase activity of XO using 
organic nitrate substrates GTN and ISDN was assessed as described in figure 2.9. 
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Figure 2.13. The effect of the xanthine oxidase inhibitor oxypurinol on the reduction 
of organic nitrates GTN and ISDN to nitrite by XO in the presence of xanthine 
and under limited oxygen conditions. Experiments were carried out as 
detailed in figure 2.9. Results are shown as the mean ± SEM (n = 3) carried 
out in triplicate.
Oxypurinol is shown to reduce the measurable nitrite generated from GTN and 
ISDN. The IC50 values for GTN and ISDN are 19.95^M and 4.64^iM respectively.
In the light of the results shown previously for DPI and inorganic nitrate, the effect 
of DPI was assessed with organic nitrates as substrates. As can be seen from 
figure 2.14, DPI has an inhibitory effect on the reduction of organic nitrate to nitrite 
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Figure 2.14. The effect of DPI on the nitrate reductase activity of XO using the 
organic nitrates GTN and ISDN. Experimental protocol and results expressed 
as detailed in figure 2.5, ± SEM (n = 3) in triplicate.
2.3.1.7 The reduction of nitrite
The proposed mechanism of action of the organic nitrates is via the generation of 
NO and then the subsequent relaxation of smooth muscle (see introduction 2.1). It 
was decided to examine the further reduction of nitrite in this system following the 
results shown in figure 2.3 where nitrite concentration began to decline after 30 
minutes of incubation with XO and xanthine. Figure 2.15 shows an attempt to 
characterise the loss of nitrite as a measure of nitrite reductase activity. It was 
shown that an initial rapid reduction in measurable nitrite occurred compared to the 
control and the known starting concentration. This initial rapid reduction is followed 
by a slower reduction up to 30 minutes, after which there is very little change in the 
overall nitrite concentration. The maximal reduction is -  6(j.M compared to the 
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Figure 2.15. The reduction of inorganic nitrite in the presence of XO and xanthine. 
Experimental protocol was as described for figure 2.5 with the introduction of 
25 i^M sodium nitrite (NaN02) in place of KN03. A control of nitrite with 
enzyme in the absence of xanthine was also used. Results are mean ± SEM 
(n = 3) in triplicate.
2.3.2. The measurement of nitric oxide
2.3.2.1 Nitric oxide generation from organic and inorganic nitrates
As discussed in the introduction to this chapter, a variety of techniques can be used 
to detect NO generation.
2.3.2.1.1 Mesenteric relaxation
The effect of various nitrates and nitrite on the relaxation response of contracted rat 
mesenteric vessels was measured by monitoring pressure changes in the perfused 
mesentery. The effect of low oxygen concentration on relaxation was also 
measured using this system.
Figure 2.16 shows the relaxation response mediated by GTN, nitrate or nitrite at a 
range of concentrations in the presence of 95% 0 2 saturated (normoxic) or 5% C 02
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balanced nitrogen saturated (hypoxic) perfusion media. Relaxation is shown as a 
positive change in perfusion pressure as opposed to contractions which are shown 



























Figure 2.16. The relaxation of constricted rat mesenteric vessels. Rat mesentery 
was constricted with a continual perfusion of Krebs-Heinslet solution 
containing 10p.M phenylephrine perfused at 5ml min'1. GTN, nitrate or nitrite 
was injected into the perfusion media and the pressure change recorded on a 
chart recorder in mmHg. Data are from mean ± SD from 1 experiment in 
duplicate from two animals.
GTN, nitrate and nitrite caused a dose-dependent reduction in the perfusion 
pressure of the constricted rat mesentery. GTN caused relaxations that were of 
greater magnitude than nitrite or nitrate using lower concentrations. Nitrite gave a 
greater magnitude of relaxation than nitrate of similar concentrations. The
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relaxation response of GTN and nitrate was greater in the 95% 0 2 saturated 
perfusion media compared to the 5% C 02 saturated media: 32.09 ± 5.95 compared 
to 18.73 ± 3.74mmHg for GTN and 8.02 ± 2.6 compared to 5.34 ± 1.65mmHg for 
nitrate at 10 and 100nmoles, 95% 0 2 to 5% C 02 balanced nitrogen respectively. 
The relaxation response to nitrite however was not affected by the oxygen 
saturation of the perfusion media with relaxations of 16.04 + 1.5 compared to 16.04 
± 2.5mmHg at 100nmoles nitrite in 95% 0 2 and 5% C 02.
The effect of allopurinol on the GTN mediated relaxation of phenylephrine 
contracted 5% C 02 balanced N2 saturated perfused rat mesentery was 
investigated. The change in perfusion pressure on the addition of various 
concentrations of GTN was measured and compared to the response to the same 
stimuli in the presence of 100pM allopurinol in the perfusion media. Figure 2.17 








Figure 2.17. The relaxation response to GTN of perfused mesentery in the 
presence and absence of 100pM allopurinol. Data are mean ± SD from 1 
experiment in duplicate from two animals.
92
Chapter 2
Allopurinol at this concentration had no effect on the GTN mediated relaxation of 
the rat mesentery.
The fixed tissue was sectioned and stained with haematoxylin and eosin and also 
stained for xanthine oxidase using a polyclonal antibody raised against bovine 
xanthine oxidase in rabbits (Chemicon, USA). Figure 2.18 shows the H+E staining 
(A) and the antibody staining (B) for one representative rat mesentery.
>nm B
Figure 2.18. The staining of rat mesentery for Xanthine oxidase. Slides were 
prepared and stained as described in appendix I.
Vessels were observed in a lattice of adipocytes following the removal of lipids in 
xylene. On staining for XO, it was difficult to interpret positive staining compared to 
background due to the lack of surrounding cell types. Some possible staining was 
seen in the smooth muscle layers surrounding the vessels and seemed to be 
absent from the endothelium. However the results were inconclusive with this 
antibody.
2.3.2.1.2 Ozone chemiluminescence
The following experiments utilised the ozone enhanced chemiluminescence (OEC) 
reaction with nitric oxide to measure NO generation from a variety of substrates 




The previous experiments on the reduction of nitrates to nitrite and the reduction of 
nitrite were all carried out in the presence of xanthine. In the following experiments 
NADH was used in place of xanthine as the electron donor. Figure 2.19 shows a 
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Figure 2.19. The generation of NO from GTN mediated by XO in the presence of 
NADH. Substrates were gassed with 5% C02 balanced nitrogen for 2 minutes 
prior to their introduction into a reaction vial. NADH and GTN were incubated 
together prior to the addition of enzyme. The NO generated was followed 
continually by the chemiluminescence analyser until a plateau was reached. 
The rate of NO generation was then read as the NO generation in ppb per 
second.
The graph shows a real time detection of NO from the apparatus setup outlined in 
figure 2.4. In chemiluminescence reactions the fastest rate of production is given 
by the peak height of OEC. In the figure above the data prior to the plateau are 
pre-steady state kinetics where the rate of reaction is continually increasing, i.e. 
acceleration. At the plateau, the rate of NO production is constant and at its
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greatest and is said to be in steady state. The rate of NO production in the figure 
shown is approximately 45ppb sec'1. Note the time taken from the injection of 
enzyme ~ 100 seconds to reaching steady state NO generation ~ 770 seconds.
2.3.2.2 The effect of XO inhibitors
The generation of NO from GTN and NADH in the presence of XO and under 5% 
C 02 balanced nitrogen was assessed in relation to the inhibitors oxypurinol, BOF- 
4272 and DPI. The maximal rate of NO generation in a reaction without inhibitor 
was used as the 100% positive control. The same reaction mixture was then run in 
the presence of a range of inhibitor concentrations. The maximal rate of NO 
generation in the presence of inhibitor was then related to the uninhibited maximal 
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Figure 2.20. The effect of XO inhibitors on the generation of NO from GTN. Using 
3mM GTN, 300pM NADH and 212.8pg of XO under 5% C 02 balanced 
nitrogen. Results shown are mean ± SEM (n = 3) in duplicate.
All three inhibitors reduce the generation of NO below that of the non-inhibited 




In the same manner as described for figure 2.19, the NO generating capacity of XO 
in the presence of GTN and methylene blue was assessed. Methylene blue 
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Figure 2.21. Effect of methylene blue incubation on the NO generating capacity of 
XO in the presence of GTN and NADH. The experiments were carried out as 
described previously and the graph shows mean values ± SEM (n = 3) in 
duplicate.
2.3.3 Kinetic determinations
In order to determine the specific activity, the maximal rate and a possible 
Michaelis constant (Km) for these reactions, the kinetic parameters were measured. 
This took the form of the oxidation of NADH in the presence of XO and a range of 
substrates in the absence of oxygen and the measurement of NO generation in the 
presence of a range of electron donors and electron acceptors.
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2.3.3.1 Measurement of NADH oxidation by XO
XO is known to oxidise NADH to NAD+ in aerobic systems with the concomitant 
generation of superoxide radical (Sanders et al 1997). The rate of NADH oxidation 
in the absence of any other electron acceptor is dependent on the concentration of 
dissolved oxygen in the reaction mixture. The rate of NADH oxidation was 
therefore monitored at a range of oxygen concentrations.
Figure 2.22 shows the effect of oxygen concentration on the rate of NADH 
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Figure 2.22. The rate of NADH oxidation compared to oxygen concentration. 
Solutions of NADH and buffer were gassed for 5 minutes with fractional 
mixtures of 100% oxygen and 5% C 02 balanced nitrogen to generate a range 
of oxygen concentrations. XO was also gassed with the same gas mixture 
and then added to a 1 ml cuvette that was sealed with an airtight cap where the 
oxidation of NADH was followed in a spectrophotometer at 340nm. The initial 
rate of each oxidation in the presence of 300|uM NADH was calculated and the 
results plotted against oxygen concentration in moles per litre as taken from
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oxygen saturation tables (Carpenter 1966 and Green and Carritt 1967). (Data 
are shown as ± SEM (n=3) in duplicate).
The rate of NADH oxidation is proportional to the concentration of oxygen. This is 
then saturated at higher oxygen concentrations and follows the law of mass action. 
The kinetic parameters were calculated by plotting the concentration [S] divided by 
the initial rate v against the initial concentration of substrate, in this case oxygen, to 
generate a Hanes-Woolf plot. From the graph shown in figure 2.23, the maximal 
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Figure 2.23. The Hanes plot of data from figure 2.22. The slope gives the 
reciprocal of vmax and the x-axis intercept is equal to -Km. Experimental 
conditions were as described in figure 2.22.
The kinetic values derived from Figure 2.23 give the vmax = 0.0214 pmoles min'1 mg‘ 
1 and Km of 73pM for oxygen.
This assay system was then used to measure the rates of NADH oxidation in the 
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Figure 2.24. The rate of NADH oxidation in the absence of oxygen and in the 
presence of alternative electron acceptors. The oxidation of 300nM NADH 
was followed as described in figure 2.21 using buffer gassed with 5% C 02 
balanced nitrogen in capped 1ml cuvettes with XO. (Data show mean ± SEM 
(n = 3) in duplicate).
All electron acceptors used followed similar kinetic parameters with saturation 
occurring first in GTN, nitrate and then nitrite. The Hanes-Woolf plot of these data 










Figure 2.25. The Hanes-Woolf plot of NADH oxidation in the presence of initrate, 
GTN or initrite.
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Table 2.1. The kinetic parameters for the oxidation of NADH by a variety of 
electron acceptors in the presence of XO at 300pM NADH.
To validate this assay, the effect of oxypurinol was assessed. Oxypurinol has no 
effect on the oxidation of NADH in the presence of oxygen (Sanders et al 1997 and 
Zhang et al 1998) but will inhibit substrates which derive their electrons by binding 
at the molybdenum site. Figure 2.26 shows the effect of oxypurinol at a range of 












Figure 2.26. The effect of oxypurinol on the oxidation of NADH by XO. In the 
absence of oxygen using 300mM NADH and 8mM nitrite. Data are ± SEM (n 
= 2) in duplicate.
Oxypurinol is seen to inhibit the oxidation of NADH in the presence of nitrite with an 
IC50 value of 28.4pM.
2.3.3.2 Kinetic determinations using NO measurements
The use of NO determination allows for the measurement of the end product of 
reactions and allows the utilisation of alternative electron donors and acceptors all 
within the same assay protocol.
2.3.3.2.1 Using NADH as the electron donor
Using NADH and nitrite the enzyme concentration dependence of NO generation 
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Figure 2.27. The Xanthine oxidase concentration-dependent generation of nitric 
oxide from nitrite and NADH. N 02‘ at 1mM and NADH at 300pM under 5% 
C 02 balanced nitrogen. Data are mean ± SEM (n = 3) in duplicate.




The initial rate of reaction was measured for the NO generation from inorganic 
nitrate at a range of concentrations against a fixed concentration of NADH 
(300pM). The resultant data were plotted as the rate of reaction (v) against 
substrate (S) concentration -  v/S, curve and then subjected to a linear transform in 
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Figure 2.28. The NO generation from inorganic nitrate.
The generation of NO from inorganic nitrate varies hyperbolically with substrate 
concentration which is indicative of Michaelis-Menten kinetics. Linear 
transformation of the data in figure 2.28A gave a straight line with intercept on the 
x-axis Km 0.321 mM with a slope vmax 98.89nmoles min'1 mg'1 2.28B. This was 
repeated for organic nitrate in the form of glyceryl-tri-nitrate (GTN) and the results 










Figure 2.29. The v against S curve for GTN in the presence of 300pM NADH.
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In the presence of GTN the generation of NO followed Michaeli-Menten kinetics 
(2.29A) and the linear transform (2.29B) gave intercept at Km 0.194mM and slope 
Vmax 156.65nmoles min'1 mg'1.
For the generation of NO from nitrite in the presence of NADH, both nitrite and 
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Figure 2.30. The v against S plots for NO generation from nitrite against NADH 
concentration (2.30A) and NADH against varying nitrite (2.30B).
For both treatments the reaction followed Michaelis-Menten kinetics. The data 
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This treatment of data generates variables that can then be subjected to secondary 
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Figure 2.32. The secondary plots for nitrite A and NADH B.
The x intercept gives the Km for nitrite as K^ wie 12.29mM and the Km for NADH at 
Knadh 0.488mM. The maximum rate of reaction is given by the slope and is equal 
to Vmax 240.98nmo!es min*1 mg*1 and 257nmoles min*1 mg*1 respectively.
Table 2.2 summarises the kinetic analysis for nitrate and nitrite substrates in the 





IN 03' (300jiM NADH) 0.321 98.89
GTN (300|liM NADH) 0.194 156.65
IN02'(NADH range) 12.29 241
NADH (Nitrite range) 0.488 257
Table 2.2. The Kinetic parameters derived from XO mediated NO generation from 
the ozone chemiluminescence assay.
The Hanes-Woolf plots show non-parallel lines with progressively smaller intercepts 
on the x-axis as the concentration of fixed second substrate is increased and
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suggests that the reaction mechanism follows a ternary complex formation of 
enzyme and substrate.
The effect of the xanthine oxidase inhibitor oxypurinol was measured in the 
presence of nitrite and NADH. The effect of oxypurinol was to inhibit the 
measurement of NO from this reaction mixture in a dose-dependent manner. 
Figure 2.33 shows the effect of oxypurinol on NO generation from nitrite and 
NADH.
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Figure 2.33. The effect of oxypurinol on NO generation from nitrite and NADH. A  
nitrite 20mM and NADH 300pM. B nitrite range and NADH at 300pM.
At a range of nitrite concentrations and three fixed oxypurinol concentrations the 
measurement of NO generation was followed. From the data generated the 
apparent Km (KaPP) for each set of results in the presence or absence of inhibitor 
was calculated. The secondary plot of KaPP values against oxypurinol 
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Figure 2.34. The KaPP (A) and Kj (B) determinations by linear transformation and 
secondary plot of data in figure 2.34.
The calculated K* for oxypurinol in the presence of nitrite and NADH for XO was Kj 
0.155|iM. The increase in slope of the plot shown in figure 2.34A is suggestive of 
competitive inhibition for oxypurinol and nitrite.
2.3.3.2.2 Using alternative electron donors
From the original observation that XO could reduce nitrate to nitrite in the presence 
of xanthine, this reaction was followed measuring the NO generation from nitrite in 
the presence of a range of xanthine concentrations.
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Figure 2.35. The NO generation from nitrite in the presence of XO and xanthine at 
varying xanthine (A) and nitrite (B) concentrations.
Varying xanthine concentration at fixed nitrite concentrations shows a point at 
which NO generation is reduced at high xanthine concentration > 50]uM compared 
to low < 50|iM xanthine. This is suggestive of substrate inhibition at high
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concentrations of xanthine. The variation of nitrite against xanthine gives 
somewhat sigmoid shaped curves, which are indicative of non Michaelis-Menten 
kinetics. This is shown further in figure 2.36 with the upward turn of the Hanes- 
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Figure 2.36. The Hanes-Woolf plots of data derived for NO generation mediated by 
XO ip the presence of xanthine and nitrite.
Due to the non-Michaelis-Menten kinetics shown only working estimates of the rate 
constants are given for reference to relative reaction rates. From the v against S 
plots the apparent vmax and Michaelis constants, KaPP for xanthine and nitrite are vapp 
75 and 110nmoles min'1 mg'1 and KaPP xanthine ~ 50pM and KaPP nitrite ~ 7mM.
The use of the purine 1-methylxanthine was also assessed in the same manner as 






























Figure 2.37. The v against S plots for NO generation from nitrite and 
methylxanthine in the presence of XO at 0%saturation oxygen.
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In the presence of nitrite and 1-methylxanthine, xanthine oxidase was able to 
generate nitric oxide to give rectangular hyperbolas when varying methylxanthine 
concentration. On varying nitrite concentration, sigmoid like curves were generated 
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Figure 2.38. The Hanes-Woolf plot of the data generated for methylxanthine and 
nitrite.
Following analysis by Hanes-Woolf plots, deviations were seen from Michaelis- 
Menten kinetics whilst varying nitrite concentration similar to those seen for 
xanthine and varying nitrite concentrations.
From the v against S plot the KaPP nitrite is given as ~ 25mM and the vapp as 
8.77nmoles min'1 mg'1. The KaPP methylxanthine is given as -  20jiM.
The ability of hypoxanthine to act as a substrate in XO mediated NO generation 















Figure 2.39. The v against S curves for nitrite and hypoxanthine.
At concentrations of hypoxanthine below lOOpM, NO generation increases with 
increasing hypoxanthine and nitrite concentrations. Above 100pM hypoxanthine at 
low nitrite concentration the NO signal is reduced. However at the highest nitrite 
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Figure 2.40. The Hanes-Woolf plots varying hypoxanthine A and nitrite B.
Similar Hanes-Woolf plots were generated for hypoxanthine / nitrite as those seen 
for the other purine substrates used previously suggesting substrate inhibition as 
shown by upward curves when varying nitrite against fixed purine substrate 
concentrations. The apparent rate constants from the v against S plots were vapp 
370 and 400nmoles min*1 mg'1 with KaPP nitrite ~ 20mM and KaPP hypoxanthine -  
25|iM.
2.3.3.3 The relative NO generation from varying electron donors
The generation of NO from nitrite by xanthine oxidase in the presence of a range of 
electron donors was measured to assess the effects on NO generation following 
the peak height measurements. Using equimolar amounts of enzyme and 
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Figure 2.41. The NO generation from nitrite mediated by XO in the presence of a 
range of electron donors. XO 52.3^ig, nitrite 10mM, hypoxanthine, NADH, 
xanthine and methylxanthine 100fiM. Figure shows a representative trace for 
each electron donor.
Methylxanthine. Both xanthine and methylxanthine showed a fast initial response 
which was relatively short lived before the NO signal dropped but remained above 
the base line for up to an hour. Hypoxanthine showed an initial sharp rise in NO 
generation which became reduced over time but at a rate slower than xanthine and 
methylxanthine. NADH showed a relatively slow rise in pre steady state NO 
generation before reaching a plateau which was kept constant for greater than an 
hour. The NO generating capacity was eventually reduced back to base line levels 
after -  2 hours with the peak height reducing steadily.
2.3.3.4 Effect of DPI on xanthine-mediated NO generation from nitrite
Due to the effect of DPI on the enhanced generation of nitrite from nitrate such that 
aerobic nitrite generation was observed (2.3.1.6) the effect on NO generation from 
nitrite in the presence of xanthine and diphenyliodonium was measured. Xanthine
The peak height data followed the order Hypoxanthine > NADH > Xanthine >
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oxidase enzyme was mixed with xanthine, nitrite and DPI at a range of 
concentrations under a reduced oxygen atmosphere as previously described. 
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Figure 2.42. The NO generation from nitrite in the presence of XO, 53.2jig, 
xanthine, 50jiM, nitrite, 1mM and DPI at a range of concentrations under low 
oxygen conditions. Results are mean ± SEM of two experiments in duplicate. 
The effect of DPI was to increase the measurable NO from XO, xanthine and nitrite 
in a dose dependent manner with a significant increase in NO generation above the 
control without DPI added at concentrations above 1 pM in this assay under these 
conditions.
To assess the possible aerobic generation of NO from this system the experiment 
was repeated at 21% oxygen saturation of the reaction mixture in figure 2.42 with 
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Figure 2.43. The NO generation from nitrite in the presence of XO, 53.2^g,
xanthine, 50pM, nitrite, 1mM and DPI lOOpM in air-saturated or nitrogen
saturated buffer. Data are mean ± SEM (n = 3) in duplicate.
There is a significant increase (p<0.05) in the measurable NO in aerobic conditions 
in the presence of lOO i^M DPI compared to a control in the absence of DPI. The 
NO signal in air with 100pM DPI compared to the NO generated in 0% oxygen 
saturated media in the presence of DPI is significantly reduced (p<0.01) with an 
apparent 10 fold reduction (1000 ppb sec'1 in 0% oxygen compared to -  100 ppb 
sec'1 in air).
2.3.4 Effect of oxygen on NO generation from nitrite
Oxygen has effects on the measurement of NO by the ozone chemiluminescence 
system using XO as the catalyst. To determine the effect of oxygen on the
measurement of NO, a range of experiments utilising various oxygen
concentrations was carried out.
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2.3.4.1 In the presence of NADH
NO was generated from a standard assay protocol for the reduction of nitrite by XO 
to NO in the presence of NADH and the absence of oxygen. The reaction rate was 
followed and the peak height measured. This protocol was repeated in the 
presence of known oxygen saturations and the results plotted as rate of NO 
generation against oxygen saturation. Figure 2.44 shows the effect of oxygen 
saturation on the rate of NO generation as measured in the ozone 












Figure 2.44. The effect of oxygen concentration on the measurement of NO from 
nitrite. All substrates were gassed using a mixture of 5% C 02 balanced 
nitrogen and 100% oxygen. The rate of reaction was measured using the 
ozone chemiluminescence detection assay. Data are mean ± SEM from 2 
experiments in duplicate.
The measurement of NO by this assay is dependent on the oxygen saturation of 
the media. The reaction rate is inversely proportional to the oxygen concentration. 
The half-maximal NO generation rate for this concentration of nitrite, NADH and XO
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occurs at 1.8% oxygen saturation and the base line readings, where no more NO 
generation can be detected occurs at -  5% oxygen by saturation.
This experiment was repeated in the presence of 10mM nitrite and the results are 
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Figure 2.45. The effect of oxygen concentration on the measurement of NO from 
nitrite. All substrates were gassed using a mixture of 5% C 02 balanced 
nitrogen and 100% oxygen. The rate of reaction was measured using the 
ozone chemiluminescence detection assay. Data are mean ± SEM from 2 
experiments in duplicate.
The measurement of NO by this assay is dependent on the oxygen saturation of 
the reaction, this being inversely proportional to the measured rates. The half- 
maximal NO generation rate for this concentration of nitrite, NADH and XO occurs 
at 12.3% oxygen saturation and the base line readings, where no more NO 
generation can be detected occurs at -  21% oxygen by saturation.
At 10mM nitrite NO generation is detectable at higher oxygen saturations than 
compared to 1mM nitrite 12.3% compared to 1.8% oxygen saturation to give half 
maximal rates, with the curve being right-shifted.
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2.3.4.2 In the presence of hypoxanthine
The effect of oxygen concentration on the generation of NO in the presence of 
hypoxanthine was also measured. Figure 2.46 shows the effect of oxygen on the 




0 31 2 4
[0 2] (%sat)
Figure 2.46. The effect of oxygen on the NO signal generated from XO, 53.2ng, 
nitrite 5mM and hypoxanthine lOO^M. Data are mean values ± SEM of two 
experiments in duplicate.
The measurement of NO by this assay is dependent on the oxygen saturation of 
the reaction, this being inversely proportional to the measured rates. The half- 
maximal NO generation rate for this concentration of nitrite, NADH and XO occurs 
at 1% oxygen saturation and the baseline readings occur at ~ 3% oxygen by 
saturation.
2.3.4.3 In the presence of superoxide dismutase.
The generation of NO from XO and nitrite with hypoxanthine was measured at a 
range of oxygen concentrations with and without the addition of bovine superoxide 
dismutase from bovine erythrocytes (Bohringer, Germany). Figure 2.47 shows the 
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Figure 2.47. The NO generation from XO, nitrite and hypoxanthine in the presence 
and absence of 250U SOD. The peak heights of reaction rates were taken 
and compared to the oxygen concentration. Mean and ± SEM of 2 
experiments in duplicate. * show significant deviation from the control p<0.01. 
The chemiluminescence signal generated by the XO/nitrite/hypoxanthine system is 
reduced as the oxygen concentration increases with a half-maximal response of 
1.19%. The signal generated from the same system in the presence of SOD is 
increased over the control level with a half-maximal response at 1.73%. The 
addition of SOD gives a statistically significant increase in the measurable signal 
from the NO generating system as the oxygen increases.
2.3.4.4 In the presence of Diphenyliodonium (DPI)
The effect of DPI was to enhance NO generation from nitrite in the presence of XO 
and hypoxanthine at low oxygen concentration. Under atmospheric oxygen 
concentrations, the generation of NO was followed using ozone 
chemiluminescence in the presence of increasing concentrations of DPI. Figure 














Figure 2.48. The effect of DPI on the NO signal generated from XO (53.2^g), 
hypoxanthine (100|iM) and nitrite (1mM). Also in the presence of bovine SOD 
(250U). Results are mean ± SEM (n = 2) in triplicate.
The effect of DPI was to allow measurement of the NO signal from hypoxanthine 
and nitrite under atmospheric air oxygen concentrations. SOD also enhanced the 
NO signal at lower levels of DPI; half maximal DPI concentration ~15nM in the 
presence of SOD compared to 30^M in its absence, but there was no further 
enhancement of NO signal at 100^iM DPI with this concentration of SOD.
2.3.5 The measurement of peroxynitrite generation
2.3.5.1 Oxidation of dihydrorhodamine
SIN-1 at a range of concentrations was added to DHR and DTPA in PBS and the 
absorbance change at 500nm followed in a spectrophotometer. Figure 2.49 shows 
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Figure 2.49. The absorbance of DHR following the addition of SIN-1. The blank 
consisted of DHR, DTPA and PBS at 37°C.
The dose-dependent increase in absorbance over time in the presence of SIN-1 
follows sigmoidal kinetics in the highest concentration range. There is an initial lag 
phase in DHR oxidation to rhodamine followed by an increasing rate of change in 
absorbance until a plateau is reached. The fastest rate of change in absorbance
was measured and the rate of generation of ONOO- calculated using the extinction
coefficient of 75000 M'1 cm'1 for the oxidation of DHR by peroxynitrite and a 
















Figure 2.50. The dose-dependent generation of ONOO- from SIN-1 in solution. 
Preliminary experiments in the presence of XO, nitrate and NADH in air-saturated 
buffer showed increasing absorbance of rhodamine at 500nm in both the control 
and experimental cuvettes. Figure 2.51 shows absorbance over time of DHR in the 


















Figure 2.51. The absorbance at 500nm of rhodamine followed over time in the 
presence or absence of nitrate A or NADH B.
The rate of rhodamine formation in the presence of nitrate was 0.000691AbSsoonm 
min'1 compared to 0.000395 AbSsoonm min'1 in the absence of 1mM nitrate. The 
experiment was then repeated in the absence or presence of NADH. Figure 2.51 B 
shows the rhodamine formation at 500nm in the presence of XO, DTPA, DHR and 
with or without 300jiM NADH. Without NADH there is little change in absorbance 
over time (0.000029 Abs50onm min'1). However in the presence of NADH the rate 
increases to 0.000333 AbSsoonm min'1.
To determine the susceptibility of the rhodamine to oxidation by compounds other 
than ONOO-, the effect of the oxidant nitrite was measured, as this can be used in 
the generation of NO by XO.
In the presence of DTPA and DHR, a range of nitrite concentrations was added to 
the system and the absorbance at 500nm was followed over time. Figure 2.52
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Figure 2.52. The effect of nitrite on the rate of oxidation or DHR to rhodamine. The 
maximal rate of change in absorbance was measured for each concentration 
of nitrite and the results plotted against nitrite concentration. Data are mean ± 
SEM (n = 3) in triplicate.
The effect of the nitrite was to increase the oxidation of DHR to rhodamine in a 
dose-dependent manner which began to plateau at ~ 30mM nitrite.
This experiment was then repeated by adding back NADH at a constant 30mM 
nitrite concentration in the presence of DTPA, DHR and PBS and again following 
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Figure 2.53. The effect of NADH on the nitrite mediated oxidation of DHR to
rhodamine. Data are mean ± SEM (n = 3) in triplicate.
NADH addition to the DHR and nitrite mixture causes a dose-dependent decrease 
in absorbance and therefore oxidation of the DHR to rhodamine, which is sufficient 
to stop the detection of rhodamine oxidation in the presence of nitrite.
2.3.5.2 Oxidation of luminol and lucigenin
The report by Radi et al (1993) on the use of luminol to measure ONOO-
generation was used as the basis of the following experiments.
SIN-1 was used to determine the possible use of luminol chemiluminescence as a 
probe for ONOO- generation. Figure 2.54 shows the luminol-enhanced 
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Figure 2.54. The luminol-enhanced chemiluminescence produced by SIN-1 
degradation in PBS at 37°C. SIN-1 was injected at a range of concentrations 
into the wells of a 96-well plate followed by luminol at a final concentration of 
500|iM and the light generated over time was measured using a 405nmGG 
filter in series with a photomultiplier tube. Data are mean ± SEM from 3 
experiments in triplicate.
The signal generated by the luminol / SIN-1 reaction leads to a peak height 
measurement which is proportional to the concentration of SIN-1 in solution until ~ 
500^M. The signal begins to saturate above this concentration of SIN-1.
Using authentic peroxynitrite, the chemiluminescence signal generated by its 
reaction with luminol was followed in the same manner as described for SIN-1. The 
results in figure 2.54 A show the chemiluminescence of a single well followed over 
time. The peak height measurements were taken for a range of ONOO- 
concentrations and shown in figure 2.54 B.
The chemiluminescence reaction of luminol with ONOO- is fast as seen in 2.55 A. 
The peak height measurements show a proportional concentration-dependent 











Figure 2.55. The luminol chemiluminescence of authentic peroxynitrite. Luminol 
(500|nM) and a range of ONOO- concentrations were reacted together and the 
chemiluminescence generated was measured in a chemiluminometer. Data 
were generated using one well of a 96-well plate as the reaction time to 
produce peak height measurements was short (figure 2.55 A). Peak height 
measurements were used to construct figure 2.55 B for a range of ONOO- 
concentrations. Data for A are from one representative well measured over 
time and data for B are the means ± SEM of 3 individual experiments carried 
out in triplicate.
The signal generated by ONOO- and luminol is very large in comparison to the 
signal from SIN-1 and also to the signal generated by XO NADH (see below).
To determine the effect of possible ONOO- scavengers, this assay was used with 
the inclusion of a range of concentrations of the flavanoid quercetin following the 
work of Haenen et al (1997) to allow further elucidation of the radical species 
generated.
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Figure 2.56. The effect of quercetin on the ONOO- mediated luminol-enhanced 
chemiluminescence (LuEC). Quercetin at a range of concentrations made up 
in PBS was added to the wells of a 96-well plate. ONOO- was injected into 
each well to give a final concentration of 1 mM and immediately followed by the 
injection of luminol. The chemiluminescence generated was measured over 
time and the peak height plotted against quercetin concentration. Data are 
mean ± SEM of two experiments in triplicate.
Quercetin is shown to reduce the ONOO- mediated LuEC in this assay over the 
concentration range shown. The half-maximal inhibition occurs at ~ 2.5|nM 
quercetin for ONOO- at 100pM.
As the chemically generated ONOO- requires H20 2 for its synthesis and following 
Mn02 treatment to remove H20 2 it is still possible that the chemiluminescence 
generated comes from species other than ONOO-. Therefore the effect of ONOO- 
on the oxidation of lucigenin was also measured as a possible alternative. 
Peroxynitrite was again injected into wells of a 96-well plate and reacted with 
500pM lucigenin and the chemiluminescence followed over time in a 
chemiluminometer as previously described. Figure 2.57 Shows the
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chemiluminescence signal from ONOO- mediated LEC and the concentration 














Figure 2.57. The chemiluminescence from ONOO- and lucigenin reactions. Data 
are mean ± SEM from 2 individual experiments performed in triplicate.
The signal generated from ONOO- and lucigenin compared to luminol-enhanced 
chemiluminescence is reduced ~ 750 ALU sec'1 for 1mM ONOO- compared to ~ 
15000 ALU sec'1 for 880fiM ONOO- with an equimolar concentration of luminol and 
lucigenin. The reaction follows similar kinetics for both enhancers requiring the 
experiments to be carried out on single well readings over time rather than in 
batches.
The response to quercetin was also monitored for ONOO- and lucigenin. Figure 
2.58 shows the results of this experiment.
Quercetin is again shown to reduce the ONOO- mediated chemiluminescence with 










Figure 2.58. The effect of Quercetin on the ONOO- enhanced LEC. The 
experiment was carried out as described for figure 2.57. Data are mean ± 
SEM (n = 2) in triplicate.
2.3.5.3 The effect of xanthine oxidase derived radical species
To assess the effect of XO derived superoxide and NO from nitrate and nitrite, LEC 
was used as a method for the detection of radical generation. Following the 
method of Crow et al (1995), which utilised the iron-chelator DTPA to stop Fenton 
type reactions of iron and superoxide which generate H20 2, the effect of DTPA was 
assessed in a superoxide generating system using XO and NADH mediated LEC. 
Figure 2.59 shows the effect of various concentrations of DTPA on the XO NADH 
mediated LEC. DTPA is shown to dose-dependently reduce the 
chemiluminescence signal from XO NADH derived species above ~ 100pM. Half- 
maximal reduction of peak height occurs at ~ 700pM. DTPA was therefore 
included in the following experiments at a concentration of 100pM.
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Figure 2.59. The XO, NADH-mediated LEC in the presence of DTPA. XO 10jig, 
NADH 500fiM lucigenin 500fiM and DTPA at a range of concentrations were 
mixed (NADH and lucigenin by injection) in the wells of a 96-well plate. The 
resultant chemiluminescence from the reaction of XO with NADH and 
superoxide with lucigenin was measured over time as previously described. 
Figure 2.59 A shows the data mean ± SD from one representative experiment 
in triplicate while figure 2.59 B shows the mean peak height ± SEM of 3 
experiments in triplicate.
The effect of inorganic nitrate incubation on the XO, NADH mediated LEC was 
assessed by the addition of various amounts of nitrate to the chemiluminescence 
reaction mixture. Figure 2.60 shows the effect of nitrate on the XO NADH mediated 
LEC.
Nitrate is shown to have little or no effect on the XO NADH LEC under the assay 
conditions described with 100mM nitrate ~ 1.4 ALU sec'1 compared to 1.35 ALU 
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Figure 2.60. The effect of nitrate on the XO NADH LEC.
The effect of nitrite incubation on the XO, NADH-mediated LEC was assessed by 
the addition of various amounts of nitrite to the chemiluminescence reaction 
mixture. Figure 2.61 shows the effect of nitrite on the XO NADH-mediated LEC. 
Nitrite shows a dose-dependent increase in XO NADH LEC up to -  10mM nitrite 
after which increasing the nitrite concentration has little effect on the peak height 
signal. The control wells show no chemiluminescence in the absence of NADH.
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Figure 2.61. The effect of nitrite on the XO NADH-mediated LEC. Nitrite at a range 
of concentration was added to the wells of a 96-well plate. Which also
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contained 10pg of XO. NADH and lucigenin were injected into the wells and 
the chemiluminescence followed over time. The control wells contained XO, 
nitrite, DTPA and PBS without the addition of NADH. Data mean ± SEM (n = 
3) of three individual experiments.
To determine the contribution to the LEC of XO derived metabolites oxypurinol was 
added as the known inhibitor of the molybdenum active site. The XO, NADH- 
mediated LEC in the presence and absence of nitrite was measured in the 
presence and absence of oxypurinol at a range of concentrations. Figure 2.62 
shows the effect of oxypurinol on the XO NADH LEC with and without nitrite. 
Oxypurinol reduces the XO NADH mediated LEC only in the presence of nitrite. 
The half-maximal reduction in LEC is > 100pM oxypurinol in this protocol. 
Oxypurinol has a small effect on XO NADH LEC at 100pM in the absence of nitrite 
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Figure 2.62. The effect of oxypurinol on the XO NADH-mediated LEC in the 
presence and absence of nitrite. XO 0.1 mg, NADH 500pM, nitrite 10mM 
lucigenin 500pM and DTPA 100pM. Data are mean ± SEM (n = 3) in triplicate.
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The effect of quercetin on the superoxide detection by this system was studied 
along with its effect on the enhanced chemiluminescence signal shown for nitrite 









Figure 2.63. The effect of Quercetin at a range of concentration on the XO 10pg, 
NADH 500pM, lucigenin 500pM and with or without nitrite 1mM LEC. Data are 
± SEM (n = 3) in triplicate.
Quercetin reduces the LEC for the signal with the addition of nitrite from ~ 1.8 ALU 
sec"1 to 1.25 ALU sec"1 a reduction of ~ 30% of the total LEC. It shows some effect 
on the LEC in the absence of nitrite at 100pM, a reduction of -  24%. However, at 
100pM, quercetin has reduced all of the nitrite-enhanced LEC signal back to the 
non-nitrite-enhanced chemiluminescence.
2.4 Discussion
The oxidation of NADPH by nitrate reductase and XO is seen in the absence of 
nitrate and is enhanced on the addition of nitrate only in the case of nitrate 
reductase in the presence of atmospheric air. It was also only possible to measure
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the generation of nitrite from nitrate by the nitrate reductase in the presence of 
NADPH and atmospheric air.
The nitrate reductase activity of XO in the presence of nitrate, xanthine and 
atmospheric air was not detectable in terms of nitrite generation. Nitrite was 
detectable however when the oxygen was removed by incubation of the reaction 
under a reduced oxygen atmosphere. This confirms the results of Sergeev et al 
(1985) and Fridovich and Handler (1962) where anaerobicity was required for the 
generation of nitrite by XO from nitrate.
When this nitrite generation was followed over time it was observed that nitrite was 
generated from nitrate and the rate of production was dependent on the 
concentration of the nitrate added. As the reaction proceeds the concentration of 
nitrite becomes reduced in what appears to be a two-phase reaction where nitrite is 
first generated and then lost from the reaction. These two observations, the 
generation and loss of nitrite only under reduced oxygen point towards a possible 
mechanism involving XO in the reduction of nitrate and nitrite in the absence of 
oxygen.
It has long been known that XO can gain electrons from a variety of substrates 
including purines and aldehydes via an active site containing a molybdenum co­
factor. The mechanism has been proposed for electron transfer around the 
enzyme to a variety of sites and electron stores. Once the enzyme has received 
electrons from a donor substrate it is not possible for more substrate to be utilised 
until the electrons can be lost. For this, the use of various electron acceptors 
allows enzymic turnover. In the case of many enzymes this electron acceptor is 
molecular oxygen. In its absence however other acceptor molecules can be 
utilised to allow enzymic turnover. Nitrate and nitrite are two such electron 
acceptors with the ultimate reduction of nitrate to nitrite and nitrite to nitric oxide.
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Thus, nitric oxide is a by-product of enzymic turnover just as superoxide generation 
is when oxygen is the electron acceptor.
The model system draws parallels from the nitrate reductase enzymes that contain 
similar active sites and facilitate the reduction of nitrate to nitrite. These enzymes 
also contain a molybdenum cofactor and gain their electrons from the oxidation of 
NADH or NADPH. The enzyme, once reduced, will donate its electrons to nitrate in 
a two electron donation to generate nitrite and this can occur in air. This now 
generates a possible paradox in the use of nitrate reductase enzymes as the model 
for XO nitrate reductase activity. The lack of nitrite generation in air by XO 
suggests that the donated electrons are lost to molecular oxygen with the 
generation of oxygen radicals. The relative concentration of nitrate and oxygen will 
serve to control the competition for electrons, with the most likely result being that, 
at equimolar amounts of oxygen and nitrate or nitrite, oxygen will gain the electrons 
due to the higher affinity for oxygen that the enzyme possesses. However, if the 
nitrate reductase enzymes utilise NADH by binding to a FAD moiety to generate 
FADH2, then is it possible that in air the electrons will be lost to molecular oxygen 
and the generation of oxygen radicals? In fact this has been shown by Barber and 
Kay (1996) in assimilatory nitrate reductase (EC 1.6.6.2) a molybdopterin, FAD and 
cytochrome b^-containing enzyme. Using Chlorella sp nitrate reductase and 
NADH, this group were able to demonstrate the reduction of molecular oxygen and 
identified the molybdopterin as the primary site of oxygen reduction resulting in the 
production of superoxide radical.
Here again a difference is seen in the utilisation of oxygen to form superoxide 
between the NR and XO enzymes. In the presence of NADH and oxygen the 
addition of cyanide to NR enzyme inhibited the reduction of molecular oxygen. In 
the case of NADH oxidase enzymes cyanide has no effect on the reduction of
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oxygen when NADH is the electron donor (Iverson et al 1977 and Morre and 
Brightman 1991) which is probably the case for xanthine oxidase NADH oxidase 
activity in the presence of oxygen.
The Km for oxygen for this Chlorella sp NR in the presence of NADH was calculated 
to be 586jiM, much higher than the oxygen concentration in air-saturated buffer 
(~250nM at 37°C). For bovine XO, Fridovich and Handler (1962) gave a figure of 
27|xM for the reduction of oxygen in the presence of hypoxanthine and from this 
thesis in the presence of NADH a KaPP of ~ 70^M. The affinity for oxygen then is 
greater for XO than NR in the presence of NADH suggesting that the available 
electrons are more likely to be donated to oxygen in the case of XO than in the 
case of NR. It is for this reason that nitrate is utilised by NR as the electron 
acceptor and the generation of nitrite in atmospheric air.
For XO, the removal of oxygen using a nitrogen atmosphere still allows the 
donation of electrons to the enzyme and the addition of an electron acceptor in the 
form of nitrate allows enzymic turnover and the generation of nitrite.
Nitrite itself has been shown to be reduced under a low oxygen atmosphere. The 
possible fates of nitrite on reduction include the generation of nitric oxide. The 
utilisation of nitrite measurements allowed the loss of nitrite to be measured over 
time, which suggested a further reduction and possible generation of nitric oxide. 
From nitrate, the time resolved reduction to nitrite also showed a loss of nitrite after 
~ 30 minutes of generation. This may lead to a possible mechanism of nitrate 
reduction to NO requiring an intermediate nitrite step. This parallels the reduction 
of nitrate by denitrifying bacteria that utilise nitrate and nitrite reductase enzymes 
for the eventual generation of dinitrogen. The intermediates of nitrate reduction to
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dinitrogen by denitrifying enzymes include nitrite, nitric oxide and nitrous oxide (Ye 
et al 1994).
It is possible then that XO can show both a nitrate and nitrite reductase activity 
liberating in order from nitrate: nitrite and nitric oxide. As a model system the nitrite 
reductase enzymes differ quite markedly from XO in their active sites. To 
investigate the involvement of the particular active sites involved in the nitrate and 
nitrite reductase activities of XO, a range of specific inhibitors were utilised.
Taking the nitrate reductase activity first, in the presence of xanthine as the 
electron donor, this thesis shows that nitrite generation from inorganic nitrate is 
inhibited by the known molybdenum site inhibitors oxypurinol and BOF 4272. The 
nature of this inhibition however is not an indication of molybdenum site 
involvement in the reduction of nitrate to nitrite. As xanthine is the electron donor, 
the addition of oxypurinol or BOF 4272 will inhibit xanthine binding to the 
molybdenum active site and therefore the availability of electrons for the reduction 
of nitrate.
In the presence of DPI, a non-molybdenum site inhibitor however, the generation of 
nitrite from inorganic nitrate is enhanced in a dose-dependent manner. This 
enhancement was to such a large extent that the experiment was repeated in the 
presence of air-saturated buffer. In this case there was also a dose-dependent 
generation of nitrite from inorganic nitrate and was the first evidence of nitrate 
reductase activity by XO in air.
This led to the proposal of a working hypothesis based on previous work on the 
nature of DPI inhibition and the known utilisation of oxygen as the preferred 
electron acceptor.
Hypothesis. In the absence of oxygen, an electron rich (reduced) XO enzyme 
could pass its electrons on to a suitable electron acceptor and cause a reduction of
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that acceptor to another species. In the presence of oxygen, this would act as the 
electron acceptor and compete for the available electrons and this competition 
would be dependent on the relative concentrations of the two acceptors. In the 
presence of DPI the leak of electrons to molecular oxygen was inhibited and 
therefore more electrons were available for the reduction of inorganic nitrate to 
nitrite thereby increasing the nitrate reduction.
The importance of organic nitrates in therapeutic use made these compounds 
important to study in this context. Using GTN and ISDN it was possible to measure 
nitrite evolution over time. The amount of nitrite generated over time from the 
organic nitrates was significantly greater than that generated with equimolar 
amounts of inorganic nitrate in the presence of xanthine. The effect of oxypurinol 
was to inhibit the evolution of nitrite in a dose-dependent manner as seen for the 
inorganic nitrates. However, on the introduction of DPI to the system a potent 
inhibitory effect was seen which was the opposite of the effect of DPI in the case of 
inorganic nitrate.
The inhibition of NO generation has been shown previously by Trujillo et al (1998). 
In the presence of XO and xanthine and the absence of oxygen the reduction of S- 
nitrocysteine (CysNO) was inhibited by DPI at -  80% at 40^iM compared to ~ 10 i^M 
for 80% inhibition in the presence of GTN (this thesis). It was suggested that the 
flavin site was therefore involved in the catalysis of CysNO. It is not known why the 
inorganic and organic nitrates should behave in such a different manner. The 
effect on inorganic nitrite was again a dose-dependent enhancement of NO 
generation in the presence of xanthine and the absence of oxygen. In the 
presence of oxygen the DPI allowed the evolution of NO from the reaction at a level 
~ 10x reduced compared to oxygen free buffer.
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Following the time resolved generation and then loss of nitrite, the effect on the 
reduction of nitrite as the initial starting substrate was measured. An initial rapid 
loss of nitrite from the standard was seen which reached a plateau after only a 
short time. This suggested that the reduction of nitrite was limited by the products 
formed. It also suggested that some reduction species of nitrite was produced 
during enzymic turnover with the possibility of NO generation. It was also possible 
that in the original experiments using nitrates, the nitrite formed was due to the 
reaction of NO with oxygen to form nitrite in solution. However as all experimental 
procedures were carried out in the glove box and the fact that the reaction of NO 
and molecular oxygen is slow in aqueous solution, with a half-life of several hours 
(Wink et al 1993), this explanation does not account for the nitrite generated.
Initial experiments to measure nitric oxide release utilising nitrates and xanthine 
were unsuccessful and because of the possibility that both xanthine and the nitrate 
were being oxidised and reduced at the same active centre an alternative electron 
donor was used.
NADH is able to donate electrons to the enzyme and under atmospheric air, 
enzymic turnover donates these electrons to molecular oxygen. In the absence of 
oxygen the electrons once again may be given up to an oxidising agent. It was 
possible to generate NO in this manner from organic and inorganic nitrates. The 
effect of the known XO molybdopterin site inhibitors was to reduce the measurable 
NO in a dose-dependent manner, which is in agreement with the reduction of 
nitrate at this centre. Here again this confirms work by Sergeev et al (1985) and 
Bray (1984) which utilised the molybdopterin centre either removed completely or 




The effect of DPI was also to inhibit the measurable NO generation in a dose- 
dependent manner, which is to be expected when NADH is used as the electron 
donor. Stopping the gain of electrons by the enzymes will stop the donation on to 
the nitrate and therefore inhibit its reduction.
The organic nitrates have been utilised for many years therapeutically and their 
method of action has been suggested to be via their donation of NO to vascular 
smooth muscle cells. The mechanism of breakdown has been followed by HPLC 
revealing a denitration of the compounds in the case of GTN to generate glyceryl di 
nitrate (GDN) and glyceryl mono nitrate (GMN). This suggests that the generation
of NO from GTN follows a nitrite intermediate step to give the reaction shown
below.
N03---------- ►  N02----------- ►  NO (13)
This complicates the measurement of NO from nitrates as the reaction to generate
NO must be dependent on the rate of nitrite formation and then on nitrite reduction 
to NO. This led to the study of the reduction of nitrite, being the relatively more 
simple reaction to follow.
On generating NO from nitrite it was clear from the data that nitrate gave a longer 
lag time before reaching peak NO generation compared to the nitrite tested. This 
follows the suggestion that nitrite is an intermediate step in nitrate reduction and the 
rate of NO generation is dependent on the rate of nitrite formation from nitrate.
The inhibition of NO generation from nitrite by oxypurinol in the presence of NADH 
also suggests that the molybdopterin site is the part of the enzyme where the 
electrons are taken from. A conflict now arises as to the possible competition 
between nitrate and nitrite for the available electrons. At the start of the reaction 
the concentration of nitrate far outweighs nitrite in the solution. As nitrates are
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reduced to nitrite the relative concentrations of the two compounds changes in 
favour of the nitrites. When the concentration of nitrite is sufficiently high, the 
available electrons will be donated to nitrite to give NO. The lag time comparison 
detailed earlier suggests this to be the case. This situation is also supported by 
earlier experiments using nitrate and xanthine where, over time, following nitrite 
generation, an initial increase in nitrite is seen followed by a loss of nitrite.
The kinetics of these reactions lead to the suggestion that the molybdenum site is 
the active domain for donation of electrons from all substrates used. Inhibition was 
seen with oxypurinol and in the presence of purine substrates, substrate inhibition 
was seen which complicated the kinetic analysis. The purines are known to be 
hydroxylated at the molybdenum site and because of the close similarity with the 
nitrate reductase molybdenum enzymes this is the most probable site of nitrate and 
nitrite reduction.
All the above determinations occur in the absence of competing oxygen. It is 
important therefore to assess the effect of oxygen on the generation of NO 
especially by the methods chosen.
By following the oxidation of NADH in a kinetic assay it was possible to show that 
the XO-mediated NADH oxidation was dependent on the concentration of dissolved 
oxygen in the buffer. This assay was then also used to determine kinetic 
parameters in the absence of oxygen for a variety of electron acceptors the nitrates 
and nitrite. This assay however is not specific for either oxygen reduction or nitrate, 
nitrite reduction and so the generation of NO was followed over a range of oxygen 
concentrations. At two concentrations of nitrite in the presence of NADH, 
increasing oxygen concentration caused a dose-dependent decrease in 
measurable NO. The effect of oxygen was less pronounced with the higher nitrite 
concentration, where greater oxygen concentrations were required to reduce the
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NO signal. This was also the case in the presence of hypoxanthine although the 
point at which the half maximal NO generation occurred was reduced at equimolar 
nitrite concentrations for hypoxanthine compared to NADH as the electron donor. 
The possible reasons for the loss of NO signal are,
I. Reaction of NO with oxygen in the aqueous phase
II. Generation of superoxide radical in stead of therefore reducing the available 
electrons for NO generation
III. Reaction of NO with oxygen in the gaseous phase to produce species not 
detectable in this assay
IV. Reaction of superoxide radical with NO to generate reactive nitrogen 
species which are again not detectable by this assay.
As has been shown by Wink et al (1993) the reaction of NO with oxygen in solution 
is slow and rules it out as a possible mechanism in this assay. However points II -  
IV are possibilities.
To test these points the assay was run in the presence of superoxide dismutase 
(SOD) which would scavenge any superoxide formed. The results of this 
experiment showed that the inclusion of high concentrations of SOD could enhance 
the NO measured from nitrite reduction in the presence of hypoxanthine. This rules 
out point II and suggests that simultaneous generation of NO and superoxide 
occurs as the oxygen concentration is increased from 0% saturation. From the 
work of Beckman et al (1990) and Kissner et al (1997) the reaction of NO and 
superoxide is diffusion limited and the most likely reaction to occur. This 
peroxynitrite generation could account for the loss of NO signal as the oxygen 
concentration is increased.
Point III, however, is less easy to prove either way and depends on the reaction 
rates of NO with the available oxygen.
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The possibility then exists that peroxynitrite is generated over a range of oxygen 
concentrations by the simultaneous reduction of nitrite and oxygen. Various 
methods for the detection of peroxynitrite formation have been utilised. Using SIN- 
1 as a simultaneous generator of both NO and superoxide and using chemically 
synthesised peroxynitrite, it was possible to screen assays for enzymic peroxynitrite 
generation.
The commonly used oxidation of dihydrorhodamine (DHR) gave a positive result in 
the presence of SIN-1. When used in conjunction with XO and nitrates in air- 
saturated buffer the control reactions showed a change in absorbance over time 
which was independent of the nitrate concentration. In fact on addition of 
increasing concentrations of nitrite the rate of DHR oxidation was increased in the 
absence of added XO enzyme. Repeating this experiment in the presence of 
increasing NADH concentrations, the oxidation of DHR was reduced suggesting a 
competition between the strong oxidant (nitrite) and the strong reductant (NADH). 
In accordance with Crow et al (1995), XO and xanthine had no effect on DHR 
oxidation, but this assay was not used further due to the problems encountered 
with the substrates to be used.
Luminol had previously been shown (Radi et al 1993) to give chemiluminescence in 
the presence of authentic peroxynitrite. It was possible to use this assay in a multi­
well set up. Authentic ONOO- caused a dose-dependent increase in the 
chemiluminescence caused by reaction with luminol and this was inhibitable by the 
inclusion of the known ONOO- scavenger quercetin (Haenen et al 1997). 
Lucigenin was also shown to luminesce on addition of authentic peroxynitrite and 
was also inhibitable by the addition of quercetin.
Lucigenin-enhanced chemiluminescence was used for the determination of XO 
mediated ONOO- generation due to the ease of use of the multi-well format. In the
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presence of nitrate, the chemiluminescence signal is not enhanced over that 
generated in the presence of NADH, XO and oxygen alone. Nitrite however shows 
a dose-dependent increase in LEC that is not due to nitrite alone. The possibility is 
that at atmospheric oxygen concentrations, NO is being generated at the high 
concentrations of nitrite used and this reacts with the superoxide generated to 
produce LEC. It is possible though that the reaction of superoxide with nitrite at 
such high concentrations may mediate the LEC seen. Trujillo and colleagues
(1998) were able to show the decomposition of s-nitrosothiols mediated by xanthine 
oxidase. They stated that this effect could been seen by two distinct mechanisms 
with the generation of peroxynitrite. The reactions showed XO/xanthine induced 
decomposition of s-nitrosothiols in air-saturated buffer due to the participation of 
superoxide. The NO generated could then react with a second superoxide to form 
peroxynitrite as a bystander reaction: mediated but not catalysed by the enzyme. 
The high concentrations of nitrite used here could also generate NO spontaneously 
which would add to the signal but would not be enzymic.
To clarify this point, oxypurinol was added at a range of concentrations and shown 
to inhibit significantly the nitrite enhanced LEC, with little effect on the XO/NADH 
mediated LEC at the concentrations used, suggesting catalytic reduction of nitrite. 
Further evidence of ONOO- generation came with the inhibition of the lucigenin 
signal in the presence of quercetin where only the nitrite enhanced signal was 
affected.
It is possible then that under the conditions described XO and a range of electron 
donor substrates in the presence of nitrite at a range of concentrations could 
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This chapter deals with the susceptibility of bacteria to oxidants generated either 
enzymically or by chemical means. It looks to determine the radical generating 
capacity of XO in a situation where the oxygen tension is variable and to assess the 
possible antibacterial action of metabolites from a milk-derived enzyme.
3.1 Introduction
3.1.1 Xanthine oxidase, peroxynitrite and bacterial viability
The study of free-radicals and their generation has gone on for many decades 
(Edwards and Plumb 1994). However, their role in physiology has usually been 
seen as a pathological one, with the dogma being that radicals were so reactive 
and unselective that they could not be involved in normal biochemical processes 
(Pryor and Squadrito 1995). Free radical publications of the time were limited to 
the situations where high concentrations of radicals were produced from exposure 
to high-energy radiation or toxins such as carbon tetrachloride.
Arguably, it was only when the enzyme superoxide dismutase (SOD) was 
described by McCord and Fridovich in 1969 that the idea became accepted that 
free-radicals could be generated by many cell types in normal physiology and 
controlled by yet further cellular mechanisms (McCord and Fridovich 1969a and b).
3.1.1.1 The antibacterial activity of NO and superoxide
Free radicals have previously been implicated in bacterial cytotoxicity (Akaike et al 
1992, Bowdy et al 1990, Pabst et al 1982) and especially in the respiratory burst of 
macrophages and neutrophils (Morel et al 1991, Miller and Britigan 1997 and 
Hampton et al 1998). The range and variety spans singlet oxygen and superoxide
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from the oxidation of NADPH in the neutrophil membrane to the generation of 
“bleach” in hypochlorous acid generation by myeloperoxidase in phagosomes 
within a restricted environment (Byun et al 1999 and Saran et al 1999). Chemically 
generated hypochlorite has also shown its efficacy as an antibacterial agent (Rusin 
ef al 1998).
Nitric oxide is generated by a variety of cell types including macrophages that have 
been stimulation with interferon gamma and E. coli lipopolysaccharide (Marietta et 
al 1988). The macrophage has also been shown previously to generate oxygen 
radicals even under resting conditions (Drath and Karnowsky 1975) which was 
significantly enhanced following phagocytosis (DeChatelet et al 1975). Tsunawaki 
and Nathan (1984) described a NADPH-dependent oxidase that could generate 
superoxide from macrophages which was also associated with the membrane in 
the guinea pig macrophage (Pick et al 1987).
Other organisms have also been shown to have susceptibility to nitric oxide. Long 
et al (1999) demonstrated the mycobacteriocidal actions of exogenous nitric oxide 
treatment and suggested this as a possible therapy in patients with pulmonary 
tuberculosis. Saura et al (1999) and Persichini et al (1999) produced evidence to 
show antiviral properties of NO and the inhibition of HIV-1 virus replication. 
Inflammatory situations and bacterial infections, which are rich in exuded 
inflammatory cells, therefore contain a range of free radical-generating systems in 
the form of activated cells.
Intragastric levels of NO have been measured to be between 10 and 100ppm and 
this is suggested as having biological effect in the stomach (Weitzeberg and 
Lundberg 1998). Acidified nitrite has also been shown recently to kill various gut 
pathogens much more efficiently than acid alone (Benjamin et al 1994 and 
Dykhuizen et al 1996).
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Nitrates are generally excreted in the urine at higher concentrations compared to 
the low level of measurable nitrites (Green et al 1981). However bacteria that 
cause urinary tract infections (UTIs) may convert nitrate to nitrite using a nitrate 
reductase enzyme and the detection of nitrite in urine has been used as a 
diagnostic tool for UTIs. Acidification and vitamin C intake have been used as 
treatment against UTIs (Weitzeberg and Lundberg 1998). The ingestion of 2g of 
vitamin C for two days induced a seven-fold increase in NO release from nitrite- 
containing urine from healthy volunteers. It was further shown that addition of 
nitrite to acidified urine dose-dependently decreased the in vitro growth of E. coli 
(Lundberg et al 1997). This may lead to the nitrate reducing bacteria participating 
in the production of the necessary substrates for their own destruction.
3.1.1.2 Bacterial survival and antioxidant mechanisms
The individual cytotoxicity of nitric oxide and superoxide relies on the susceptibility 
of the target organism to the stress derived from these free radical species. 
Nunoshiba et al (1992 and 1995) have shown that nitric oxide signals E. coli 
through the same transcription factors as superoxide and the genes induced by 
nitric oxide are those essential for the protection against oxidative damage. Also in 
Salmonella typhimurium Crawford and Goldberg (1998) have shown that a 
flavohaem protein regulates gene expression on stimulation by nitric oxide. It has 
also been confirmed in E. coli that a flavohaem affords protection from NO. 
Specifically, the haem serves a dioxygenase function that produces mainly nitrate. 
These studies identify enzymes with reactions that were thought to occur only by 
chemical means. It was also emphasised that the reactions of NO with 
haemoglobins were evolutionarily conserved and have been adapted for cell- 
specific functions (Hausladen et al 1998).
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The presence of oxygen radical detoxification systems in bacteria is well 
documented (Fee 1991 and Nunoshiba 1996). E. coli possess a superoxide 
dismutase-like enzyme which generates hydrogen peroxide. This species is then 
detoxified by a catalase-like enzyme to oxygen and water (McCormick et al 1998). 
The importance of SOD in the defence of bacteria against superoxide generation 
was assessed by Gort and Imlay (1998). They ■ controlled the expression of 
cytoplasmic SOD within the E. coli to show the relative amounts of superoxide 
generation that were required to cause enzyme inactivation, growth deficiencies 
and DNA damage. These studies showed a graded response to the loss of SOD in 
the cells. At small reductions in SOD activity, a substantial reduction in the activity 
of labile dehydratases was seen. An increase of more than four-fold superoxide 
generation measurably impaired growth and a five-fold increase sensitised cells to 
DNA damage.
Schwartz et al (1983), however, showed the cytotoxicity of neutrophils to bacteria 
and suggested that even though the bacteria contained the protective antioxidant 
enzymes, under the conditions within the phagosome, the flux of superoxide and 
hydrogen peroxide generated was sufficient to overwhelm the cells antioxidant 
mechanisms.
Other proteins have been associated with antioxidant mechanisms. Lundberg et al
(1999) suggested that Glucose-6-phosphate dehydrogenase is required in S 
typhimurium resistance to reactive oxygen and nitrogen species. The DNA repair 
enzyme formamidopyrimidine-DNA glycosylase was also essential to antioxidant 
defence from E. coli treated with high levels of hydrogen peroxide (Alhama et al 
1998).
It is clear then that bacteria and viruses can be susceptible to free radical attack but 
also have some relevant antioxidant enzymes to survive particular stresses.
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Xanthine oxidase has been shown previously to generate superoxide and, in this 
thesis, nitric oxide. Xanthine oxidase-derived superoxide and hydrogen peroxide 
have been indicated in antiviral activity by causing apoptosis in the infected cells 
(Skulachev 1998), in association with duodenal ulcers and Helicobacter pylori 
infections (Ben-Hamida et al 1998) and in vitro susceptibility of Mycobacterium 
leprae to oxygen-mediated damage (Dhople 1996).
However the effectiveness of either superoxide or nitric oxide alone has been 
questioned in the light of their possible reaction products.
3.1.2 The role of peroxynitrite
Reactions and effects that were once attributed to either NO or superoxide may 
now be reassessed. The evidence comes from the combination of the radicals 
forming the strong oxidant peroxynitrite (Beckman et al 1990 and Beckman and 
Koppernol 1996). This reaction leads to the modulation of the effect of each 
individual radical. For example, superoxide can reduce the effects of nitric oxide by 
causing the generation of ONOO- (Gryglewski et al 1986 and Rubbo et al 1994). In 
the same manner the capture of superoxide by nitric oxide has been suggested as 
the modification of actions previously described for superoxide alone (Bautista and 
Spitzer 1994 and Wink et al 1994).
The ability of ONOO- to cause nitration reactions with a variety of residues has 
been suggested as one of the methods leading to pathology (Beckman and 
Koppernol 1996). ONOO- reacts with tyrosine residues to generate nitro-tyrosine 
and can also react with DNA to generate nitrated bases and strand breakage 
(Szabo and Ohshima 1997).
Following strand breakage a secondary effect has been suggested involving the 
activation of the nuclear enzyme poly(ADP-ribose) synthetase (PARS) and
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apoptosis. Single (not double) strand breakage is an obligatory signal for PARS 
activation. PARS causes the ADP-ribosilation of a number of important proteins 
involved in repair including topoisomerase I and II, DNA polymerase a  and p and 
DNA ligase 2. This ribosylation tends to decrease their activity and therefore has 
an effect on the cell function (Szabo et al 1996).
Activation of PARS can also deplete cell energy stores by using up the electron 
transport substrate, NAD+, which can then go on to cause acute cell dysfunction. 
The ability of ONOO- to cause DNA damage in bacteria was therefore studied as a 
measure of the oxidative damage that may be the cause of ONOO- bacterial killing. 
Peroxynitrite has been shown previously to be formed by macrophages during 
bacterial engulfment (Ischiropoulos et al 1992) and to have an effect as a 
bactericidal agent (Zhu et al 1992 and Brunelli et al 1995).
The following experiments were designed to assess the effect of ONOO- on 
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Figure 3.1. Summary of the possible effect of NO derived species on DNA 
damage.
3.2 Method and materials
3.2.1 Enzyme activity in bovine and human milk products
The activity resident in non-purified milk samples from both bovine and human 
sources was measured. Bovine milk was taken from commercially produced 
sources following pasteurisation. Also samples of raw milk were taken from cows 
and assessed in the same manner. Human samples were taken at various time 
points post partum and stored frozen at -20°C in a domestic fridge freezer for over 
a year before being assayed. Commercially produced infant feed formulas were 
also used as packaged by the manufacturer. Commercially produced Golden 




3.2.2 Lucigenin-enhanced chemiluminescence measurements
The generation of superoxide radical from various enzyme sources was measured 
using the oxidation of lucigenin as a marker. Superoxide radical reacts with 
lucigenin in a radical -  radical addition reaction to yield an unstable dioxetane; the 
decomposition of which produces the excited state acridone. Decomposition of this 
acridone to the ground state emits light which can then be detected using a 
photomultiplier tube (PMT) (Faulkner and Fridovich, 1993 and Liochev and 
Fridovich, 1997).
These experiments were completed using a 96-well plate-reading 
chemiluminometer (Anthos, Lucy 1) with the capability to vary the chamber 
temperature and wavelength of measured light. As the peak light emission for 
lucigenin is 500nm, to remove unwanted non-lucigenin-emitted light, a green glass 
bandpass filter of 492nm (GG492nm) was used for lucigenin enhanced 
chemiluminescence (LEC).
Chemiluminescence (CL) enhancement was also used in the measurement of 
hydrogen peroxide (H20 2) and peroxynitrite (ONNO-). For luminol-enhanced 
chemiluminescence (LuEC) the peak-emitted wavelength is 425nm therefore a 
green glass 405nm (GG405nm) bandpass filter was used.
Xanthine oxidase has been show previously to generate superoxide radical using 
xanthine or NADH as substrates with oxygen as the terminal electron acceptor. 
The CL assay therefore provides a quick and reproducible method for obtaining 
information on the activity of a range of samples, from purified enzyme to human 
plasma samples and cultured cells.
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3.2.2.1 Basic assay protocol
Assays were performed usually in triplicate in a final volume of 200|il. Lucigenin 
was made up to a stock concentration of 2mM in PBS. Substrates were made up 
at a range of concentrations in PBS. Samples were added to plates at a final 
volume of 100pl either as neat solutions or the volume difference made up to 100pl 
in PBS. Each plate was allowed to equilibrate to 37°C by placing the plate into the 
closed reaction chamber of the chemiluminometer (Lucy) for 5 min. The reactions 
were initiated by the injection of 50pl volume of substrate followed by 50pl of 
lucigenin into the wells of a 96-well plate.
Each particular protocol had its own-programmed routine of injection and 
luminescence readings. Typically, each well was measured with an integration 
time of one second sequentially before the initiation of the reaction. Injections of 
the substrate and enhancer were followed immediately by a second measurement. 
Once all the reactions had been started, the luminometer made readings in each 
well sequentially to follow the CL reaction. Due to the time taken for injection, 
reading and integration of each well, experiments were restricted to 24 wells (eight 
sets of triplicates) to allow the reaction to be followed. Measurements of the peak 
height of reaction were made, as this is where the reaction rates were at their 
maximal. On occasions the reaction rates were particularly fast which meant that 
the cycle time for each reading had to be reduced. This was accomplished by 
reducing the number of samples down to a suitable level allowing the measurement 
of peak height data.
Inhibitors were added into the plates prior to the initiation of the reactions so that 




3.2.3 Western blot analysis
To determine the XO protein content of milk and other samples an antibody raised 
against bovine butter milk XO was used to detect immobilised proteins by Western 
blot analysis. Typically, proteins were electrophoresed through a SDS 
polyacrylamide gel under reducing conditions before transfer to a nitrocellulose 
membrane. This membrane was then probed for the appearance of XO protein 
using the anti-XO antibody and a chemiluminescence detection technique. The 
appearance of a 150KDa band was indicative of XO protein but some preparations 
would also show the typical degradation products of this enzyme.
This assay system allows the determination of individual proteins from a mixture by 
separating them according to molecular weight. Proteins in a solution of negatively 
charged detergent (SDS) are unfolded and negatively charged. The addition of a 
reducing agent such as mercaptoethanol or dithiothrietol breaks di-sulphide bonds. 
Applying a current across the gel causes the charged proteins to migrate toward 
the positive anode with the larger proteins being retarded by the gel which is 
dependent on the gel concentration relative to small proteins
3.2.3.1 Protocol
Proteins for analysis were isolated by a variety of means and the absolute protein 
concentration measured by a modification of the Bradford assay. An eight percent 
sodium dodecyl sulphate polyacrylamide gel (SDS gel) was prepared (See 
appendix II) and allowed to set before the addition of a five percent stacking gel to 
form running wells. Proteins which had been previously denatured in stacking 
buffer were loaded on to the gel in equal volumes. A voltage of 120V was applied 
to the gel, typically for 1 and a half hours before the gel was removed for protein
151
Chapter 3
determination by blotting onto nitrocellulose or staining the gel itself in Coomassie 
blue.
3.2.3.2 Coomassie blue stain
A solution of 1% Coomassie blue was made up by dissolving Coomassie brilliant 
blue dye in 55% glacial acetic acid 10% methanol made up in ddH20 . SDS gels 
were added to square plastic staining dishes in the presence of Coomassie blue for 
45 minutes. The gel was then destained with a solution of Destain (7.5% glacial 
acetic acid, 5% methanol in ddH20 ) for 1 hour. This Destain was then replaced by 
fresh Destain and the gel left overnight at room temperature.
3.2.3.3 Gel blotting
The blotting apparatus was set up for wet blotting. Gels for blotting onto 
nitrocellulose were layered onto two pieces of Whatman 3mm blotting paper cut to 
size and soaked in blotting buffer (see appendix II) inside a blotting cassette. Onto 
this was layered a piece of Hybond-C nitrocellulose paper soaked in blotting buffer 
with the air bubbles removed by rolling a 10ml pipette over the paper. Onto this 
was layered a further 2 pieces of blotting paper and the blotting cassette closed to 
hold the layers in place. This cassette was then removed to the blotting apparatus 
where a current of 150mA was applied to the gels for 2 hours.
3.2.3.4 Probing the blots
Following blotting, the nitrocellulose was blocked by incubation with 5% non milk-fat 
protein (Marvel) made up in PBS/0.5% Tween 20 (MPT) for 1 hour. Specific 
primary antibodies were then added to the nitrocellulose for between 1 hour and 
overnight incubations. The nitrocellulose was washed 6x 5 minutes in PBS/0.5% 
Tween 20 (PT) before the addition of secondary Horseradish peroxidase (HRP)-
152
Chapter 3
labelled antibodies in MPT for 2 hours at room temperature or overnight at 4°C. 
The blots were then washed for a further round of 6x 5 minutes in PT before the 
detection of reaction products.
3.2.S.5 Chemiluminescence detection of reaction products.
Antigenic proteins were detected by the utilisation of a light-emitting non-radioactive 
method and x-ray film detection. Only proteins bound by the primary and 
secondary antibodies will be detected by the utilisation of the hydrogen 
peroxide/HRP oxidation of luminol. The oxidised luminol emits light at a 
wavelength of 425nm which is detected by blue light sensitive autoradiography film. 
Using this system blots were soaked in luminol/H20 2 solution for two minutes 
before drying on paper towels. In a dark room, under safe light conditions, the blots 
were exposed to autoradiography film for a range of time points. The films were 
then processed to reveal the reaction products in an automated processor.
3.2.4 Bacterial culture and preparation
The infective bacterial strains Escherischia coli NCTC 86 (E  coli), Salmonella 
enteritidis DV 232 (S. enteritidis), Lactobacillus casei 6375 and Staphylococcus 
aureus 6751 were cultured on nutrient agar at 37°C by streaking out using a flamed 
tungsten loop from frozen stock cultures kept at the University of Bath. Colony 
formation usually occurred with overnight incubation. These stock cultures were 
used for subsequent experiments including sub-culturing in nutrient broth (NB Lab 
Lemco broth, Oxid, UK) and plating onto nutrient agar weekly.
Strains of Micrococcus sp and Bacillus sp were isolated from commercially 
pasteurised semi skimmed bovine milk onto nutrient agar and identified by 
morphological examination of colonies and by Gram’s stain.
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Experimental overnight cultures of bacteria were set up by inoculating 25ml of 
sterile NB with a single bacterial colony taken by a sterile loop from an inoculated 
agar plate. Cells were cultured at 37°C in sterile conical flasks with shaking at 100 
revolutions min'1. Cells were harvested by centrifugation at 400g and resuspended 
in either sterile NB or sterile PBS. Counts were performed by adding 10^ 1 of cell 
suspension into 990^1 of either NB or PBS in a plastic cuvette. The absorbance of 
this mixture was then measured at 470nm in a spectrophotometer with a 1cm light 
path against a blank of NB or PBS alone. The absorbance was then related to a 
standard curve which had been previously determined under the same conditions 
of absorbance against viable count for each cell type used (See figure 3.2). Final 
working cell concentrations were then produced by using the appropriate dilutions 
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Figure 3.2. The correlation of absorbance at 470nm against viable count for E. coli 
NCTC86 grown in NB with shaking at 100 revolutions min'1.
Viable counts were performed by plating bacteria onto agar and incubating over 
night at 37°C. Colonies were seen as glassy white plaques against the agar 
background. The number of colonies counted per plate (Colony forming units, 
CFU) was related to the absorbance of the seeding population R-value = 0.991
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from n = 6. The cell count can be taken directly from the graph or by multiplication 
of the absorbance with the slope of the line (Viable count x107 ml'1 = Abs47onm x 
64.64).
3.2.5 Viability assay
The viability of control and treated bacteria was assessed by viable count of colony 
forming units (CFU).
Agar plates were set up by fist dissolving 28g agar in 500ml of Ultra pure H20. 
This solution was then subjected to sterilisation by autoclaving for 15 minutes at 
121°C under pressure. The still molten agar solution was poured into sterile plastic 
petri dishes (Sterilin) and allowed to cool. On cooling, the agar solidified to form a 
gel that was then covered by the petri dish lid and the plates kept at 4°C until use, 
which was typically within one week.
Prior to use, the agar plates required air drying to remove condensation that formed 
within the petri dishes during storage. This was achieved by inverting each plate 
and removing the lid in a warm room (37°C). The plates were allowed to dry until 
all signs of condensation had been removed which was typically within 30 minutes. 
The plates were then recovered with their lids and stored at room temperature 
before use which was within 4 hours of air drying.
Plates were inoculated using sterile technique in the presence of a Bunsen flame 
and under a class I safety cabinet by the addition of cells in 100jil of either NB or 
PBS. Following inoculation, cells were spread onto the agar using an ethanol- 
flamed, glass spreading rod. The inoculated plates were incubated at 37°C 
overnight. Each batch of incubated cells also had a non-inoculated plate that had 
undergone the air drying procedure to show the level of background contamination.
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This contamination, tended to be low with a maximum of 0-2 colonies formed per 
plate.
3.2.6 Cell growth assay
The rate of cell growth was assessed by utilising the change in absorbance over 
time of cells in NB as a modification of the cell counting assay. Two procedures 
were used incorporating a manual and an automatic assay.
The manual assay used a spectrophotometer with a 1cm light path and 1ml plastic 
cuvettes. NB (990pl) was inoculated with 10pl of a known number of cells as 
assessed by the standard curve assay and the absorbance at 470nm was 
measured every 15 minutes against a blank of NB until a plateau in absorbance 
measurements was reached. The cuvettes were kept sealed with Parafilm™ 
(Parafilm “M”, American National Can, USA) in a water bath at 37°C.
This assay was automated using a plate reading chemiluminometer (Anthos, Lucy) 
using it in an absorbance measurement mode. This was achieved using a 
GG492nm filter and clear bottomed sterile plastic 96-well plates. The 
chemiluminometer was temperature-controlled at 37°C and the plates were left in 
situ during the experiments. A final volume of 200jnl was used throughout the 
experiments using this automated technique. A program of measurement steps 
was written for the Lucy to follow, including multiple readings and incubation wait 
times of 15 minutes between each measurement.
This automated technique allowed for large throughput experiments to be carried 
out in triplicate with little intervention once the assay was running.
Figures 3.3 and 3.4 show the growth of E. coli as followed in both assays at a 
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Figure 3.4. The change in absorbance caused by inoculating NB with E. coli at a 
range of seeding densities assessed by using the automated 96-well plate 
assay as described above.
The two assay protocols show similar growth curves for E. coli. The manual assay 
was hindered by the fact that it was labour intensive for multiple replicate samples 





The automated assay however removed both of these obstacles and allowed the 
possibility for many more readings to be taken. The difference in final volume 
1 OOOjllI -  200^1 made little difference to the overall outcome and growth rates seen. 
The smaller volume in use with the automated assay could have caused problems 
with concentration of cells due to increased evaporation of media from the wells, 
since the plates were not sealed as was the case for the manual assay. The plates 
were set up so that the wells around the edge of the plate contained 200jil sterile 
water to reduce edge effect evaporation in an effective “water jacket” for the 
bacterial cultures. No evidence of evaporative loss was seen in the experimental 
wells for the duration of these experiments.
All experiments into the effect of various treatments on bacterial growth were 
carried out using one or both of these assays.
3.2.6.1 The effect of hypoxia on growth rate
The effect of low oxygen concentration on growth rate was measured to 
characterise this parameter during further experiments that required a hypoxic 
approach. Both E. coli and S. enteritidis are facultative anaerobes, being able to 
utilise a range of electron donors other than oxygen in its absence.
Cells were cultured overnight as described previously and then added to fresh 
nutrient broth in 1 ml cuvettes which were either saturated with room air or gassed 
with 5% C 02 balanced nitrogen. The oxygen concentration was measured with the 
oxygen probe and then the cuvettes sealed with Parafilm. The absorbance at 
492nm was measured over time to compare the growth rates.
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Figure 3.5. The effect of low oxygen and concentration and nitrite on the growth 
rate of E. coli in nutrient broth.
The growth rate of E.coli was not affected by the removal of oxygen from the 
nutrient broth. The oxygen concentration remained low <0.5% saturation 
throughout the time of the experiment.
This experiment was also repeated in the presence of 1 mM sodium nitrite. Figure 
3.5B shows the effect on E. coli growth rate with added nitrite under reduced 
oxygen conditions. Nitrite has no effect at 1mM concentration on the growth rate of 
E. coli in the absence of oxygen.
3.2.7 Peroxynitrite generation
Various methods for the generation of ONOO- now exist and are routinely used 
(Crow et al 1995, Pryor et al 1995 and Uppu et al 1996). For the experiments 
shown here a modification of the technique described by Crow et al (1995) was 
used.
Peroxynitrite was generated using a quenched flow reaction apparatus as 
described by Reed et al (1974). An aqueous solution of 0.6M sodium nitrite 
(NaN02) was rapidly mixed with an equal volume of 0.7M hydrogen peroxide 
(H20 2) containing 0.6M hydrochloric acid (HCI) and immediately quenching with the 
same volume of 1.5M sodium hydroxide (NaOH). All reaction solutions were kept
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on ice. The concentration of peroxynitrite was determined spectrophotometrically 
at a wavelength of 303nm in 0.3M NaOH using an extinction coefficient of 1670M'1 
cm'1 (Hughes and Nicklin 1968). Solutions of freshly synthesised peroxynitrite 
ranged from 150 -  200mM (~ 95% yield). Stock solutions of ONOO- were stable 
for several weeks (Crow et al 1995) at -20°C. However stock ONOO- was 
generated weekly and ONOO- was not used after 7 days of synthesis.
This method leads to some residual nitrite and hydrogen peroxide contamination. 
The hydrogen peroxide was removed by reacting solutions of chemically formed 
ONOO- with manganese dioxide (Mn02) for 5 minutes followed by filtration through 
0.22jim filter (Haenen et al 1997). Also ONOO- was allowed to decompose 
(dONOO-) at room temperature for 3 days to be used as the control for the residual 
nitrite/nitrate and NaOH (Bauer et al 1992 and Pfeiffer et al 1997). Sufficient 
buffering and dilution in PBS reduced the effect of the residual NaOH further.
3.2.8 The effect of peroxynitrite addition on cell growth in bovine milk
Commercially generated bovine milk was incubated with ONOO- and dONOO- 
before being plated onto nutrient agar and incubation overnight with viable 
counting. Each day a 1ml aliquot was removed and mixed with 100|uM ONOO- or 
the equivalent dONOO- dilution. The viability of naturally occurring bacteria was 
assessed over time.
3.2.9 The effect of hypoxanthine addition to bovine milk.
Commercially produced pasteurised bovine milk was incubated in the presence of 
hypoxanthine and the viability of infecting organisms was assessed by viable count 




3.2.10 the effect of hydrogen peroxide and ONOO- on cell growth
Monocultures of bacteria isolated from milk or from stock cultures kept at the 
University of Bath were incubated in the presence of hydrogen peroxide or ONOO- 
and the growth rate determined using an automated assay as described in 3.2.6.
3.2.11 The effect of XO metabolites on bacterial viability
Xanthine oxidase was used as a generator of radical species in the presence of 
bacteria and its effect was measured on the viability of two bacterial species, 
namely E. coli and S. enteritidis.
Bacterial cultures were grown overnight in NB as previously described. Aliquots of 
2x107 cells ml"1 were taken and incubated with a reaction system consisting of 
bovine xanthine oxidase (XO, 53.2 pgml"1), nicotinamide adenine dinucleotide in 
reduced form (NADH, 300jiM) or hypoxanthine or xanthine (100jiM), sodium nitrite, 
(NaN02, 1-1 OmM) and oxygen at a range of concentrations as described in section 
2.2.6.2. The initial reaction chamber set up was modified for the reaction and 
environmental control of reactions with bacteria. Figure 3.6 shows the modified 
water bath and the experimental set up for four reaction chambers. This allowed 







Figure 3.6. The modified reaction cell set up. Shown is the water jacketing system 
and the gas flow from four reaction cells (A) into a fifth cell (B) which was 
linked to the analyser.
This reaction mixture was followed at 37°C for 30 minutes with mixing before an 
aliquot was taken and plated onto agar and incubated overnight as described. 
Viable cell counts were performed in triplicate and the results expressed as a 
percentage viable count related to a non-enzyme control.
This procedure was repeated using xanthine and hypoxanthine as electron donor 
substrates and the results were expressed in the same manner.
3.2.12 The effect of XO metabolites on cell growth
Various bacterial isolates were grown in monoculture over night in nutrient broth. 
Sterile nutrient broth was inoculated with 2x107 cells well'1 of a 96 well plate. To 
each well was added either xanthine oxidase enzyme, hypoxanthine or a mixture of 
the two and the growth rate in each well calculated by following the change in 




3.3.1 Enzyme activity of various milk-derived sources
3.3.1.1 Bovine milk
The superoxide generating capacity of milk-based products was measured using 
lucigenin-enhanced chemiluminescence (LEC). Superoxide can be measured from 
xanthine or NADH in the presence of xanthine oxidase and oxygen. The 
superoxide generating capacity of raw bovine milk was assessed in this manner for 









Figure 3.7. The lucigenin-enhanced chemiluminescence of raw unpasteurised 
bovine milk. Aliquots of milk were mixed with NADH, 500pM or xanthine, 
250^M and lucigenin, 500pM and the chemiluminescence was measured in a 
96-well plate reader as described in 3.2.2. Data are mean ± SEM (n = 3) in 
triplicate.
The chemiluminescence signal is proportional to the amount of total protein in each 
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Figure 3.8. The effect of DPI on the NADH-mediated LEC from raw bovine milk. 
DPI was dissolved in PBS and added to the wells of a 96-well plate by using a 
doubling dilution in PBS before the addition of raw bovine milk at 3.4mg well'1. 
The reaction was started by the addition of NADH and lucigenin and the 
chemiluminescence measured over time. The data are means ± SEM (n = 3) 
in triplicate of the peak height chemiluminescence.
The effect of DPI is shown in figure 3.8. DPI inhibited in a dose-dependent manner 
the LEC derived from the raw milk in the presence of NADH and gave an IC50 value 
in this protocol of 2.45|iM.
The xanthine-mediated LEC was assessed in the presence of a range of oxypurinol 
concentrations. Figure 3.9 shows the effect of oxypurinol on the xanthine-mediated 








Figure 3.9. The effect of oxypurinol on the xanthine-mediated LEC of raw bovine 
milk. The assay was carried out as described in figure 3.2 where xanthine, 
250pM was substituted for NADH and oxypurinol for DPI. Data are mean ± 
SEM (n = 3) in triplicate.
Oxypurinol caused a dose-dependent inhibition of the xanthine-mediated LEC of 
raw bovine milk and gave an IC50 value in this protocol of 117.5pM.
The effect of pasteurisation and fat content of milk was assessed by measuring the 
NADH-mediated LEC of full fat (FF) and semi-skimmed (SS) pasteurised milk. 
Figure 3.10 shows there to be no significant difference between the signal LEC 
generated from FF compared to SS milk. However, when compared to the raw milk 
in figure 3.7, the peak height signal generated under the same conditions for NADH 
is reduced in both FF and SS milks ~ 2.2 ALU sec'1 compared to ~ 4.5 ALU sec'1 










Figure 3.10. The NADH-mediated LEC of full fat and semi-skimmed pasteurised 
milk. The activity of these milks was measured as described in figure 3.7.
The difference between raw and pasteurised milk may suggest an effect of the 
pasteurisation process although the samples tested were not from the same herd. 
The measured activity of raw bovine milk was therefore treated by microwave 
exposure to show the effect of heating on the activity and temperature.
3.3.1.2 The effect of microwave treatment
To determine the effect of the commonly used microwave method of reheating 
human milk and to assess the effect of temperature on activity, raw bovine milk was 
subjected to microwave radiation and XO activity studied. 200ml of raw 
unpasturised bovine milk were subjected to microwave radiation on full power 
(900W) over time in an open glass container. At each time point a 300jil aliquot 
was removed from the milk and added to the wells of a 96-well plate. At each time 
point the temperature of the milk was measured using a mercury thermometer after 
shaking to homogenise the milk. This process was repeated for 120 seconds of 
microwave exposure and the aliquoted milk was allowed to warm or cool to room 
temperature. The milk was then tested for its NADH-mediated LEC as a measure
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of the superoxide generating activity in the milk. Figure 3.11 shows the effect of 



















Figure 3.11. The effect of microwave treatment on the NADH-mediated LEC from 
bovine milk. NADH 500jiM with lucigenin 500ja.M enhancement run at 37°C. 
Data show the activity against temperature of bovine milk whilst the inset 
shows the effect of microwave time on the temperature of the milk. Data are 
mean ± SEM (n = 2) in triplicate.
Microwave treatment causes the temperature of the milk to increase proportionately 
to the time of microwave exposure. The NADH-mediated LEC from the 
temperature-matched samples remains constant until the temperature exceeds ~ 
70°C after which the LEC is reduced significantly * at 76°C (p<0.05) and ** 86°C 
(p<0.01) compared to the activity in untreated milk (~ 6°C).
3.3.1.3 Human milk
The NADH and xanthine-mediated LEC of human milk were measured in the same 
manner as for bovine milks. Figure 3.12 shows the NADH and xanthine-mediated 
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Figure 3.12. Human milk-mediated LEC in the presence of NADH or xanthine. 
Data are shown as described in figure 3.7 for human milk 30 days post 
partum. Experiments were run on three consecutive days and show mean ± 
SEM (n = 3) in triplicate of one sample from one mother.
Human milk shows a proportional increase in activity for NADH LEC. The xanthine- 
mediated LEC however is not detectable by this method with values similar to a 
PBS blank.
3.3.1.4 Infant milk formula
The activity of infant milk formulas was assessed in the same manner to determine 
both xanthine and NADH activity. Pre-formed formula feeds were added to the 
assay system as described previously at a range of concentrations. Feeds used 
were Aptamil® first with Milupan™ (Milupa, UK), SMA Gold® (SMA Nutrition, UK) 
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Figure 3.13. The NADH and xanthine-mediated LEC in infant milk formula Aptamil. 
For Aptamil, Cow and gate and SMA Gold infant milk there was no measurable 
activity above background counts in this assay system (See also figures 3.14 and 
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Figure 3.14. The NADH and xanthine-mediated LEC for infant milk formula Cow 







Figure 3.15. The NADH and xanthine-mediated LEC of infant formula SMA Gold. 
Data shown as ± SEM (n = 3).
3.3.1.5 Buttermilk from Golden churn
Some commercially produced spreads contain a potential source of XO activity in 
that they are supplemented with bovine buttermilk. The NADH-mediated LEC of 
Golden Churn spread which contains 20% buttermilk was tested. From a solid at 
room temperature, the spread forms a bilayered system when heated to 40°C. The 
upper layer consists of sunflower and vegetable oils whereas the lower phase 
contains proteins. Both phases were tested for their NADH-mediated LEC activity. 




Figure 3.16. The NADH-mediated LEC from the two-phase system of heated 
Golden Churn spread. Data are ± SD (n = 1) of triplicate results.
Using this system it was not possible to detect NADH-mediated LEC.
The buttermilk was then assessed for its ability to generate NO from nitrite and 
NADH under a nitrogen atmosphere using the OEC assay. Figure 3.17 shows the 
effect of buttermilk addition and oxypurinol addition on the NO generation from 
nitrite and NADH.
NO was measured from buttermilk in the presence of nitrite and NADH and this 
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Figure 3.17. The NO generated from buttermilk. Buttermilk was isolated from St 
Ivel Gold spread as described above. Using 500jnl buttermilk, 1mM NADH, 
10mM nitrite and 100^M oxypurinol under a nitrogen atmosphere.
3.3.2 Protein analysis of various milk sources
To determine the XO content of a range of sources, each milk product was 
subjected to gel electrophoresis and Western blotting.
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3.3.2.1 Protein gel of milk products
A gel was run of human and bovine milk, Aptamil and Cow and Gate infant 
formulas and Golden Churn spread. Figure 3.18 shows the proteins in each of 
these preparations by Coomassie blue stained gel.







Figure 3.18. The protein gel for various milk based products. MW = molecular 
weight markers in KDa, hM = human milk, C+ = Cow and Gate, Ap = Aptamil, 
bM = bovine milk and GC = Golden Churn spread.
The milk products were also blotted onto nitrocellulose and probed for the 
appearance of XO. Figure 3.19 has the results of this analysis.
MW (KDa) hM C+ Ap bM GC
9 0 ---------
5 0 ---------
Figure 3.19. The response of various milk products to probing for XO.
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Human and bovine milk both show strong staining at 150KDa and bovine milk and 
the Golden Churn protein shows degradation products at ~ 90 and ~ 50KDa. Both 
the Cow and Gate and Aptamil milk formulas show no reactivity towards the anti- 
XO antibody in this preparation.
3.3.3 Human milk XO protein
To assess the levels of enzyme secreted in human milk a study was undertaken to 
measure the activity and specific protein content of human milk post partum. Five 
samples were collected on days 7, 30, 36, 66 and 158 days post partum from a 
mother who gave birth to a full term healthy baby and was herself generally fit 
throughout the time of the collections. Milk was collected during spontaneous 
expression with the aid of a breast pump at times when the infant was not feeding.
3.3.3.1 Total protein determination
The total protein content of the human milk samples was measured using a 
modification of Bradford’s assay (see appendix II). Figure 3.20 Shows the effect of 
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Figure 3.20. The total protein content of human milk post partum.
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The total protein content of the human milk varies post partum with a general 
downward slope. The visual inspection of the milk samples showed that when 
homogenised by mixing the general turbidity of the milk on visual inspection 
decreased as the post partum time increased.
3.3.3.2 XO protein measurements
To assess the relative activities of enzymic action the amount of XO protein as 
opposed to the total protein amount was measured. This information linked with 
the activity will show changes in activity corrected for enzyme concentration and 
will possibly show changes in relative activity over time. This was determined by 
the use of Western blot analysis.
Milk samples at 10pg total protein per well were subjected to SDS page 
electrophoresis on an 8% gel as described in section 3.2.3, run in duplicate with 
one gel stained with Coomassie blue and the other gel used for Western blot 
analysis. Figure 3.21 shows the Coomassie blue stained gel
Days post partum 









Figure 3.21. Human milk samples following SDS PAGE electrophoresis and 
staining for protein with Coomassie blue. Also shown are the molecular 
weight marker and bM (bovine milk).
The nitrocellulose blot was probed using anti-bovine XO antibody raised in rabbits 
with a secondary swine anti-rabbit HRP-labelled antibody. Figure 3.22 shows the 
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Figure 3.22. The staining of human milk for XO
This was repeated with the addition of purified human milk XO of known protein 
concentration. The optical density of the 150KDa band was measured and related 
to the known dilution series. The concentration of the unknown milk protein was 
then calculated and is shown in figure 3.23.
The reactivity of the immobilised protein shows changes over time post partum. 
There is reactivity in all samples, the optical density measurements of which 
increase from day 7 to 30 and thereafter begin to fall to levels below that of 7 days 
by 158 days post partum. On longer exposure of the membrane further 
degradation products begin to appear which are indicative of XO protein.
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Figure 3.23. Repeat of Western blot of human milk samples with purified human 
XO as internal standard.
3.3.3.3 XO enzymic activity
The enzymic activity of human milk was assessed by measuring the NADH and 
xanthine-mediated LEC and correcting for XO enzyme content as measured in
3.3.3.2.
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Figure 3.24. The response of human milk with NADH and xanthine in LEC. Data 
are mean ±SEM (n = 2) of triplicate values corrected for amount of XO enzyme 
present.
The activity of the human milk is shown to increase relative to the amount of 
enzyme present. A straight line over time would show that the enzyme generated 
had the same activity throughout the lactation period. These data however show 
that as the time post partum increases the activity of the enzyme found in milk 
increases.
The conversion of pterin to isoxanthopterin by human milk xanthine oxidase was 
measured using a fluorimeter with excitation at 345nm and emission at 390nm in 
quartz cuvettes with stirring at 25°C. Figure 3.25 shows the rate of product 
formation for each time point post partum.
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Figure 3.25. The XO activity of human milk samples as assessed using the rate of 
production of isoxanthopterin from pterin substrate. Rates were taken in the 
presence of 500jaI human milk and 200^iM pterin made up to a final volume of 




Human milk was found to metabolise pterin to its fluorescent oxidation product 
isoxanthopterin. The rate of reaction varied across the time post partum but gave a 
peak activity at ~ 30 days.
The NO generating capacity of human milk was determined using the Ozone 
enhanced chemiluminescence (OEC) analyser. Human milk was reacted with 
nitrite and NADH under reduced oxygen conditions as described in section 2.2.6.2. 
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Figure 3.26. The generation of NO from nitrite (10mM), NADH (1mM) and human 
milk (500^1) day 7 post partum in the absence of oxygen. All reactants were 
gassed with 5% C 02 balanced nitrogen and added to the reaction chamber 
sequentially, NADH at time zero, nitrite at A and human milk at B.
The milk gave a typical reaction curve with the exception that the signal showed 
some variation and was pulse-like. It was noted at the time that the impellar 
caused the reactants to foam, forming bubbles. As the bubbles burst the stored 
NO would be seen as a spike in the readings. The average of the top of a spike 
and its associated trough was taken as the rate of NO generation per second.
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This procedure was repeated for all the post partum milk samples and is shown in 
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Figure 3.27. The NO generating capacity of human milk in relation to time (days 
post partum) for one mother.
The NO generating capacity of the human milk correlates to the amount of XO 
enzyme in each sample as estimated from the Western blot analysis over the first 4 
time points. Following 158 days post partum there is a deviation in the activity 
relative to the amount of enzyme, which also mimics the total protein 
measurements (section 3.3.3.1). By calculating the NO enzyme activity to XO 
protein the relative activity over the 6 months post partum milk samples can be 
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Figure 3.28. The data from figure 3.25 Transformed to show activity of human milk 
samples per milligram of XO protein.
The NO generating activity in the human milk samples stays relatively constant 
over the first 66 days post partum. At 158 days post partum, as the total protein 
content of the milk drops, the amount of estimated XO enzyme also falls. However 
at this 6 month time point the activity of the milk is increased relative to the amount 
of protein present.
3.3.4 Peroxynitrite effect on cell viability
3.3.4.1 Bolus additions to stationary phase bacterial cultures.
Peroxynitrite at a range of concentrations was added to cultures of E. coli and S. 
enteritidis of known cell concentration and the cells then plated onto agar for viable 
count determination. Figure 3.29 shows the effect of ONOO- addition and also the 
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Figure 3.29. The bolus addition of ONOO- to E.coli and S. enteritidis. Cells were 
diluted to suitable working concentrations (107 -  108 cells ml'1) in sterile 
phosphate buffered saline (PBS). ONOO- at a range of concentrations was 
added as a bolus dose to cells and incubated at room temperature for ten 
minutes. Aliquots were taken from the treated cells, plated on to nutrient agar 
and incubated in a warm room at 37°C overnight. Viable counts were 
performed as described previously and the number of colonies formed was 
related to a control consisting of decomposed ONOO- diluted in the same 
manner as 100pM ONOO-. Shown in the inset is the effect of decomposed 
ONOO- (dONOO-) on cell viability against control cells in PBS. Graphs show 
mean ± SEM (n = 2) experiments in triplicate.
The effect of ONOO- is to significantly reduce viability in both cell types compared 
to the dONOO- and naive controls. The IC50 value for ONOO- in this experimental 
set up was for E. coli and S. enteritidis 1.402 and 2.026jiM respectively.
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3.3.4.2 Effect of peroxynitrite addition to bovine milk
To assess the effectiveness of peroxynitrite as an anti-bacterial agent in milk, bolus 
additions of ONOO- were made to commercial sources of semi-skimmed milk. The 
milk was treated in a manner similar to general household use in that it was kept at 











Figure 3.30. Effect of peroxynitrite addition to bovine milk. Aliquots were taken on 
day one of experimentation and plated onto nutrient agar for viable count 
determination. Treatments consisted of milk, milk plus a single bolus addition 
of 100pM ONOO- or dONOO-, and milk plus bolus additions of ONOO- or 
dONOO- daily for 5 days. Data show mean ± SEM (n = 2) in triplicate 
ONOO- addition to semi-skimmed milk showed a time-dependent retardation of 
colony forming units on plating on agar. A single bolus addition of ONOO- 
significantly (p<0.01) reduced the CFU ml"1 compared to control values at all time 
points. Multiple additions of ONOO- also significantly reduced CFU ml"1 (p<0.01) 
compared to control values and also showed a significant reduction (p<0.05) 
compared to a single bolus dose (by students t-test).
182
Chapter 3
3.3.4.3 Effect of hypoxanthine on bacterial growth in bovine milk
Semi skimmed and pasteurised bovine milk was incubated at 4°C for seven days. 
Each day an aliquot of 1ml was removed and incubated at 37°C for 30 minutes. 
This aliquot was then plated onto agar and incubated overnight at 37°C. Any 
colonies formed were counted and expressed as colony forming units per ml of milk 
against time. From the same milk, an aliquot was taken on day 0 and 100jiM 
sterile hypoxanthine was added and then incubated and treated as described for 
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Figure 3.31. The effect of hypoxanthine on the naturally occurring flora in 
commercially generated pasteurised semi-skimmed milk. Results are mean ± 
SD in triplicate from one experiment.
Hypoxanthine has the effect of reducing the number of viable colonies when grown 
on agar compared to the untreated controls.
Assessment of the colonies by Grams stain (see appendix II) picked out Gram 
positive rods and Gram positive cocci in bunches shown in figure 3.32.
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Figure 3.32. The Gram stain of colonies cultured on agar from bovine milk. 
Individual colonies were inoculated into nutrient broth and incubated at 37°C 
overnight with shaking. The resultant monocultures were Gram stained and 
viewed using a microscope with oil immersion. A Gram positive rods and B 
Gram positive cocci in bunches.
3.3.4.4 Peroxynitrite effect on cell growth.
The apparent difference in killing effectiveness seen by the bolus addition of 














Figure 3.33. ONOO- effects were measured following the bolus addition of lOO i^M 
ONOO- at various time points in the growth of cells. Also, continuous 
production of ONOO- was assessed in this system using a 1mg ml'1 solution of 
3-morpholinosydnonimine (SIN-1) which releases both superoxide and NO 
simultaneously on hydration.
Figure 3.33 shows the effect of continuous ONOO- generation on bacterial growth. 
SIN-1 addition causes the reduction in growth compared to the control. The serial 
addition of ONOO- causes the greatest effect but the concentration of ONOO- 
required is far in excess of that generated continually by SIN-1 (~1 nmole min'1 mg' 
1) (Crow etal  1995)
This effect was further investigated by the addition of lOO^M ONOO- at single time 
points throughout the growth phase. Figure 3.34 shows that addition of ONOO- 
one hour after seeding causes a significant reduction in absorbance compared to 
the additions at time 0, 2 and 3 hours following seeding. An effect of each addition 








Figure 3.34. The effect of growth phase on bacterial susceptibility to ONOO-. E. 
coli were seeded into the wells of a 96-well plate in NB and their growth 
followed by measuring absorbance. ONOO- was added at various time points
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after seeding 0,1,2,3 hours respectively. Also a control of untreated cells was 
run for comparison with cells treated every hour (CON and 0N 004x). Data 
are mean ± SEM of 2 experiments in triplicate.
To assess the effect of ONOO- addition to a range of bacteria the automated 
absorbance assay was used. By calculating the growth rate constant for each cell 
type in the absence and presence of a range of concentrations of oxidants it was 
possible to determine the growth rate relative to an untreated control.
Using equation (15) below the growth rate constant was calculated.
(Iog10 Nt1- log10 Nt0) x 2.303
"  = (15)
Where ji = the growth rate constant, NM the absorbance at t1, Nro the absorbance at 
to, t1 time in minutes in exponential growth and to time in minutes at the start of 
exponential growth.
Using Staphylococcus aureus, Lactobacillus casei, Bacillus sp and a Micrococcus 
sp, E. coli and S. enteritidis, the effect of ONOO- addition was assessed. Figure 
3.35 shows the effect of ONOO- addition on the growth rate constant related to a 









































Figure 3.35. The effect of ONOO- on the growth rate of various bacteria. Cells 
were seeded into fresh nutrient broth after over night culture at 2x107 cells 
well'1. ONOO- was added at the start of the exponential growth phase for 
each species. Results are mean ± SEM of three individual experiments 
carried out in triplicate.
The effect of ONOO- addition reached significant difference for Staphylococcus at 
25jiM ONOO-, at 25[xM for S. enteritidis whereas significant deviation p<0.05 was 
reached for the other four bacterial species at all concentration of ONOO- used in 
this experiment (Students t-test)
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Figure 3.36. The effect of H20 2 on growth rate of various bacteria. Protocol as 
described in figure 3.35. Results are ± SEM of three individual experiments 
carried out in triplicate.
There was no significant deviation from the control for Staphylococcus at the 
concentrations tested and only concentrations of 200 and 400pM H20 2 were 
significant p<0.05 and <0.01 respectively for Lactobacillus. For Bacillus and 
Micrococcus species both show significant reduction in growth rate: Bacillus 
significance reached at >50pM H20 2 and Micrococcus at all concentrations tested 
by students t-test. Both E.coli and S. enteritidis showed significant deviation 
(p<0.05) from the control at concentrations above 12.5pM H20 2.
The dose of ONOO- and H20 2 at which 50% reduction in growth rate is observed 
for each species is shown in table 3.2.
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E. coli 96.1 -
Salmonella 114.6 -
Staphylococcus 290 -
Table 3.2. Summary of the half maximal growth rales of bacteria exposed to
ONOO- and H20 2.
3.3.5 Effect of xanthine oxidase-derived metabolites on cell viability
3.3.5.1 Effect of Hypoxanthine and xanthine oxidase in air
To asses the effect of enzyme derived metabolites, monocultures of various 
bacteria were grown overnight in nutrient broth and then grown in the presence of 
purified bovine xanthine oxidase and hypoxanthine. This was assessed by 
calculating the growth rate constant for each cell type in the absence and presence 
of a range of concentrations of enzyme and substrate as previously described for 
ONOO- and H20 2.
Figure 3.37 shows the effect of increasing hypoxanthine concentration at 30^g XO 










































Figure 3.37. The effect of XO and hypoxanthine on the growth rate of various 
bacterial species. Protocol as described for ONOO- effects except that all 
substrates and enzyme were added at time 0 minutes. Results are mean ± 
SEM of three individual experiments in triplicate.
The addition of hypoxanthine alone at 200jiM caused no significant deviation from 
cells grown in the absence of hypoxanthine. Significant reduction in growth rate 
(p<0.05) was measured for all six bacteria with the half maximal concentration of 
hypoxanthine and is summarised in table 3.3.
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Species Significance p<0.05 
(^M hypoxanthine)






E. coli >3.125 151
Salmonella >12.5 -
Table 3.3. The summary of XO / hypoxanthine effect on bacterial growth rate in
atmospheric air.
All growth rates were significantly reduced compared to control cells. The 
reduction in growth rate to the half maximal level was seen in all species except 
Staphylococcus with maximal reduction in growth of ~ 20% at the concentration of 
enzyme and hypoxanthine used.
3.3.5.2 Effect of oxypurinol on XO and hypoxanthine mediated growth effects
Oxypurinol was added to the wells of a 96 well plate as part of a growth assay for 
Lactobacillus casei. The effect of 30jj.g XO and hypoxanthine at 100fiM was to 
reduce growth rate significantly in this bacteria. The addition of oxypurinol was to 
determine the enzymic nature of the growth retardation. Figure 3.38 shows the 
effect of a range of oxypurinol concentrations on the growth of Lactobacillus. 
Oxypurinol in the absence of XO and hypoxanthine had no effect on the growth rate 












Figure 3.38. The effect of oxypurinol on the XO, hypoxanthine mediated growth 
retardation in Lactobacillus. Cells were grown in a 96 well plate format and 
exposed to XO and hypoxanthine. Oxypurinol was added at a range of 
concentrations and results are shown as the % of control growth rate from 
cells in the absence of XO but in the presence of 100pM hypoxanthine. 
Results ± SEM (n = 3) in triplicate.
Oxypurinol reversed the inhibition of growth rate mediated by XO / hypoxanthine in 
a dose dependent manner.
3.3.5.3 The effect of oxygen concentration on bacterial viability
As the type of oxidant generated is dependent on the oxygen concentration of the 
reaction mixture, the effect of oxygen was assessed on the viability of bacteria in 
the presence of nitrite, XO and an electron donor. It was not possible to run the 
experiments using the automated assay so cells were incubated with radical 
generating systems for 30 minutes before plating onto agar for viable count 
determination as described in section 3.2.8. Figure 3.39 shows the effect of 
oxygen concentration on the viability of E. coli and S. enteritidis following 30 minute 
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Figure 3.39. The viability of bacterial strains in the presence of XO metabolites. 
2x107 cells ml'1 were added to XO, 53.2pg, NADH, 300jiM and nitrite, 1mM 
and incubated for 30 minutes under defined oxygen concentrations. Data are 
mean ± SEM (n = 2) in triplicate shown as percentage against control cells in 
the absence of NADH.
For both cell types viability is reduced compared to controls incubated under the 
same conditions. Viability varies with oxygen concentration in the media. S. 
enteritidis is more susceptible to the metabolites at 0% oxygen (viability -75%  
compared to -  90% viability for E. coli). The peak killing oxygen concentration for 
E. coli and S. enteritidis is 2.9% and 0% respectively. As the oxygen concentration 
increases the viability of both bacterial strains increases with little or no killing 
above -  8% oxygen. However there does seem to be some killing at higher 
oxygen concentrations with -  10% and 5% killing for E. coli and S. enteritidis 
















Figure 3.40. The effect of hypoxanthine on the viability of bacteria. Exposure to a 
range of oxygen concentration in the presence of XO 53.3ng, hypoxanthine 
100|xM and nitrite 2.5mM. Data are mean + SEM (n = 2) in triplicate.
The peak killing for E. coli and S. enteritidis in the presence of hypoxanthine was 
seen at 6.4% and 1.5% respectively. Some killing was also seen at 21% oxygen 
for both bacterial strains but was only significant for E. coli.
120-.
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Figure 3.41. The effect of xanthine as electron donor on bacterial viability. 
Exposure to a range of oxygen concentrations in the presence of XO 53.3ng, 
xanthine lOO i^M and nitrite 2.5mM. Data are mean ± SD (n = 1) in triplicate.
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The effect of xanthine was small compared to control levels at all concentrations of 
oxygen utilised.
3.4 Discussion
In the light of the oxygen and nitrogen radical-generating capacity of XO and its 
high concentration in mammalian milk, the possibility of its utilisation as an 
antibacterial enzyme has been studied.
XO enzymic activity was assessed in a variety of milk products to compare them 
with milk formulas often used as a substitute to maternal milk in feeding neonates. 
Bovine and human milks both contain large amounts of NADH active enzyme. The 
xanthine activity of human milk was very low compared to bovine milk and this 
compares well with previously published data on the differences between bovine 
and human milk-derived XO enzyme (Sanders et al 1997). Infant milk formulas 
showed no NADH or xanthine mediated LEC. However these formulas contain the 
antioxidants Vitamins C and E which have been shown previously to reduce LEC in 
the presence of superoxide. When probed for XO protein by Western blot analysis 
these formulas were found to be lacking in this reactive protein using this antibody. 
In the case of butter milk derived from Golden churn a similar lack of LEC was seen 
for both substrates. However, the butter milk was active when tested for NO 
generating activity and this activity was also oxypurinol inhibitable. With Western 
blotting there was also a strong signal for the 150KDa band when probed with the 
Chemicon anti-xanthine oxidase antibody. This preparation also contains 
antioxidant vitamins and it is possible that it was these factors that reduced the LEC 
even when active enzyme was available.
In the light of evidence suggesting that breast milk confers protection on the infant 
from enteritis compared to infants fed formula preparations, it is a possibility that
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xanthine oxidase-derived radicals may play a role in protecting the infant from 
enteric infections.
Human milk showed activity in both xanthine and NADH-mediated LEC, pterin 
mediated activity and also as a generator of NO in low oxygen conditions in the 
presence of nitrite and NADH. The human milk also showed a variation in activity 
data over time post partum. When corrected for XO protein, the activity per mg of 
protein remained relatively constant over 66 days. Only at ~ 6 months had the 
protein content per millilitre fallen but the enzyme activity per milligram was 
increased over the previous time points per milligram of XO protein. It is possible 
that the activity of the enzyme is controlled such that on reduced protein generation 
the activity is increased in some way to confer more radical generating capacity. 
Also the size of feed and therefore amount of enzyme in the gut is generally 
increased over time post partum and this may also confer a greater protective 
effect.
This is the first description of the NO generation from nitrite in the presence of 
NADH from a human source of XO. From the previously described superoxide 
generation from both human and bovine milk XO, the possibility exists to generate 
NO and superoxide simultaneously.
The effect of ONOO- addition to bacterial cultures was to decrease viability and 
growth rate constant in a dose-dependent manner for all bacteria studied.
Two assays were utilised for the measurement of ONOO- effects on the two Gram 
negative bacteria, E. coli and S. enteritidis. The viability assay used where cells 
were incubated with ONOO- in PBS gave the inhibitory dose of 1 pM which is far 
reduced compared to the growth rate assay which utilises growing cell in culture 
media. The previously stated IC50 values for a different strain of E. coli are 
somewhat higher than the viability assay stated here but are similar to the data
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shown in the growth assay (Brunelli et al 1995). This may be due to strain 
characteristics or the state of the cells on addition of peroxynitrite. In this thesis the 
point of addition of ONOO- has also been shown to greatly effect the outcome for 
growing cultures suggesting the growth cycle as a possible target for therapy.
The variation in susceptibility to ONOO-, H20 2 and enzyme derived metabolites 
may in part be due to the generation of antioxidant enzymes by the bacteria. The 
effect of ONOO- addition on early log phase cultures showed the greatest effect 
and it is at this time that most of the bacteria will not be generating their antioxidant 
enzymes.
If the radical products of milk XO are to be bactericidal, they must be able to 
mediate their effects in milk with al! the associated proteins and lipids. Using the 
model of pasteurised, semi-skimmed milk, which contains naturally occurring 
environmental contamination, the effect of chemically synthesised ONOO- showed 
a reduction in viability of the species contained in the milk over time. A single dose 
of ONOO- significantly reduced the viability of contaminating organisms as did the 
multiple doses of ONOO-.
The single addition of a bolus of hypoxanthine also reduced bacterial growth in milk 
and it is suggested that this was through the action of xanthine oxidase derived 
metabolites. Indeed in the XO / hypoxanthine susceptible Lactobacillus, the 
addition of oxypurinol protected the cells and allowed growth.
Recently, it has become of importance to reduce the utilisation of antibiotics as 
growth supplements in animal feeds and across the spectrum of bacterial infections 
because of the resistance developed by many bacteria to commonly used 
antibiotics. Work in pigs fed a diet containing increased lactose has seen a 
reduction in the amount of antibiotic required for health. This has been suggested 
to be due to the selection of non-harmful, commensal bacteria such as the
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Lactobacilli sp which out-compete possibly harmful bacteria (Oli et al 1998). 
Although Lactobacillus were affected by XO / hypoxanthine it is possible that due to 
an increased lactose diet the effects on growing Lactobacillus sp may be to out 
compete the more infective bacteria even in the presence of the radical generating 
system with the combination of approaches of synergistic benefit.
The effect of ONOO- on growing cell cultures showed a difference in susceptibility 
which was dependent on the point of the growth cycle. Cells were more 
susceptible to ONOO- during the early part of the log phase compared to the lag 
and stationary phases as assessed by sequential additions of ONOO- to the 
cultures. The addition of ONOO- at the start of the log phase had the greatest 
effect on growth. At this point, the cycle time can be as short as 20 minutes 
between divisions. At this time the production of antioxidant defence proteins such 
as SOD and catalase are not expressed to such a high extent as seen in the 
stationary phase. The particular effect of ONOO- addition depends on the mode of 
action of ONOO- on growth and viability. It has been previously shown (Beckman 
and Koppenol 1996) that ONOO- has a variety of effects on proteins of particular 
importance and on DNA (Szabo and Ohshima 1997). Strand breaks in DNA 
require repair enzymes which themselves can be inhibited by ONOO- which can 
cause a reduction in growth rate if the breakages are not lethal in nature (Szabo et 
al 1996). It is also known that ONOO- can be transported through membranes 
either passively in the protonated form or actively using a 4,4’- 
diisothiocyanatostilbene-2,2’-disulphonic acid (DIDS) inhibitable HC037Cr ion 
channel in the anionic form where it can cause nitration of proteins especially of 
tyrosine residues and inhibit various activities (Denicola etal 1998).
The sensitivity of bacterial species must depend on the antioxidant mechanisms 
that they utilise, and the ability to block the entry of ONOO- into the cell. The form
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of the peroxynitrite may also have a differential effect with peroxynitrous acid able 
to passively diffuse through membranes and may therefore be a more potent 
intracellular oxidant and nitrating agent.
The viability of bacteria in the presence of XO-derived metabolites varied with 
oxygen concentration under the conditions used. Using the combined activities of 
NO and superoxide generation at a range of oxygen concentrations, peak killing 
activity could be seen in the range of oxygen concentrations where simultaneous 
generation is expected.
This effect is seen at relatively low enzyme concentrations. From the levels used 
here (~ 50fAgml'1) the concentration of XO enzyme in human milk from this thesis 
covers the range from 300 -  800ngmr1, greater than a ten fold increase in the 
amount of available enzyme.
It is possible then that the radical generating activity of xanthine oxidase in the 
environment of the neonatal bovine or human gut may play a role in mediating the 
growth and colonisation of bacteria and the onset of infection by pathogenic strains 
of bacteria.
Further work on the variation in oxygen content on the viability of bacteria in the 




The binding of xanthine oxidase to endothelial cells
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This chapter deals with the possibility that XO circulates as an active enzyme in 
man and can bind to cellular surfaces to allow relocation of active enzyme to sites 
distant from protein synthesis.
4.1 Introduction
4.1.1 The cellular expression of XO
Previously, the expression of XO had been localised to a variety of organs and this 
finding spawned the ideas surrounding its possible role in reperfusion injury 
(McCord 1985). This also suggested that other diseases may be due to or have 
some component that is due to oxidant stress and the localisation of XO enzyme to 
a particular tissue may suggest that an oxidant forming role may occur in that 
tissue. It was surmised that in joint inflammation many oxidant processes were 
occurring one of which may well be linked to the expression of XO.
Work carried out by Stevens et al (1991) and others pointed to a change in the 
vascularity found between normal and inflamed rheumatoid synovium. By 
measuring the relative density of the vasculature it was shown that inflamed 
synovia were relatively poor in blood vessels. The relative hyperplasia of the 
surrounding tissue had led to an outstripping of the blood supply to the synovium 
and eventually this would lead to a chronically hypoxic tissue.
Also shown was the expression of XO protein in the synovium. This was localised 
to the microvascular endothelium that lined the vessels. This produced the 
proposal that on a primary insult leading to increased pressure in the synovial 
capsule, phases of acute hypoxia followed by reperfusion of the tissue occurred.
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The localisation of the oxidant producing enzyme XO to the EC would cause 
damage during reperfusion as the oxygen was reintroduced.
4.1.2 Xanthine oxidase binding studies
The apparent functions of xanthine oxidase enzyme and its relative expression 
among various organs has led to the development of literature that aims to describe 
its role as an enzyme involved in pathology. From experiments carried out on the 
inhibition of enzyme activity, it was clear that an intracellular source of the enzyme 
was responsible for the damage seen. However, further reports suggest that the 
use of specific inhibitors of XO caused an inhibition of damage at locations far from 
the target organs. Experiments using allopurinol or by pre-treatment of animals 
with tungsten to inactivate XO were shown to decrease lung vascular barrier 
function secondary to splanchnic ischaemia-reperfusion (Terada et al 1992 and 
Koike et al 1993). It was also noted that, at allopurinol concentrations lower than 
those at which antioxidant effects are observed, there was a display of tissue 
protection in organs apparently low in or devoid of detectable endogenous XO 
activity (Zimmerman et al 1988). Examples of this came from both rabbit and 
human heart studies where myocardial ischaemia-reperfusion injury was 
significantly attenuated by allopurinol despite the apparent lack of enzyme activity 
in these organs (Gardner et al 1983, Grum et al 1986, Terada et al 1988 and 
Sarnesto et al 1996).
The suggested reason behind these findings is the possibility that XO circulates in 
the blood plasma either as a free protein or complexed with anti-XO antibodies 
(Benboubetra et al 1997). Plasma levels of XO were also shown to rise following 
ischaemia-reperfusion injury to the splanchnic system or following hypovolemic
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shock with further increases seen on perfusion of high levels of intravenous heparin 
(Terada etal 1992, Tan etal 1993 and 1995).
This system then, utilising a range of stimuli may allow the release of XO from 
various organs into the circulation by secretion or other means. The binding of this 
circulatory form of XO onto the surface of endothelial cells could concentrate the 
enzyme at specific points where its reaction products may have their actions. 
Previously, XO has been shown to associate with the endothelium and also to bind 
to heparin-sepharose 6B complexes in vitro (Radi et al 1997).
Recently it has also been observed in isolated and cell line derived endothelial cells 
that XO can localise to the cell surface. It was also observed that the staining 
pattern of individual cells was polarised with accumulation of antigen at specific 
sites on the cell, often on pseudopod like processes abutting other cells (Rouquette 
et al 1998).
The apparent affinity of XO for glycosaminoglycans may be used to exploit the 
radical generating capacity of the enzyme. Virulent strains of bacteria must often 
bind to a substrate to allow invasion particularly in gut associated pathogens. This 
adhesive process has been shown to involve certain matrix proteins including 
fibronectin, collagen and fibrinogen. It has also been noted that certain 
glycosaminoglycans (GAGs) can mediate bacterial and virus binding.
Heparin is a sulphated GAG known for its anti-coagulant activity that is exclusively 
produced by the mast cell and is not usually a part of the extra cellular matrix. 
However, it has close structural relationship to heparan sulphate which is found in 
the extracellular matrix and on the surface of most animal cells. Heparin is more 
sulphated than heparan sulphate and a basic protein that nonspecifically binds the 
strong polyionic heparin may not necessarily have an affinity for heparan sulphate 
(Ortega-Barria and Pereira 1991 and Frevert etal 1993).
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Many microorganisms express heparin binding surface proteins and the 
internalisation of several viruses involves the binding of the virus to heparan 
sulphate proteoglycans at the cell surface. Chlamydia trachomatis is an obligate 
intracellular bacterium that requires adhesive processes to enter animal cells. It 
apparently synthesises a heparan sulphate like GAG that is bound to its surface. 
The heparan sulphate then serves as a bridge that can bind other heparin binding 
proteins to the host cell surface (Patti et al 1994).
4.1.3 Circulating plasma xanthine oxidase
To study the activity of circulating proteins a range of assays were employed. 
Using blood from normal healthy volunteers pre and post exercise NADH activity 
was assessed by NADH mediated chemiluminescence and NADH oxidation. The 
oxidation of NADH in the absence of oxygen and the presence of nitrite was also 
measured. Finally Western blots of normal human plasma were run and blotted for 
xanthine oxidase protein.
The following experiments were designed to further the evidence for the circulating 
form of XO and the ability of XO to bind on the surface of live cultured endothelial 
cells and bacteria in the form of E. coli cultures. The mechanism by which this 
occurs was also studied by the measurement on endothelial cell surface heparan 
sulphate glycosaminoglycan expression and the effect of heparinase treatment. 




4.2 Method and materials
4.2.1 Flow cytometry
4.2.1.1 Introduction
Flow cytometry grew out of various other disciplines used to quantify individual cells 
or organelles. Techniques such as microfluorimetry, microspectrophotometry and 
microinterferometry provided a means to quantify DNA, RNA or proteins. Flow 
cytometry and associated electronic cell sorting offered advances in that it was 
capable of rapid measurement of several hundreds and thousands of cells per 
second with high accuracy and reproducibility. This in turn lead to the development 
of probes for various physiological parameters especially early on in cell cycle 
analysis (Darzynkiewicz and Crissman 1990).
4.2.1.2 Basic background
The basis behind all flow cytometers is the use of light scattering as a method to 
visualise particular cell types including size, morphology and granularity within a 
population. To do this, the cytometers use a focused beam of light usually from a 
laser that interacts with particles flowing in a stream of fluid. Using a method 
known as hydrodynamic focussing; a stream of fluid, the sample stream, is 
encapsulated in a second sheath of fluid where turbulence has been removed. 
This allows the sample stream to exist within the sheath stream without mixing of 
the two fluids. The laser is then focussed onto the sample stream and illuminates 
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Figure 4.1. The basis behind hydrodynamic focussing.
The subsequent light scattering of the particles is measured using detectors which 
are set at two points relative to the light direction. These two parameters low angle 
or forward scatter (FSC) detector is set at ~ 10 degrees deflection from the primary 
laser beam. The side scatter (SSC) detector is set at 90 degrees to the primary 
laser beam. With these two parameters it is possible to discern a population of 
cells from debris and also to discern individual populations such as mononuclear 
leukocytes and granulocytes from a mixed population of white cells.
Using electronic gating it is also possible to identify a cell population of interest and 
analyse that population whilst collecting data for the whole sample. This technique 
is required when cells are to be discerned from debris and other non-cellular 
contaminants which may cause false positive results. Electronic gating was used in 
all experiments described below to remove such debris.
Also used was the threshold parameter. This allows the removal of some of the 
smaller particles before electronic gating. In all experiments with human cells the
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laser beam was focused through a neutral density filter which effectively limits the 
resolution of the cytometer to particles greater than 5 micrometers in diameter. The 
cytometer used for these experiments had its laser focussed onto the sample 
stream in air. That is to say that a nozzle of 100jim in diameter is used as the 
hydrodynamic focussing device. This allows for relatively large cell types such as 
EC to be used.
4.2.1.3 Cell surface measurements
Cellular antigens can be measured using a range of fluorescent probes. The laser 
emits light at a particular wavelength, commonly 488nm, which will excite specific 
molecules such as fluorosceine-iso-thiocyanate (FITC) and propidium iodide (PI) 
and cause them to fluoresce. Using a range of wavelength filters, multiple probes 
may be used simultaneously and fluorescent parameters of cell surface and/or 
intracellular antigens may be measured. Due to the Stokes shift of these 
fluorescent probes the emission wavelength does not overlap with the excitation 
wavelength and by using filters of known bandwidth the overlap of fluorochrome 





Figure 4.2. The basic set up of the flow cytometer. X is the direction of sample 
fluid flow down through the page and point of excitation. Shown here are the 
detectors for multiparameter analysis of up to 4 fluorescence signals and 
analysis of light scattering parameters. (FL-1 refers to fluorescence channels 
for the detection of a discreet wavelength of emitted light, FL-2 -  4 being 
further fluorescence detectors).
Each detector consists of a filter of known band width and a photon multiplier tube 
(PMT). The particular light that reaches the PMT is coded into a digital signal and 
amplified. The electronics of the cytometer can then display each parameter event, 
light scattering and fluorescence as a series of plots.
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The sensitivity of the cytometer depends on the voltage being applied to each of 
the PMTs. These can be varied by the user and is used during routine alignment of 
the instrument with fluorescent beads.
The information generated can be shown as a series of plots including histogram 
plots, usually showing event number against measured parameter such as 
fluorescence and dot plots, showing two parameters simultaneously. To display 
the data two systems are used: logarithmic and linear scales. Each system lies 
over 1024 channels (0-1023) and information can be shown as mean channel 
height which relates to the mean position of the data showing a normal distribution 
along a particular axis. In the following experiments mean channel height is used 
as the measure of fluorescence for each of the sets of data generated.
4.2.2 Tissue culture
4.2.2.1 Cell isolation
4.2.2.1.1 Human umbilical vein endothelial cell (HUVEC) isolation
Large vein endothelial cells have been cultured as relatively pure populations since 
the early 1970s. The following isolation technique is a modification of methods 
described by Jaffe et al (1973) and Gimbrone et al (1974).
Human umbilical cords were collected from neonates following birth and stored at 
4°C until use, which was typically within 48 hours of delivery. Cords were prepared 
under sterile conditions in a class II flow cabinet (Microflow biological safety 
cabinet, MDS, UK) on a dissecting tray previously swabbed with 70% ethanol. The 
outer surface of the cords were swabbed with pink chlorhexidine gluconate (0.5% 
w/v in 70% v/v IMS - Depuy® Healthcare, UK) as a disinfectant. Each cord was 
then inspected for clamp marks caused during the delivery and also for needle
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marks which would cause leakage in the following procedure. The vein of each 
cord, identified by its lack of intimal smooth muscle, was then cannulated using two 
plastic leur adapters in series which were fastened in the cord by plastic bag ties to 
produce a tight seal. Phosphate buffered saline (PBS) solution was then flushed 
through the cords to remove any residual blood remaining in the vein. This was 
repeated until the PBS ran clear and all the blood had been removed from the vein. 
The opposite end of the cord was then also sealed with two plastic bag ties to 
which was added a 0.5mgmr1 solution of type II collagenase (SIGMA, UK). The 
cords were then left to incubate at room temperature for 30 minutes to 1 hour after 
which the collagenase solution was removed and PBS flushed through the vein to 
remove any remaining endothelial cells. The resulting cell suspension was then 
centrifuged at 400g to pellet the cells which were resuspended in “HUVEC culture 
medium” (HM) (see appendix III) and plated typically onto T-25cm'2 tissue culture 
treated culture plates (Falcon, UK) and placed in an atmosphere of 5% C 02 95% 
air at 37°C. These cells were then washed in HM on the day following isolation and 
the media replaced every two to three days.
On reaching confiuency, the cells were passaged at a split ratio of 1:5 and used in 
experiments between passage 1-5. The purity of the isolated population, measured 
by immunological staining of vWF antigen: a marker for endothelial cells, was 
consistently over 99% reflecting the lack of contaminating cells from other lineages.
4.2.2.1.2 Synovial microvascular endothelial cell (SMEC) isolation 
The methods used to generate cultures of synovial microvascular endothelial cells 
were based wholly on the work of Abbot et al 1992. The method described below 
is a modification of that published protocol.
Human synovia were collected from the joints of patients undergoing total knee 
(TKR) or total hip (THR) replacements in the treatment of rheumatoid and
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osteoarthritis. The synovia were removed under sterile conditions and stored at 
4°C until use which was typically within 12 hours following excision. The 
microvasculature was removed by dissection of the synovial membrane. 
Hyperplasic tissue which is villus like and highly vascularised was removed by 
immersion of the synovium in media which caused the villi to float upward and 
facilitated dissection. Removed villi were placed into medium and minced with 
crossed scalpel blades before being incubated for 60-90 min in 2mgml'1 type IV 
collagenase (Worthington, UK) at 37°C. Following incubation, the tissue was gently 
homogenised in a loose fitting siliconised/PTFE homogeniser. The resulting cell 
suspension was then sequentially filtered through 100 and 40pm sterile filters 
(Falcon, UK) to further dissagregate the cells and remove cell clumps. Cells are 
counted and their viability was assessed by the means of trypan blue exclusion. 
The endothelial cell proportion of the whole cell suspension are calculated 
assuming that they comprise 3-5% of the total cells isolated. To select the 
endothelial cells from this heterogeneous population, immuno-magnetic sorting is 
utilised. This procedure involves the labelling of the endothelial cells with an 
antibody directed to a surface antigen expressed only on endothelial cells. This 
antibody then acts as an antigen to a second layer of antibody to which is 
conjugated a magnetic bead. On binding of the second layer, the cells can be 
separated by subjecting them to a magnetic field; the labelled cells being dragged 
out of the suspension towards the magnet.
The following procedures were all carried out at 4°C. Cells were pelleted by 
centrifugation at 400g for 5min before being resuspended in 1 ml PBS/bovine serum 
albumin (PBS/BSA - 1%). To this was added 10pl of anti-CD31 antibody per 106 
endothelial cells (1mgml'1 mouse lgG1, R and D systems, UK) for ten minutes on
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ice. Following incubation, the cells were shaken to resuspend them and a further 
10 minute incubation was performed before the cells were washed in PBS/BSA. 
The second layer sheep anti-mouse lgG1 antibody coated paramagnetic 
Dynabeads® (Dynal, Sweden) were added to the cell suspension on ice for 15 min 
at a ratio of 3:1 (beadsicells). Following this incubation, the cells were subjected to 
a magnetic field which selected out the CD-31 expressing cells. The endothelial 
cells remained attached to the side of the collection vessel whilst the endothelial 
depleted cell suspension was removed for a further round of bead labelling. The 
isolated cells were then washed and subjected to the magnetic field for a second 
time before being plated onto fibronectin coated (5 i^gcm'2 SIGMA, UK) 6 well plates 
in SMEC media (SM) (see appendix III).
Cells were grown to confluence before passaging at a 1 in 3 ratio onto fibronectin 
coated tissue culture plastic. Cells were used up until their 5th passage. 
Endothelial origin was defined by the positive labelling by anti-vWF antibody. This 
technique has the capacity to produce a greater than 90% purity of endothelial 
cells.
4.2.2.1.3 Synovial fibroblast (SF) isolation
Synovial fibroblasts were isolated in a modification of the SMEC isolation 
procedure. The cells were isolated as the negative (unsorted) population from the 
CD-31 expressing cells in that they were not attached to magnetic carrier beads 
and were therefore left behind in the media once the SMEC had been removed. 
These cells were grown to confluence on T-75cm'2 flasks in SF media (see 
appendix III). The fibroblast nature of these cells was assessed by their spindle 
shaped morphology and cultures were passaged at a 1 in 5 ratio at confluence.
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The purity of such cultures was generally high due to the rapid growth of fibroblasts 
over any contaminating cells in this media preparation.
4.2.2.2 Culture of cell lines
4.2.2.2.1 Culture of EA hy 926
EA hy 926 cell line was an epithelial / HUVEC fusion. Cells were maintained frozen 
under liquid nitrogen at -196°C in 50% FCS and 10% DMSO diluted in M199 
media. Before use, cells were rapidly defrosted under warm running water and 
resuspended in HM to dilute the DMSO by mixing 2ml cell suspension into 13ml 
HM. These cells were pelleted by centrifugation and resuspended in HM and 
seeded onto T-75 cm'2 tissue culture flasks. Cells were grown to confluence as 
described for HUVEC and passaged at a 1:5 ratio.
4.2.2.2.2 Culture of HTB4 human mammary epithelial cell line
These cells were cultured as described for EA hy 926 cell (4.2.2.2.1) and grown to 
confluence in fibroblast media.
4.2.3 Cell characterisation
4.2.3.1 Endothelial cell immunoreactivity to vWF
Localisation of vWF was one of the first specific criteria to characterise the lineage 
of endothelial cells (Jaffe et al 1973). More recently however, Chung-Welch et al 
(1989) have shown vWF in mesothelial cell but not in certain microvascular 
endothelial cells in vitro (Shaw et al 1984).
The expression of vWF in HUVEC, SMEC, and EA hy 926 was conducted on the 
cells in culture following the protocol below. This forms part of a standard staining 
procedure for cultured and fixed cells.
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Confluent passage 1 cells were seeded either onto Thermanox® cover slips in 24 
well or 4 well plates or onto 4 or 8 well glass chamber slides (Falcon, UK). Cells 
were allowed to adhere for up to four hours before the wells were flooded with the 
appropriate media. Following overnight culture the cells were washed three times 
in PBS before fixation in ice cold acetone:methanol (1:1 ratio) for 3 minutes. The 
cells were then washed a further 3 times in ice cold PBS/0.5% tween 20 (PT).
Cells were then blocked with the addition of 5% Marvel PT (MPT) for one hour at 
room temperature. Primary antibody dilutions were carried out in MPT and added 
to the cells for 1 -  2 hours incubation at room temperature. For vWF staining either 
a range of dilutions from 1/500 -1/2000 of rabbit anti-human vWF (SIGMA, UK) in 
MPT or MPT alone.
The cells were washed 3 times in PT and then the secondary antibody added. 1 
drop in 5 ml MPT of goat anti-rabbit HRP conjugated antibody (Vector Labs, UK). 
Cells were washed 3 times in PT prior to the addition of Vectastain ABC-Alkaline 
phosphatase which was made up in PT 30 min before addition and added for a 
further 30 minutes incubation at room temperature. The chromagen used was 
Fast-Red TR/naphthol AS-MX insoluble Alkaline phosphatase substrate with 1mM 
Levamisole (SIGMA, UK). This solution, in Tris buffer, was added on to the cells 
and the reaction was followed by observing colour development using light 
microscopy. The reaction was quenched by washing the cells in Ultra Pure H20 . 
Counter staining was performed using Mayers haematoxylin. Cells were immersed 
in haematoxylin solution (SIGMA, UK) for 30 seconds before being washed in 





4.3.1 Expression of XO (INTRACELLULAR) in EC
4.3.1.1 In endothelial cells
HUVEC were grown in glass chamber slides and fixed in ice cold methanol/acetone 
1:1 for 3 minutes followed by washes 3x in ice cold PBS. The cells were stained for 
xanthine oxidase using a range of primary antibody concentrations (rabbit anti- 
bovine xanthine oxidase, Chemicon, USA) in MPT over night at 4°C. The cells 
were washed 6x 5 minutes in PT followed by incubation with a goat anti-rabbit 
horse radish peroxidase labelled secondary antibody for 2 hours in PT. Cells were 
washed 6x 5 minutes in PT before the addition of avidin biotin complex alkaline 
phosphatase (ABC-AP, Vectastain, Vector Laboratories, UK) for 30 minutes. Cells 
were washed 6x 5 minutes in PT before the chromagen Fast Red TR/Naphthol AS- 
MX (SIGMA, UK) was added in tris buffer. The reaction was stopped by the 
addition of copious amounts of Ultra pure water. Slides were counterstained in 
Meyers haematoxylin for 5 minutes followed by washing in running tap water before 
mounting in aquamount. Figure 4.3 shows HUVEC stained for both xanthine 
oxidase and for vWF for comparison.
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Figure 4.3. The staining of HUVEC for XO (A and B) and vWF (C and D).
HUVEC stained for XO showed both perinuclear and diffuse granular staining when 
grown to subconfluence as shown. In comparisson, vWF stained HUVEC showed 
strong granular staining indicative of Weibel-Palade bodies localisation of vWF 
protein.
4.3.1.2 Effect of hypoxia on cellular enzyme activity
Endothelial cells were cultured to confluence in T-75cm'2 tissue culture flasks 
(Falcon, UK). Cells were then incubated in reduced serum SMEC media (1% FCS, 
rSMEC) for 24 hours before being washed and the media changed for SMEC 
media. The cells were then subjected to 24 hours of 5% C02 balanced air or 5% 
C02 balanced nitrogen at 37°C in a humidified atmosphere. The cells were then 
harvested by scraping and washed in PBS containing anti proteinases
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(homogenisation wash, HW) and resuspended in homogenisation buffer (HB) (see 
appendix III). The cell pellets were then homogenised and drawn 3x through a fine 
gauge needle (18G) using a 1ml syringe. The resulting suspensions were pelleted 
by centrifugation and stored at -70°C. Enzyme assays were carried out in air 
saturated PBS in the presence of 20|iM pterin and the fluorescence measured over 
time with excitation at 345nm and the emission wavelength of 390nm. The rate of 
product formation was measured as the slope of the graphs and calibrated with a 
known amount of isoxanthopterin fluorescence. Figure 4.4 shows the effect of 24 
hour hypoxia on pterin mediated activity from cultured endothelial cells.
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Figure 4.4. The pterin activity of cultured endothelial cells exposed to normoxic or 
hypoxic environments for 24 hours. Data are mean ± SEM of 3 experiments in 
duplicate.
Pterin mediated activity is observed in all three cell types following both normoxic 
and hypoxic incubations. The effect of hypoxia on HUVEC and SMEC was to 
increase the pterin mediated activity significantly above that of the normoxic 
exposed cells, HUVEC p<0.05 and SMEC p<0.01. There was no significant 
difference between cell types exposed to normoxic conditions and there was no
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significant increase in activity of EA hy 926 cells following 24 hour hypoxia. 
HUVEC showed a small but significant p<0.05 increase in activity following hypoxia 
treatment compared to EA hy 926 cells. SMEC showed strong significant increase 
in activity over both EA hy 926, p<0.01 and HUVEC, p<0.01 following 24 hour 
hypoxia by students t-test.
The samples were also tested for their ability to cause NADH mediated lucigenin 
enhanced chemiluminescence. Cell homogenates were incubated with NADH 
(500pM) in the presence of lucigenin (500pm) in a chemiluminometer and the 
reaction followed over time as previously described for purified xanthine oxidase 
enzyme. The peak height of reaction was measured and corrected for total protein 
content and is shown in figure 4.5 as the peak height ALU min'1 mg'1 for each cell 
type following 24 hour normoxic or hypoxic exposure.
All cell types showed a significant chemiluminescence signal above a PBS control. 
There was no significant difference between EA hy 926 and HUVEC in normoxic 
exposed cells. SMEC showed a significantly greater chemiluminescence, p<0.01 
compared to both EA hy 926 and HUVEC following 24 hour normoxic exposure. All 
cell types showed a significant increase p<0.05 in NADH mediated LEC following 















Figure 4.5. The effect of hypoxia on the NADH mediated LEC from endothelial 
cells. Data are mean ± SEM of 3 experiments in triplicate.
4.3.2 Expression and binding (SURFACE) of endogenous and exogenous XO
4.3.2.1 FACs of surface XO expression
4.3.2.1.1 Determination of antibody concentration
To determine the appropriate antibody dilutions for use in the following 
experiments, a pilot study was run where HUVEC were stained for XO using a 
primary antibody raised in rabbits to bovine butter milk XO (Chemicon, USA). This 
was then labelled with a FITC conjugated goat anti-rabbit IgG (whole molecule) 
secondary antibody (SIGMA, UK). The protocol was as follows:
HUVEC were isolated as described previously (4.2.2.1.1) and grown to confluence 
on T25cm*2 tissue culture flasks. Cells were harvested by the addition of cell 
dissociation solution (CDS), typically 2ml in T25cm'2 and tapping the side of the 
flask to dislodge cells. The cell suspension was then added to 13ml HM and 
centrifuged at 400g for 5min at room temperature to pellet the cells. The CDS/HM 
supernatant was then removed by aspiration and the cells were resuspended 
before the addition of 1ml PBS. Cell concentration and viability was then assessed 
using trypan blue exclusion with a haemocytometer (see appendix III).
Cells were then diluted to 5x105 cell ml*1 in PBS. The cells were then divided into 
two sets labelled Chemicon and FITC. To the Chemicon set of cells a dilution of 
Chemicon antibody (stock at 10mgml*1) was added prior to 10p.l of FITC conjugated 
goat anti-rabbit antibody (SIGMA, UK). To the FITC set of cells 10jxl of Chemicon 
antibody was added as the primary followed by a dilution of the FITC conjugated 
goat anti-rabbit antibody. Each antibody labelling step was carried out over 20
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minutes at room temperature. Between each addition of antibody the cells were 
washed 2x in PBS by centrifugation and resuspended in PBS. During the addition 
of the FITC antibody all procedures were carried out under low light and the tubes 
were wrapped in foil.
As part of the routine flow cytometer set up, a set of control cells was also used. 
This comprised of completely unstained cells, cells stained with primary antibody 
alone and cells stained with secondary antibody alone. Using the variable voltage 
applied to the PMT, the population of HUVEC flowing through the cytometer at 
-200 events sec'1 was focussed to form a discreet area related to their side and 
forward light scattering parameters. Figure 4.6 shows a typical dot plot of SSC 




Figure 4.6. A typical dot plot of SSC-H versus FSC-H for a population of passage 3 
HUVEC. The area marked as A is to show the effect of electronic thresholding 
on the signal. Area B is the population of interest. A total of 10,000 events 
were measured inside the quadrant area. However the total number of events 
actually measured may range from 10,000 to 20,000 depending on the
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number of events outside of the selected area. This data was accumulated 
using a lOO^m nozzle size with the neutral density filter in place.
The fluorescence parameters of the unstained control cells were measured to set 
the auto fluorescent background levels. Figure 4.7.shows a typical fluorescence 
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Figure 4.7. A typical histogram plot for unstained HUVEC measuring the 
fluorescence parameters for emission wavelengths of 510 -  520nm (FL1-H). 
Shown is the number of events (10,000 from the gated quadrant area shown 
in figure 4.6) against fluorescence on a logarithmic scale.
Once this process had been completed, the cytometer was not adjusted further 
throughout the experimental run.
On addition of cells stained with primary antibody alone, no change in fluorescence 
was observed. This was also the case on the addition of cells stained with
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Figure 4.8. Overlaid plots of individual primary (red background) and secondary 
(heavy black outline) antibody stained HUVEC fluorescence.
This process was repeated for all the antibody concentrations and figure 4.9 shows 
the fluorescence of control cells overlaid by HUVEC stained with both primary and 
secondary antibodies using 5jliI of each antibody respectively.
The mean channel height for each antibody concentration was measured for each 
10,000 event data set and plotted against antibody concentration for each antibody 
as shown in figure 4.10. This shows a dilution effect in fluorescence that is 
dependent on the concentration of both antibodies and that the optimum antibody 
concentration for these unstimulated passage 3 HUVEC to show positive surface 
staining for XO is to use 5pl per 2.5x105 cells. These concentrations were used for 





Figure 4.9. The fluorescence of passage 3 control HUVEC (secondary antibody 
stained -  red background) overlaid by HUVEC stained with both primary and 
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Figure 4.10. The mean channel height of fluorescence for unstimulated passage 3 
HUVEC.
The above protocol was repeated for HTB4 cells and human synovial fibroblasts. 
Figure 4.11 shows the FITC fluorescence of HTB4 cells labelled with anti-XO
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antibody and FITC labelled secondary antibody. There is a clear shift of the 
fluorescent population to the right suggesting increased fluorescence and positively 
stained cells.
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Figure 4.11. The surface expression of XO on HTB4 cells
Human synovial fibroblasts were cultured to confluency and live passage 2 cells 
were stained for XO. Figure 4.12 shows a fluorescence histogram of the controlled 
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Figure 4.12. The surface antigenicity of passage 2 synovial fibroblasts stained for 
XO in the same manner as previously described.
There is shown a positive right shift in the fibroblast cell population stained with 
both antibodies compared to controls suggesting increased fluorescence and 
positively stained cells.
4.3.2.2 Flow cytometric determination of XO binding to live HUVEC
HUVEC were cultured to confluence and harvested as previously described 
(4.2.2.1). Cells were then exposed to a range of purified xanthine oxidase enzyme 
concentrations (1000ng -  10jag 2.5x105 cells'1) for 20 minutes at room temperature 
and washed 2x in PBS. The cells were then stained using anti-XO antibody and a 
FITC labelled antibody as previously described (4.3.2). The cells were then 
characterised by flow cytometry measuring their forward and side light scattering 
parameters and their FITC fluorescence.
Figure 4.13 shows the FITC fluorescence of cells following incubation with a range 
of XO enzyme concentrations and staining with anti-XO antibody. The control cells
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were incubated with the highest concentration of XO enzyme without antibody 
labelling and were of similar fluorescence to the unstained controls. FITC labelled 
antibody control with cells incubated with enzyme also showed no increase in 
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Figure 4.13. Flow cytometry data of surface XO binding. The insert shows the 
mean fluorescence channel height against enzyme concentration from mean ± 
SEM (n = 2) in duplicate of 10,000 events.
The fluorescence of each cell population was seen to increase relative to the 
concentration of XO enzyme with which it had been incubated in a dose dependent 
manner.
4.3.2.3 The effect of hypoxia on surface expression and binding of XO to 
HUVEC
HUVEC were exposed to 24 hour hypoxia to assess the effect on the surface 
expression of XO. Control cells were cultured under 5% C 02 balanced air mixtures 
at 37°C in a humidified atmosphere. Cells were made hypoxic by culturing in a 5%
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C02 balanced nitrogen atmosphere at 37°C in a humidified atmosphere. The 
surface antigenicity to an anti-XO antibody was measured as previously described 
using a flow cytometric assay.
Figure 4.14 and inset show the effect of hypoxia on the surface antigenicity to anti- 
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Figure 4.14. Effect of Hypoxia on surface expression of XO.
Both cell populations, hypoxic and control cells, showed positive fluorescence 
compared to unstained control HUVEC. Hypoxic exposed cells showed a small 
increase in fluorescence compared to cells exposed to air for 24 hours which was 
not significant (MFCH 20.6 ±3.56 in air and 24.5 ±3.11 under hypoxic conditions). 
The hypoxic cell population shows a shoulder on the normal distribution histogram 
plot compared to the normoxic control cells of higher fluorescence.
Cells that had been made hypoxic for 24 hours were harvested and incubated with 
a range of XO enzyme concentrations as previously described (4.3.2.2). The
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fluorescence of cells stained for XO was measured by flow cytometry and 
compared to the fluorescence of cells incubated with XO in the same manner 
having been cultured under 5% C 02 balanced air conditions.
Figure 4.15 shows the effect of XO enzyme incubation to cells following 24 hour 
culture in 5% C 02 balanced air (normoxic) or 5% C 02 balanced nitrogen (hypoxic).
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Figure 4.15. Effect of Hypoxia on surface XO binding. Figure shows the mean 
fluorescence channel height from 2 experiments in duplicate ± SEM using the 
normal distribution of 10,000 events for each treatment.
Cells from both treatment protocols bind XO in a dose dependent manner and 
show saturation of XO binding per cell at -  100 -  300pgml'1. The cells exposed to 
low oxygen concentration however show a significant increase in fluorescence 
p<0.05 by students t-test compared to enzyme concentration matched controls.
4.3.2.4 The effect of heparinase I treatment on surface expression and 
binding of XO in HUVEC
HUVEC were harvested as previously described and exposed to one hour of 
Heparinase I (EC 4.2.2.7) enzyme treatment (SIGMA, UK) (1U ml"1) or incubation in 
PBS for 1 hour (control cells). The antigenicity to anti XO antibody was then
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assessed in both cell populations using flow cytometry. Figure 4.16 and inset show 
the effect of Heparinase I treatment on the fluorescence of HUVEC stained for XO.
Figure 4.16. Effect of Heparinase I treatment on surface XO expression.
Both cell populations show positive fluorescence for XO labelling compared to the 
unlabelled control cells. The Heparinase I treatment has no significant effect on the 
fluorescence of HUVEC stained for XO compared to the untreated cell population. 
The effect of Heparinase I treatment on the binding of purified XO to HUVEC was 
assessed by flow cytometry. Cells were exposed to Heparinase I for 1 hour 
followed by washing in PBS and incubation with a range of XO concentrations for 
20 minutes. The cells were then washed and stained for XO using an anti XO and 
FITC labelled antibodies as previously described.
Figure 4.17 shows the effect of Heparinase I treatment on the fluorescence of 
HUVEC following incubation with purified XO enzyme.
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Figure 4.17. Effect of Heparinase I treatment on surface XO binding. Figure shows 
the mean fluorescence channel height from 2 experiments in duplicate ± SEM 
from the normal distribution of 10,000 events for each treatment and 
experiment.
Both treated and control cells show a dose dependent increase in fluorescence 
relative to the concentration of added enzyme. Both treatments show saturation of 
the fluorescence at -  100jig of added enzyme. The Heparinase I treated cells 
show significantly increased fluorescence p<0.05 by students t-test compared to 
the equivalent added XO enzyme concentration in non treated cells.
4.3.2.5 The effect of Trypsin on the surface expression and binding of XO to 
HUVEC
As Trypsin has been shown to cause proteolysis of XO its use as a dissociation 
solution compared to a non enzymatic cell dissociation solution (CDS) was 
assessed in terms of the surface expression and binding of XO to HUVEC.
Passage 2 HUVEC were harvested in 2ml Trypsin EDTA (GIBCO, UK)) solution or 
with 2ml CDS (SIGMA, UK) and washed in PBS. Cells were then either incubated 
with purified XO enzyme (100jxg) and stained for XO or stained for XO as
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previously described. Figure 4.18 shows the effect on fluorescence of trypsin 
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Figure 4.18. Effect of trypsin on surface XO binding. Results are mean ± SD of 
one experiment in duplicate from 10,000 events 
Trypsin is shown to cause an increase in the fluorescence of HUVEC in the 
absence of added purified XO enzyme compared to CDS treated cells. On the 
addition of purified XO enzyme the fluorescence of CDS removed cells is increased 
as was shown previously. The Trypsin treated cells however show no increase in 
fluorescence over cells without the addition of XO enzyme and the fluorescence 
signal is reduced compared to the CDS treated XO incubated cells.
4.3.2.6 The surface expression of Heparan sulphate proteoglycan
The surface expression of Heparan sulphate proteoglycan (HSP) was assessed 
using a monoclonal antibody raised to bovine HSP (mouse anti bovine Heparan 
sulphate proteoglycan, subclass lgG1t Chemicon, USA) and a FITC labelled 
secondary antibody. These cells were then subjected to flow cytometric analysis 
and the levels of fluorescence compared for labelled and unlabelled cells. As the 
monoclonal antibody was raised in mouse an isotype control raised in mouse
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against keyhole limpet haemocyanin can be used to assess the non-specific 
binding of the primary antibody.
Figure 4.19 shows the fluorescence of passage 2 HUVEC stained with anti HSP 




Figure 4.19. FACs of surface Heparan-sulphate GAG expression. Representative 
of 10,000 events.
The HSP labelled cells show significant (p<0.01 by student t-test) positive 
fluorescence (MFCH 41.3 ±3.44) compared to the isotype control cell population 
(MFCH 3.6 ±1.12) suggesting the surface expression of HSP in naive passage 2 
HUVEC from two experiments in duplicate.
4.3.2.7 The effect of hypoxia on surface expression of Heparan sulphate 
proteoglycan by HUVEC
Passage 2 HUVEC were subjected to 24 hour hypoxia as previously described 




Figure 4.20 shows the fluorescence histogram of cells stained for HSP following 24 
hours normoxic or hypoxic exposure.
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Figure 4.20. Effect of Hypoxia on surface Heparan sulphate GAG expression. 
Representative histogram of 10,000 events for each treatment. Hyp = hypoxic 
cells.
HUVEC stained for the expression of HSP under normoxic and hypoxic conditions 
show positive fluorescence compared to the isotype control. The cells incubated 
under low oxygen conditions show increased fluorescence compared to the 
normoxic controls (MFCH 63.2 ±4.12 versus MFCH 41.3 ±3.44 from two 
experiments in duplicate). The shape of the curve from hypoxia treated cells shows 
a shoulder not seen in the normoxic controls. This may be due to a sub-population 
of cells that express greater HSP in response to hypoxia compared to the 
population as a whole.
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4.3.2.8 The effect of Heparinase I treatment on HUVEC Heparan sulphate 
proteoglycan expression
HUVEC were removed by CDS treatment from tissue culture plates and washed in 
PBS. Cells were then incubated in Heparinase I (1U ml'1) for 1 hour before 
washing and staining for HSP and subjected to flow cytometric analysis. Figure 
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Figure 4.21. The effect of 1 hour Heparinase I treatment on HSP expression by 
HUVEC. Representative histogram of 10,000 events for each treatment.
HSP stained Control cells were shown to have positive fluorescence compared to 
the isotype control stained cells. The cells treated with Heparinase I show reduced 
fluorescence compared to naive cells stained for HSP but still show greater 
fluorescence when compared to the isotype control stained cells (MFCH 17.5 ± 2.2 
following heparinase treatment compared to non heparinase treated cells MFCH
41.3 ±3.44 and Isotype controls MFCH 5.9 ±4.01).
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4.3.3 Xanthine oxidase binding to bacterial cell surface
4.3.3.1 Analysis by enzyme assay
To determine the possibility that XO can bind to the surface of bacteria allowing 
closer proximity of radical generating systems, bacteria were incubated in the 
presence of purified enzyme. Following incubation the bacteria were centrifuged at 
high speed to form pellets and the supernatant removed for analysis of enzyme 
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Figure 4.22. The xanthine to urate activity of E. coli after incubation with purified 
XO enzyme at a range of cell densities. E. coli were incubated with XO before 
washing and measurement of the activity contained in the supernatant A and 
pelleted B fractions. Mean ± SEM (n = 2) in duplicate. * line indicates 
significant difference from XO control p<0.05 by student t-test.
The amount of activity contained within the supernatant is inversely proportional to 
the cell concentration previously incubated: activity decreases as cell number 
increases. The amount of activity found associated with pelleted cells is 
proportional to the cell number: enzyme activity increases with increasing cell 
number.
The supernatant was also probed for appearance of XO by staining for protein 
following 1 dimensional electrophoresis. Figure 4.23 shows the relative proportions
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of protein from 10|xl of supernatant from each treatment. Here the optical density is 
inversely proportional to the cell number which mirrors the effect by measuring 
activity in the supernatant.
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Figure 4.23. The relative amount of protein found in the supernatant after 
incubation with various concentrations of E. coli. The supernatants were 
electrophoresed on an 8% gel which was then stained with Coomassie brilliant 
blue stain and fixed in acaetic acid/methanol before being scanned and the 
relative optical density of the characteristic 150KDa band was measured for 
each cell concentration.
4.3.3.2 Flow cytometric analysis
The ability of XO to bind to bacterial cell surfaces was assessed using flow 
cytometric analysis in an adaptation of techniques developed for endothelial cells. 
The size of the bacteria make their analysis by flow cytometry more difficult to 
interpret because of the greater signal to noise ratio. To combat this a modification 
of a technique determined for the study of human platelets was used. This entails 
the use of logarithmic scales for both SSC and FSC and a removal of the neutral 
density filter which increases the sensitivity of the instrument to particles of ~ 1 fim
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and greater. This causes an increase in the signal to noise ratio of the particulate 
material in the buffer used. To combat this the threshold voltage is increased whilst 
running only buffer through the instrument until counts per second are below -  10 
events. The bacteria are then run through the instrument and the SSC and FSC 
parameters are determined for the particular population of interest. Figure 4.24 
shows a typical SSC against FSC dot plot for E. coli in solution.
FSC-H
Figure 4.24. The SSC and FSC parameters of unstained E. coli in a suspension of 
PBS. The population was detected using 172mW argon ion laser (Enterprise, 
Coherent, USA) exciting at 488nm with the threshold set at ~ channel 400 of 
1024 (~ 103 on the FSC-H scale). Only events lying within the marker region 
were counted.
The fluorescence characteristics of these bacteria was measured simultaneously. 
The fluorescence data for the region shown in figure 4.24 is shown in figure 4.25 A. 
The fluorescence signal from unstained bacteria was set as the background auto 
fluorescence by adjusting the voltage of the fluorescence PMT and the settings 
were not changed throughout the rest of the experiments. Figure 4.25 A shows the
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fluorescence signal from unstained control and cells stained with primary antibody 
and there is no shift in the fluorescence of the population. On the addition of FITC 
labelled secondary antibody to cells the fluorescence of this population is increased 
above the background control 4.25 B.
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Figure 4.25. The fluorescence associated with E. coli stained with various 
antibodies and with XO added. E. coli from an overnight culture were washed 
in PBS and resuspended in either PBS or PBS and XO protein for 20 minutes 
at RT. The cells were further washed in PBS and incubated with or without 
primary antibody for 20 minutes at RT. Further washings were followed by 
incubations with or without FITC secondary antibody for 20 minutes at RT. 




To assess the binding of primary antibody to the bacteria both primary and 
secondary antibodies were incubated with the bacteria 4.25 C. The fluorescence is 
enhanced in this population over the control cells but not above the fluorescence 
signal from secondary antibody labelled cells. Figure 4.25 D shows the effect of 
adding 100jig of purified XO against the primary and secondary antibody 
fluorescence alone. This population is further enhanced over the unstained control 
and also the antibody control suggesting that XO protein is associated with the 
bacteria in a manner that allows labelling with primary and secondary antibodies. 
The cells incubated with enzyme alone showed no enhanced fluorescence above 
the control cells 4.25 A.
4.3.4 Measurement of plasma activity.
In the circulation of patients with rheumatoid arthritis there is a DPI inhibitable 
plasma activity that can oxidise NADH and can generate superoxide radical 
(Benboubetra et al 1997 and Zhang et al 1998). The activity in apparently healthy 
individuals was assessed using a variety of assay techniques.
To assess the activity in plasma venous blood was collected by venepuncture in to 
citrate buffer as an anticoagulant at a 1:9 citrate to blood ratio. The blood was 
immediately centrifuged to pellet the red cells and leave a supernatant that 
contained plasma proteins. This upper layer was removed and frozen immediately 
in 1 ml aliquots at -70°C.
4.3.4.1 Plasma NADH oxidation
Plasma was thawed on ice and then added into a 1 ml plastic cuvette with PBS and 
NADH at 100^M final concentration. The rate of NADH oxidation was followed by 
measuring the absorbance of the reaction mixture at 340nm with a 1cm light path
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over time. The initial rate of change in absorbance was measured for dilutions of 
plasma and related to the total protein content of the plasma as assessed by 
Bradford’s assay as previously described. Figure 4.26 shows the rate of oxidation 
of NADH at 340nm against total plasma protein for one subject using an extinction 
coefficient of 6.22 mM*1 cm*1.
Plasma causes the dose dependent oxidation of NADH in the presence of 
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Figure 4.26. The oxidation of NADH by human plasma. Inset shows raw data set 
for one individual experiment with the main figure showing the oxidation rate 
against total protein content. Data are mean ± SEM (n = 2) in duplicate of 
plasma from one volunteer from one sample.
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4.3.4.2 Plasma NADH chemiluminescence
The same samples as used in 4.3.4.1 were assessed for the ability to generate 
superoxide radical from NADH using the oxidation of lucigenin enhanced 
chemiluminescence. Figure 4.27 shows the NADH mediated LEC of human 
plasma and the LEC from purified XO protein for comparison.
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Figure 4.27. The NADH LEC for human plasma and bovine XO protein. Bovine 
XO at 100 and 50fig in the presence of 500|xM NADH and 500|xM lucigenin as 
previously described. Results are mean ± SD for one sample in triplicate. 
Plasma caused chemiluminescence in the presence of NADH and lucigenin which 
was equivalent to the CL signal from ~ 50|ig of purified bovine xanthine oxidase.
4.3.4.3 Plasma NADH oxidation in the absence of oxygen and the addition of 
nitrite
To measure the possible xanthine oxidase activity of plasma, the utilisation of nitrite 
as the terminal electron acceptor from NADH oxidation was used as an assay. The 
oxidation of NADH was followed in a spectrophotometer as preciously described.
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Cuvettes containing NADH and nitrite were gassed with 5% C 02 balanced nitrogen 
and capped with Parafilm™ following the addition of gassed plasma. The rate of 
NADH oxidation in the presence of nitrite and the absence of oxygen was 
calculated and is shown relative to air saturated plasma / NADH in the absence of 
added nitrite.
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Figure 4.28. The effect of nitrite on the oxidation of NADH by human plasma in the 
absence of oxygen. Results are mean ± SD of one sample in triplicate.
NADH was oxidised by plasma in the presence of nitrite and the absence of 
oxygen. The oxidation of NADH was dependent on the nitrite concentration with 
equivalent oxidation to air saturated media at ~ 5mM nitrite.
4.3.4.4 Plasma NO activity
Following the results in figure 4.28 the possibility that plasma could mediate the 
reduction of nitrite to NO was assessed. Using ozone enhanced 
chemiluminescence (OEC), plasma was reacted with nitrite and NADH under 
reduced oxygen concentrations. Figure 4.29 shows the NO generation from nitrite 









0 100 200 300 400
Time (sec)
Figure 4.29. The NO generation from human plasma in the presence of nitrite and 
NADH. NADH, 1mM, nitrite 10mM and 500pl human plasma. Plasma was 
added at 60 seconds following the injection of Nitrite and NADH at time 0 
seconds.
The measurement of NO from plasma in the presence of nitrite was difficult and the 
figure shows the small response measured in mV sec'1 for NADH mediated NO 
generation (mV sec'1 equivalent to -  0.5ppb sec'1).
The utilisation of xanthine was also assessed as an alternative electron donor and 
due to the enhancement in NO generation shown in the presence of DPI this was 
also added to increase the signal as described in chapter 2. Figure 4.30 Shows the 
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Figure 4.30. The generation of NO from human plasma. In the presence of 
xanthine, IOO^ iM, DPI, 100^M, nitrite, 10mM and 500^1 human plasma at 
15mg ml'1 to a final volume of 1ml. Plasma was added at A, nitrite, DPI and 
xanthine at B and oxypurinol (100jaM) was added at C.
In the presence of xanthine and DPI an increase in NO generation can be seen 
with human plasma. On the addition of oxypurinol C (lOO^M) the NO signal is lost 
and returns to baseline levels.
The effect of xanthine concentration was also measured with the addition of 100jiM 
or 50nM xanthine to the reaction mixture. Figure 4.31 shows the effect of xanthine 
concentration on the NO generation from human plasma.
Reducing the xanthine concentration reduces the peak height to which the NO 
generation reaches with 10mV sec'1 at 100jxM xanthine compared to ~7mV sec'1 in 
the presence of 50jiM xanthine (after correction for background NO signal). Both 
reactions were still generating measurable NO after 2 hours of incubation at the 
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Figure 4.31. The NO generation from human plasma dependent on xanthine 
concentration. Protocol as for figure 4 .3 0  with the addition of 1 0 0  or 5 0 jiM  
xanthine.
4.3.5 The effect of exercise on plasma activity
To assess the effect of exercise and oxygen debt on the activity found in plasma a 
healthy volunteer was exercised for a total of 12 minutes. The measured heart rate 
during exercise peaked at 183 beats per minute (bpm) and was above 140 bpm for 
at least five minutes following cessation of the exercise and above 100 bbp for a 
further five minutes. Venous blood was taken immediately before exercise and at 
regular intervals following exercise by intravenous cannulation (20G/32mm Venflon 
cannulae, Ohmeda, Sweden) with sodium citrate as the anticoagulant. The plasma 
was produced by centrifugation of the samples and 1ml aliquots were frozen at -  
70°C. Fresh plasma was assessed for the total protein, NADH oxidation and 
NADH mediated LEC to determine activity.
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4.3.5.1 The effect of exercise on plasma total protein levels
Plasma protein was measured by a modification of Bradfords assay. The results 
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Figure 4.32. The total plasma protein from plasma taken before and immediately 
following exercise. Bar shows period of exercise.
The plasma protein levels were reduced immediately following exercise compared 
to pre exercise levels and remained so for some 30 -  40 minutes. By 52 and 67 
minutes however the plasma protein concentration had returned to pre exercise 
levels.
4.3.5.2 The effect of exercise on plasma NADH oxidation
The oxidation of NADH by pre and post exercise plasma samples was followed at 
340nm in a spectrophotometer. The results are shown in figure 4.33 corrected for 
total protein against time.
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Figure 4.33. The effect of exercise on the oxidation of NADH by plasma. NADH 
oxidation in the presence of plasma was followed over time and calculated 
using the initial rate data and an extinction coefficient of 6.22mM*1 cm'1. 
Results are mean ± SD (n = 1) in triplicate.
The pre exercise rate of NADH oxidation was ~ 150nmoles min'1 mg total protein*1 
compared to ~ 660nmoles min'1 mg total protein*1 seven minutes after the cessation 
of exercise. This activity is increased above pre exercise levels in all but the 52 
minute time point. The general trend follows a peak of activity which returns 
towards pre exercise levels over an hour after exercise.
4.3.5.3 The effect of exercise on plasma NADH mediated LEC
The chemiluminescence mediated by NADH was measured in the pre and post 
exercise plasma samples and the activity corrected for total protein content. The 
results are shown in figure 4.34.
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Figure 4.34. The effect of exercise on the plasma NADH mediated LEC. Peak 
height measurements were measured as previously described. Results are 
mean ± SD (n = 1) in triplicate.
Human plasma pre exercise was shown to have NADH mediated LEC suggesting 
the generation of superoxide. The post exercise samples show an immediate 
reduction in chemiluminescence signal compared to the pre exercise levels. The 
general trend for activity shows an initial drop which recovers to the pre exercise 
levels by 52 minutes post exercise.
4.3.5.4 Western blot of exercise plasma samples
Exercise samples were subjected to Western blotting with an antibody raised to 
bovine xanthine oxidase (Chemicon, USA). Figure 4.35 shows the results of gel 












Figure 4.35. The Western blot of human plasma pre and post exercise. Shown are 
bovine xanthine oxidase of known concentration (XO) against 30jig lane'1 of 
human plasma with times pre and post exercise. Molecular weight markers 
are shown in KDa to the left of the figure.
The bovine enzyme shows the typical staining gained with this Chemicon antibody. 
The plasma samples show strong banding patterns at -  40KDa, -  70KDa and 
some banding at ~ 150KDa size. There is also an increase in the intensity of 
staining over the time of post exercise compared to pre exercise levels in all bands 
apart from 37 minutes post exercise. Measuring the optical density of the apparent 
150KDa band it was possible to generate a graph of optical density against time of 
exercise.
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Figure 4.36. The optical density of 150KDa band from human plasma.
The optical density of the 150KDa band increases following cessation of exercise 
which drops at 37 minutes but is raised again following 52 minutes before being 
reduced again at 67 minutes.
4.4 Discussion
The release of XO in to the circulation following heparin addition or in a range of 
pathologic conditions suggest a mechanism as to the effect of enzymic products on 
a range of tissues which would otherwise be devoid of activity. Previous 
experiments into the binding of exogenous XO have taken the path of purified 
binding substrates and enzyme activity measurements to determine the degree of 
binding. Here an ex vivo system has been developed using live endothelial cells 
and the sensitive and specific measurement of bound enzyme using flow 
cytometry.
This system utilises the size dependent cut off criteria to avoid false positive results 
that flow cytometers employ. The fluorescence measurements are related to the 
concentration of protein and will only be detected when bound to particles greater 
than 5 microns in diameter. By selecting the endothelial population, non viable
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cells and particulate materials are excluded from the analysis. The limit of 
detection for the flow cytometer used in terms of fluorescence measurements was 
~ 800 bound molecules of FITC. The right shifted normal distribution curves 
suggest that greater than that number of FITC molecules were bound to each 
individual cell. However it is not possible to determine the binding site number 
which is related to the number of bound or expressed molecules due to the use of a 
polyclonal primary antibody. For this reason the relative fluorescence 
measurements are used.
In the absence of added exogenous XO, primary cultured naive endothelial cells 
show a right shifted curve suggesting surface expression of antigen(s) recognised 
by the primary antibody. All other combinations of added antibody were proven to 
be negative and this suggests that XO protein was expressed on the surface of 
endothelial cells. However it was not possible to produce a Western blot of 
endothelial cell protein using the same polyclonal antibody to give a distinct 
150KDa band indicative of XO. Also it was not possible to discern whether the 
protein was expressed from internal stores or was attached in the membrane or 
attached to the surface from the circulation before isolation.
In the case of exogenously added XO, the purified bovine enzyme used gave the 
characteristic XO banding pattern on Western blots probed with the polyclonal 
antibody. Therefore the added enzyme was recognised by the primary antibody 
and suggests that XO added to endothelial cells binds in a dose dependent 
manner. As the analysis was of individual cells it also suggests that each cell was 
capable of binding a finite amount of enzyme as the fluorescence was seen to 
plateau indicating saturation of the binding sites on the cell.
As hypoxia is an inducer of xanthine oxidase in terms of activity (Terada et al 1997) 
its effects on surface expression of XO protein and XO binding capacity was
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assessed. Hypoxia had little effect on endogenously expressed enzyme where as 
it caused an increase in the enzyme binding capacity compared to cells incubated 
under atmospheric oxygen concentrations. This suggests that following a period of 
hypoxia there is a change in the binding capacity of the endothelium which may 
cause the concentration of circulating proteins and in particular circulating XO.
It has been suggested that the binding of XO to cell surfaces is dependent on the 
glycosaminoglycans expressed to form the glycocalix and in particular heparan 
sulphate glycosaminoglycan. Heparinase I treatment of the cells for one hour 
caused an increase in the binding capacity of each cell. The removal of heparin 
and heparan sulphate glycosaminoglycan had the opposite effect to that which was 
expected. If XO bound to the cell via heparan sulphate, its removal should reduce 
the apparent binding to the cell surface. Previous reports have suggested that XO 
may bind to other proteoglycans including dermatan sulphate and chondroitin 
sulphate (Adachi et al 1993 and Radi et al 1997). It is possible therefore that other 
binding sites become available or that the overall surface charge of the cell 
changes to increase the binding of added XO protein.
It has been reported that heparinase treatment reduced the binding of XO to 
endothelial cells (Adachi et al 1993) or had no effect on the binding capacity of 
endothelial cells (Houston et al 1999) whereas chondroitinase treatment reduced 
binding by up to 50% (Houston et al 1999). The discrepancy between all three 
studies may be due to the different approaches to the measurement of binding. 
The two published accounts used enzyme activity rather than protein measurement 
(as is the case in this flow cytometric assay). Radi et al (1997) had described a 
reduction in activity of enzyme bound to heparin sepharose whilst Houston et al 
(1999) measured rates of superoxide production by soluble and cell bound XO and 
found there to be no difference. By using enzyme activity as the measure of
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binding it may be possible to under estimate the amount of bound enzyme due to 
changes to activity that may occur. The use of both an activity assay and protein 
concentrations may give more information as to the specific effects of heparinase 
treatment.
The expression of heparan sulphate glycosaminoglycan was also assessed by flow 
cytometry in naive, hypoxic and Heparinase I treated endothelial cells. Endothelial 
cells showed a right shifted curve suggesting increased fluorescence in naive cells 
stained with a monoclonal antibody raised against bovine heparan sulphate GAG. 
On treatment of the cells under hypoxic conditions, the fluorescence was increased 
over the naive control cells and also showed a possible greater fluorescent sub­
population of heparan sulphate GAG labelled cells. This experiment linked with the 
increased fluorescence associated with endogenously added XO to previously 
hypoxic cells suggest that an increase in GAG expression leads to an increased 
binding potential.
The effect of hypoxia on the GAG expression of endothelial cells has been 
measured previously. Levine et al (1982) showed an increase in synthesis and 
secretion of dermatan sulphate and heparan sulphate GAGs in porcine aortic 
endothelial cells following hypoxic treatment. Humphries et al (1986) showed a 
decreased secretion of GAGs but no change in the cell associated GAG expression 
following hypoxic treatment of bovine aortic endothelial cells. Also in bovine aortic 
endothelial cells, Karlinsky et al (1992) showed reduced incorporation of 
radiolabelled sulphate into cell layer associated heparan sulphate in hypoxia but 
the binding of antithrombin III was markedly increased suggesting an increase in 
affinity. There was also a change in molecular weight of the heparan sulphate 
GAGs in hypoxic exposed cells.
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The change in affinity caused by hypoxic treatment may be reflected in the high 
fluorescent sub-population seen. This may be due to increased binding or affinity 
for the antibody in this sub-population along with an increase in the antigen 
available. It may be possible by using dual labelling techniques to assay the sub­
population of high fluorescent cells for their XO binding capacity and select them 
out by sorting for further evaluation.
It was important to assess the ability of Heparinase treatment to affect the cell 
surface expression of heparan sulphate GAG expression. Heparinase reduced the 
fluorescence signal due to cells stained with anti heparan sulphate GAG antibody. 
All of these experiments taken together suggest that whilst hypoxia stimulates 
binding and heparan sulphate GAG expression this may not be the only 
mechanism for binding of XO. The increase in apparent binding caused by the 
removal of heparan sulphate GAG suggests an associated mechanism, such as 
chondroitin sulphate GAG as shown by Houston et al (1999).
Other receptors for many proteins are also expressed on the surface of endothelial 
cells. One such protein is ICAM-1, the receptor for CD11b used for neutrophil 
binding. ICAM-1 however will also bind to the RGDS binding motif found in 
fibronectin and other matrix proteins. From the published amino acid sequence 
(Ichida et al 1993) however, XO does not contain an RGDS motif in its primary 
sequence. The heparin-binding site of XO has been described (Fukushima et al 
1995) and it is possible that more binding sites will be determined as the secondary 
and tertiary structure of the enzyme is elucidated.
Recently it has been suggested that XO is endocytosed from the surface of cells to 
be located in some intracellular compartment (Houston et al 1999). The possibility 
exists that the staining seen in these experiments was not of surface expressed or 
bound enzyme but of intracellular localised antigen. It is possible that the whole
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complex of enzyme, primary and secondary antibody was endocytosed which 
would generate a similar staining pattern as that produced. However, this would 
still suggest that a binding event with associated signalling in the cell had occurred 
prior to endocytosis with endocytosis being a relative fast event compared to the 
staining procedure used here.
In order to remove the possible problems associated with antibody staining an 
alternative may be to utilise fluorescently labelled XO enzyme. A population of 
cells can be monitored in real time using flow cytometry and plotted as 
fluorescence against time. Unstained cells would show little fluorescence and on 
the addition of labelled enzyme, only cells binding the enzyme would begin to 
fluoresce. Commercially available kits utilise the binding of fluorescent dyes to free 
amino groups. One such kit FluoroLink from Amersham uses a bisfunctinal NHS- 
ester cyanine dye. With a combination of real time flow cytometry and confocal 
laser scanning microscopy which allows the optical sectioning of cells, the binding 
and subsequent movements of the labelled enzyme could be followed.
In the case of XO, this approach may also contain problems in that the apparent 
enzyme binding is dependent on electrostatic attractions between the enzyme and 
cell surface components. The use of amino groups on the enzyme to bind dye 
causes a change in the electrostatic charge over the whole enzyme. This in turn 
would reduce the binding capacity of the enzyme for its target.
Endocytosis of the enzyme as a mechanism of capture suggests an active event 
requiring signal transduction pathways. This may be useful in determining the 
relationship between the binding event and subsequent fate of the bound enzyme. 
Using cell calcium flux as a measure of interaction may show insights into the 
events initiated by protein binding especially in an electrostatic manner rather than 
the more formal receptor-ligand approach.
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The binding of XO to GAGs may be of importance in the cytotoxicity displayed to 
bacteria. Many viruses and bacteria bind to their target via heparin like GAGs as 
part of their infection strategy (Patti 1994). Foot and mouth disease virus (FMDV) 
for example will bind integrin molecules on the host cell but the majority of binding 
occurs through heparan sulphate. The initial binding is to heparan sulphate 
followed by high affinity binding to integrin receptors (Jackson et al 1996).
Using E. coli it was possible to show by flow cytometry and enzyme activity the 
binding of XO to bacteria. This binding may be important in terms of the proximity 
of enzymic products to the bacteria. It is even possible that the bacteria may 
provide the substrates for the enzyme to generate the reactive species for bacterial 
self destruction.
In bacteria the binding characteristics are mediated by a range of surface 
expressed pili or fimbriae and it has been determined that in clinical isolates of E. 
coli from urinary tract infections, the addition of GAGs can have an anti-adhesive 
effect (Busolo et al 1995). Esosaminoglycan sulphate showed greatest effect 
against P-fimbriated E. coli whilst galactosaminoglucuronglycan sulphate was anti­
adhesive on type one fimbriated E. coli showing differential effects on a range of 
adhesive molecules.
Milk itself contains complex carbohydrates, including glycoproteins and 
glycosaminoglycans. It has been suggested that these compounds offer an anti­
adhesive action to bacteria reducing their infective capability (Newburg 1999). In 
HIV-1 infection GAGs have been implicated in the inhibition of gp120 binding to 
CD4 which is the first step in HIV infection. XO may therefore not only bind to 
bacteria to increase the proximity to the target for radical mediated damage but 
may also reduce infection by a physical impairment of bacterial binding. However it 
must also be noted that the concentration of enzyme compared to GAGs and
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glycoproteins may cause competition for binding sites on the bacteria which may in 
turn reduce the proximity killing effect. In this thesis XO protein in human milk 
accounted for ~ 10% of total protein which is variable over time of lactation post 
partum and also to some extent to the diet and health of the mother.
Intracellular XO expression in endothelial cells was determined by immunolabelling 
and enzyme assay of isolated and cultured endothelial cells. The reaction product 
from the peroxidase labelled secondary antibody was localised to the perinuclear 
region but also with diffuse granular cytoplasmic staining in naive cells. The 
subcellular localisation to the cytoplasm in rat hepatocytes has been previously 
described by Ichikawa et al (1992) using electron microscopy techniques. Further 
to this the same group analysed fractionated cells and found activity in the cytosol 
but not in cellular organelles.
The staining pattern in endothelial cells showed a slight resemblance to cells that 
were stained for vWF. This shows a granular staining pattern as the Weibell- 
Palade bodies are picked out being the organelle of storage for vWF. If XO co- 
localises in the WPB then this may account for a mechanism of secretion along 
with vWF and p-selectin translocation to the membrane. As the XO protein does 
not include a signal sequence to target it for secretion, an alternative mechanism 
would be required. Alternatively, the endothelial cell has been shown to contain 
other discrete storage granules which are small and dense and contain tissue-type 
plasminogen activator (tPA) (Emeis et al 1997) that are released on stimulation with 
thrombin or heparin (Klocking and Markwardt 1994). tPA being part of the 
coagulation cascade and fibrinolysis is therefore secreted along with vWF on 
stimulation of the endothelium. Heparin has been shown to cause XO release into 
the circulation from two patients infused with heparin which was suggested as 
causing the release of GAG bound heparin (Adachi et al 1993). It is also possible
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that stored granules containing XO either from intracellular generation or from 
endocytosis of surface bound XO are secreted on addition of heparin if co-localised 
with vWF or tPA into the circulation which would not be discernible from the release 
of surface bound XO.
vWF release is also stimulated by hypoxia (Pinsky et al 1996) and hypoxia causes 
the endothelium to become prothrombotic (Ogawa et al 1990). IL-8 secretion is 
also stimulated by hypoxia and has been localised in a preformed state to the 
Weibel-Palade bodies (Utgaard et al 1998). The effect of hypoxia on endothelial 
XO enzyme activity was to increase the pterin mediated and NADH mediated 
activities per milligram of total protein.
Also noted was that on exposure to hypoxia, HUVEC would begin to secrete vWF 
into the culture media (Pinsky et al 1996). This led from earlier observations that 
vWF staining in synovia did not always pick out the endothelium when it has been 
the method of choice for EC labelling experiments (Stevens et al 1991).
The differences seen in the superoxide generation and NADH utilisation may 
suggest that the superoxide generating system was not solely responsible for all of 
the NADH oxidation. Other NADH oxidising enzymes are found circulating 
naturally and neither of the above assays are specific for xanthine oxidase as such. 
However, the generation of NO from plasma in the presence of xanthine or 
hypoxanthine and the absence of oxygen is probably the most specific measure of 
xanthine oxidase activity as yet there have been no alternative systems described 
that generate NO in this way.
The simulated hypoxia or oxygen debt endured by high output exercise may have a 
mediating effect on the circulating xanthine oxidase levels. Further study in to the 
levels of hypoxia simulating either altitude induced or pressure induced low oxygen 
may allow for the determination of the importance of this activity for normal subjects
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and also for the response to exercise of subjects with inflammation and particularly 
joint inflammation.
The prevalence of a circulating radical generating enzyme then is important. This 
is particularly so if this enzyme is a nitric oxide /  superoxide generating system that 
is stimulated by hypoxia and inflammatory cytokines. On the one hand a NO 
generating enzyme destined for an area that suffers hypoxia may relieve that 
oxygen debt by supplying endothelial relaxation factor. One the other hand this 
may eventually lead to the reperfusion of the site causing the generation of 
superoxide and possibly peroxynitrite which may be deleterious.
Further work to determine the secretion, binding, intracellular location and possible 
endocytosis of xanthine oxidase is required in order to elucidate its role in 









In this thesis the well-established ability of xanthine oxidase to generate oxygen 
free radicals has been extended to highlight the fact that the particular species 
generated is dependent on the available substrates and prevailing reaction 
conditions. As the predominant substrate requirement for the generation of 
superoxide and hydrogen peroxide is oxygen for the classical activity of XO, the 
rates of generation are therefore limited by its availability. As oxygen is acting as 
the oxidising agent, it is itself reduced to superoxide by the addition of an electron 
donated from a variety of substrates. In the same way, nitrate or nitrite will 
reoxidise the reduced enzyme whilst becoming themselves reduced to nitrite and 
nitric oxide respectively. The rate of these reactions is dependent on the 
concentration of nitrate and nitrite and on the concentration of oxygen. As the 
oxygen concentration is increased then the rate of measurable NO generation is 
decreased. In the case of all oxidising substrates, therefore, there is competition 
for the available electrons.
The reduction in measurable NO seen in previously hypoxic systems where 
oxygen is reintroduced can be explained by the simple competition between 
oxidising substrates for electrons. However, simultaneous generation of 
superoxide and nitric oxide is indicated by the experiments where the addition of 
superoxide dismutase (SOD) increased the measurable NO signal as oxygen 
concentration was increased. This strongly suggests that the reaction product of 
NO and superoxide, peroxynitrite, is formed as the concentration of oxygen is 
increased in a previously hypoxic system. As the concentration of nitrite is
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increased, the concentration of oxygen at which the loss of the NO signal occurred 
is also increased. Therefore the generation of NO or superoxide is dependent 
upon the concentration of the oxidising species. It is known that the generation of 
peroxynitrite is dependent primarily upon the flux of NO and, therefore, as the nitrite 
concentration is increased the concentration of oxygen at which peroxynitrite 
generation occurs is shifted to the right of the oxygen curve. The likelihood of 
peroxynitrite generation is therefore dependent on the flux of NO, which is itself 
dependent upon substrate availability.
Assays of peroxynitrite that were previously published were not suitable for the 
measurement of the products of nitric oxide and superoxide generated from nitrite 
and NADH or xanthine in the presence of xanthine oxidase. The oxidation of 
dihydrorhodamine is the basis of a commonly used peroxynitrite assay, however, 
dihydrorhodamine was shown to be oxidised in the presence of nitrite. This 
oxidation was reduced on the addition of the strong reducing agent NADH and for 
this reason the signal generated in the presence of enzyme could not be discerned 
from the controls.
Using chemiluminescence, it was possible to show an enhanced signal that is 
dependent upon nitrite concentration above that of enzyme and single substrate 
alone. The precise identity of the luminescent molecule is unknown, but the use of 
controls containing specific scavengers, strongly suggest the species to be 
peroxynitrite. This is dependent upon the reaction of peroxynitrite with the 
scavenger rather than with the luminescent compounds before the luminescence 
pathway is initiated. It is entirely possible that the reaction of superoxide with nitrite 
leads to a molecule that reacts with lucigenin to generate luminescence. The 
suggestion of a bystander reaction has been proposed by Trujillo et al (1998) 
where superoxide reacted with S-nitrosocystene to form peroxynitrite. The use of
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specific inhibitors of the enzyme will not necessarily distinguish peroxynitrite 
generation as both superoxide and nitric oxide would be inhibited by the known 
xanthine oxidase inhibitors of any of the active sites involved. It is only the use of 
scavengers that are specific for peroxynitrite, superoxide and nitric oxide alone that 
will allow the calculation of the products using a reporter assay such as the 
chemiluminescence assay used here.
Other assays employing antibody staining for nitrated residues may be suggestive 
of ONOO- generation, such as the immunodetection of 3-nitrotyrosine (3-NT). 
Although this is not a kinetic assay, this may be used as a marker of ONOO- 
generation using reporter proteins such as bovine serum albumin. The effect of 
ONOO- on the activity of human SOD has been used as a measure of ONOO- 
generation (Macfadyen et al 1999). Both the nitration and inhibition of superoxide 
dismutase activity can be used as the human SOD enzyme contains a tyrosine 
residue at its active site, the nitration of which causes a loss of activity. This differs 
in the bovine enzyme as the tyrosine residues are far removed from the active site. 
The nitration of XO enzyme itself may be useful in determining ONOO- generation 
and this could be related to the possible inhibitory effect on enzyme turnover. 
ONOO- has also been shown to inhibit iron-sulphur proteins by disruption of the Fe- 
S moiety, xanthine oxidase is such a protein. It is possible, therefore, that the 
generation of ONOO- by the enzyme may lead to a reduction in catalytic activity in 
a self-regulating manner in a similar manner to the effect of NO binding to the haem 
iron in nitric oxide synthase self regulation (Abou-Soud et al 1995).
Recently it has been suggested that NO binding to xanthine oxidase can cause the 
desulphuration of the enzyme leading to inactivity (Ichimori et al 1999). This may 
also be a self-regulating mechanism as the nature of the inhibition was reversible 
by resulphuration of the molybdopterin active site. In this thesis, however, under
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enzyme turnover conditions generating NO, no such inhibition was observed. This 
may be accounted for by the assay used, as the measurement of NO requires the 
NO to be forced into the gas phase by vigorous stirring which may reduce the effect 
of NO in solution on the activity of the enzyme.
In a physiological setting, the generation of superoxide from xanthine oxidase 
would be dependent upon the availability of oxygen in the tissues. At lower oxygen 
concentrations the superoxide generating capacity would also be lowered. The 
availability of nitrite has been shown in the plasma to range from low micromolar, 
~1nM to over 500jiM depending on diet and health of the subject (Baylis and 
Vallance, 1998). The oxygen concentration is dependent upon perfusion and 
oxygenation of the haemoglobin. In acute low oxygen it is possible that XO could 
play a role in the generation of NO from the available substrates to allow for the 
reoxygenation of hypoxic tissues. As the concentration of available oxygen rises, 
the flux of NO would be decreased as the generation of superoxide occurs. The 
further reaction of NO and superoxide to generate peroxynitrite would then occur. 
To some extent however, endothelial SOD could detoxify this environment by 
reduction of the available superoxide and enhancement of the nitric oxide flux. At 
higher concentrations of available oxygen, the activity of SOD as a scavenger of 
superoxide would be overwhelmed with the subsequent generation of peroxynitrite. 
This in turn could lead to the inhibition of further SOD activity by inactivation of the 
enzyme and subsequent exacerbation of the peroxynitrite generating capacity by 
increasing the oxygen range over which this occurs.
The generation of peroxynitrite is known in a variety of pathological conditions 
through the use of antibody staining for the nitration product of peroxynitrite and 
tyrosine residues, 3-nitro tyrosine. The nitration of enzymes has been implicated in
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their loss of activity. This has particular importance in the case of the human SOD 
enzyme where inactivation leads to the loss of cellular function and tissue 
breakdown (Beckman and Koppernol, 1996). The effect of peroxynitrite on cell 
replication has also been shown with strand breaks in DNA and inhibition of the 
repair enzymes by the direct action of peroxynitrite (Burney et al 1999).
The possible beneficial effects of reactive species generation on bacterial killing 
was also tested for this enzyme in the light of its expression in milk of both human 
and bovine origin. The high concentration present in milk and epidemiological 
evidence suggested that parental milk feeding to the neonate enhanced survival 
and fitness compared to milk substitute-fed individuals. It was clear that 
peroxynitrite and hydrogen peroxide had a negative effect on bacterial survival and 
that, in the presence of xanthine oxidase and substrate, the survival of bacteria was 
reduced.
The limited killing effect seen at a range of oxygen concentrations in the presence 
of nitrite requires further study. The assays used require development to allow 
large through-put growth assays to be utilised at a range of oxygen concentrations. 
The development of such a 96-well assay requires the incubation of plates in situ 
with gassed atmospheres of known oxygen content. It is also important to assess 
the surface characteristics of cells incubated at varying oxygen concentrations, 
since bacteria cultured under hypoxic conditions generate surface proteins which 
may allow enhanced binding of enzyme and therefore mediate any killing effect by 
enhancing the proximity effect of oxidant generation (James and Keevil 1999). 
Utilisation of strains expressing a range of surface molecules may help to increase 
the understanding of the binding characteristics of enzyme to bacteria, and also to
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determine whether this is a mechanism in milk and feed stuffs that occurs in the 
presence of other possibly competing molecules.
The milk mucins comprise an array of anti-adhesive molecules for enteroinvasive 
E  coli and Rotavirus (Newburg 1999). The association with these molecules and 
the milk fat globule may allow for the close association of enzyme and bacteria, but 
may also generate a protective bridge between the enzyme and cell surface to 
reduce the proximity killing effect. The effect of mucins on the protection and or 
binding of enzyme to bacterial strains could also be assessed using the assays 
employed above.
The mechanism by which ONOO-, H20 2 and xanthine oxidase-derived metabolites 
have their effect on bacteria was not investigated here. However, both ONOO- and 
H20 2 have been suggested to cause strand breaks in DNA and have an effect on 
DNA repair enzymes. This was also a similar case to the effect of NO and the final 
effector molecule could range from the original oxidants to their breakdown 
products and especially the hydroxyl radical. The utilisation of specific scavenger 
molecules may help to elucidate the effectors. Measurement of strand breaks in 
isolated bacterial DNA can be made by agarose electrophoresis, which can also be 
used for nitration studies by blotting of DNA on to nitrocellulose and probing with 
anti-nitro base antibodies. The specificity of action could then be discerned for 
ONOO- and H20 2.
The bacterial resistance mechanisms could also differ with the detoxification of 
hydrogen peroxide following a catalase-like step compared to the ONOO- 
decomposition, possibly leading to positive identification of the toxic species 
mediating the killing. However, because of the possibility of other breakdown 
products, such as the hydroxyl radical from ONOO- and Fenton-mediated H20 2 
breakdown, the effector molecule may be difficult to determine and may be
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dependent upon the bacterial antioxidant systems as to which toxic species is 
generated.
The apparent toxicity of ONOO- and peroxynitrous acid (ONOOH) have been 
disputed because of the ionisation of the toxic species ONOO- and therefore its 
movement through membranes is hindered by charge interactions. However 
ONOOH can diffuse through membranes and cause nitration of proteins shown by 
nitration of haemoglobin in erythrocytes (Denicola et al 1998). The transport of 
ONOO- and the diffusion of ONOOH may allow the use of the HC037Cr transport 
inhibitor 4,4,-diisothiocyanatostilbene-2l2,-disulphonic acid (DIDS) to elucidate the 
role of either species in the killing effect seen with bacteria. Reducing the 
extracellular pH to move the ratio of ONOO- towards ONOOH, the pKa for the 
equilibrium being 6.8, may enhance the toxicity of the generated species by 
selecting the protonated form. Those bacterial strains possessing a means of 
active transport may be more susceptible to ONOO- toxicity than those which can 
block the entry of or modify the oxidant properties of ONOOH. This may also be 
strain and species specific.
In certain diseases, circulating xanthine oxidase activity has been identified. How 
the enzyme is released into the circulation and what its possible function may be 
are still unclear. It does, however, confer the ability of the enzyme to relocate to 
tissues via the circulation, suggesting an active mechanism of secretion and 
recruitment to endothelial cell surfaces. The nature of the nitric oxide-generating 
activity may suggest a role of radical generation for reoxygenation strategies or the 
more deleterious role as a reactive oxidant generator.
It has been suggested that following binding of the enzyme to endothelial cells, the 
active process of endocytosis accounts for the loss of enzyme from the circulation
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and the uptake of enzyme into the cell (Houston et al 1999). This also suggests 
some kind of signalling event occurs following binding, however this has yet to be 
observed. Other bound proteins may give clues as to the mechanism and to the 
fate of captured enzyme. The association of enzyme with clathrin would point to a 
clathrin-coated pit event with endosome formation and recycling to alternative 
membranes as a mechanism for redistribution within cells.
It has also been noted that sulphated proteoglycans are endocytosed in cultured 
skin fibroblasts suggesting that the mechanism of binding and endocytosis may be 
mediated by a single event or chain of events initiated by the binding of surface 
protein (Prinz et al 1978).
The initial binding to GAGs by XO may mimic the binding of certain infective 
bacteria which bind first by electrostatic interaction followed by a stronger receptor 
ligand binding such as that seen in Neisseria gonorrhoea (Duensing and Putten 
1998). This infective bacteria binds to vitronectin on the cell via a heparin-binding 
outer membrane protein OpaA causing the glycosaminoglycan to act as a 
molecular bridge.
Fibrinogen is a circulating protein that binds to cellular surfaces via the interaction 
of ICAM-1 and an RGDS binding sequence. This binding also causes calcium flux 
in the bound cells. Such an arrangement of amino acids is not seen in the 
published primary sequence data for human xanthine oxidase, which may suggest 
an alternative receptor interaction if binding occurs, or that the tertiary structure 
causes the alignment of such amino acid residues to form a recognised binding 
domain.
Xanthine oxidase possesses two heparin binding domains within its sequence 
(Fukushima et al 1995), which can be located to the 85KDa subunit following
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proteolysis. However, as yet the tertiary structure is unknown and it is not possible 
to suggest that these binding sites are available in the native form of the enzyme. 
The extracellular bound SOD enzyme also has a heparin-binding motif (Oury et al 
1996). It has been shown that this motif can be proteolytically cleaved to produce a 
non-bound inactive form that will diffuse into the surrounding tissue or circulation 
(Enghild et al 1999). It was suggested that this might represent a regulatory 
pathway effecting distribution and activity and therefore the effectiveness of SOD at 
particular tissues. It is possible therefore, that the circulating xanthine oxidase may 
occur as a result of cleavage of the heparin binding domain and that protein not 
bound by another means could be lost to the circulation. This would therefore 
preclude further binding of this cleaved enzyme to heparin or heparan GAGs. 
Proteolysis of extracellular SOD can occur by trypsin treatment and it is well known 
that trypsin causes the proteolytic cleavage of xanthine oxidase into subunits of 20, 
40 and 85KDa where the redox centres, iron-sulphur, FAD and molybdenum 
domains are located respectively (Nishino 1994). Cleavage of bound enzyme 
would release the protein from the surface of the endothelium by the loss of heparin 
binding capacity and the breakdown of the enzyme into its constituent subunits 
could remove molybdenum-based superoxide activity. However, it is entirely 
possible that the NADH-oxidising activity would remain intact, as the FAD active 
site does not require the other redox sites to be available for superoxide formation. 
As for the molybdenum domain, the NADH-mediated reduction of nitrite to NO 
would not occur. However, the xanthine and hypoxanthine-mediated nitrite 
reductase activity is still possible as only the molybdenum active site seems to be 
involved. From the evidence shown by inhibiting the FAD site with DPI and 
enhancing the generation of nitrite from nitrate and NO from nitrite suggests this as 
a mechanism. It is also possible that this active subunit would lose its oxygen-
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dependent NO generation and be capable of generating NO at relatively high 
oxygen concentrations in the presence of suitable substrates.
The binding of proteolysed XO enzyme could also be measured by the use of flow 
cytometry in a manner as described in Chapter 4 and compared to non-proteolysed 
enzyme on endothelial cells. The ability of blood plasma to generate NO in the 
presence of purine substrates and nitrite in air would also point to this mechanism.
It is also possible, however, that the proteolysis of the heparin-binding domain 
causes the loss of molybdenum-mediated activity as the domain is found within the 
85KDa subunit that contains this active site. It was noted, however, that the 
heparin-binding domain does not overlap the molybdenum binding site and no 
change in activity was seen in the presence of heparin (Fukushima et al 1995). 
The determination of the specific activity of isolated enzyme subunits may point 
towards the change in activity seen in plasma samples.
To have a similar strategy of control over oxidant-producing and antioxidant 
enzymes may suggest a link between XO and SOD expression and activity, as they 
are closely associated both on the endothelium and in their evolutionary linkage. It 
has been suggested that xanthine oxidase and superoxide dismutase are linked by 
virtue of the fact that their genes are inherited together, being located on the same 
chromosome, as measured by the recombination rate in Western palearctic frogs 
(Hotz et al 1997). These data also suggest that the two enzymes may have been 
linked, in at least the early vertebrates, some 400 million years ago as they are also 
linked in teleost fish and mammals and both protein sequences are extensively 
conserved.
The use of mesenteric perfusion and the effect of hypoxic exposure may allow the 
testing of enzyme binding from the circulation. Using the perfused mesentery a 
solution of enzyme could be perfused through the vessels with subsequent staining
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with antibody or by activity measurements to show binding of circulating enzyme to 
vessel endothelium. It is also possible to test the effect of hypoxic exposure on the 
adhesivness of the endothelium by using rats exposed to chronically reduced 
oxygen levels.
Also seen in this thesis was the possibility that exercise with associated oxygen 
debt may cause an increase in circulating radical-generating enzymes. Further 
work utilising exercise regimens under controlled oxygen conditions in an isolation 
chamber, the oxygen concentration of which is reduced compared to atmospheric 
concentrations, may show increased levels of oxidant-generating enzymes in the 
plasma. This technology is already available as a method of training elite athletes 
by simulating exercise at altitude in such a chamber giving all the benefits 
associated with altitude training. The possibility therefore exists that an oxygen 
debt exercise may lead to the generation of NO from nitrite and XO to cause 
relaxation of constricted hypoxic vessels followed by a reperfusion with the 
associated oxygen radical generation also mediated by XO.
A possible hypothesis, taking into account the above information is that xanthine 
oxidase, as an ancient enzyme, was redox active and could utilise a range of 
substrates for the turnover of purines or NADH reducing equivalents with the 
subsequent fixation of nitrogen as nitrite in a oxygen free atmosphere. As oxygen 
became more abundant, the generation of reactive oxygen species began to occur. 
If the organisms were utilising the nitrite and NO as signalling molecules generated 
by xanthine oxidase in some manner, then the appearance of superoxide and 
therefore peroxynitrite would starve the organism of the required NO signal. Co­
expression of the SOD enzyme would then allow the generated NO to cover a 




In the circulation this can be used as a hypoxia escape mechanism for relaxation of 
hypoxic vessels when other oxygen-dependent enzymes such as NOS are starved 
of their substrate. The generation of NO may also include a signalling role in terms 
of oxygen-sensing mechanisms and the turnover of NAD+ and NADH ratios which 
are perturbed due to the lack of the terminal electron acceptor oxygen during times 
of hypoxia.
The dual role of oxygen and nitrite utilisation may also serve as an antibacterial 
agent in milk allowing natural control of the gut flora in the neonate at a time when 
other anti-bacterial mechanisms such as stomach acid production are not yet 
initiated.
The studies in this thesis have highlighted a level of mutifunctionality of xanthine 
oxidase that has been previously overlooked. Knowledge of this allows the 
consideration of many new physiological roles for the enzyme and the possibility of 
novel therapeutic intervention where the enzyme is beneficial but deficient or 
inappropriately expressed and pathogenic. In this respect, the studies of this thesis 
have formed the basis for two international patents:
1. International Patent No. PCT/GB99/02845 - Ingestible compositions 
comprising anti-bacterial agents.
2. International Patent No. PCT/GB99/02844 -  Treatment of Lesions.
The higher profile of physiological importance given to xanthine oxidase by 
publications arising from these studies warrants an increase in research 
effort in specific areas. In this respect this work is being followed up and 











Stock solution Final concentration (mM)
KCI 4.7
MgS04 1.2
k h 2p o 4 1.2
CaCI2 1.2
Made up in 5L distilled water. Once dissolved the solution was filtered through a 
0.22nm filter (Sartorius).
Microscopy
Cells were visualised in culture on an inverted microscope Nikon Diaphot TMD® 
with phase contrast.
All photographs were taken using cells or tissue mounted on to polished glass 
slides or Thermanox® coated cover slips. Photographs were taken under white 
light using a Zeiss photomicroscope lie® with filters for correction of the light 
emitted from the tungsten lamp.
Tissue fixation
Tissue fixation used the following procedure
I. Rat mesentery was stored in formal saline 40% volume formaldehyde in
0.9% NaCI (made up in ddH20 , BDH, UK) for seven days.
II. Each tissue sample was enclosed within a plastic cassette and subjected to 
dehydration in increasing concentration of ethanol, 65, 75, 95% and 
absolute ethanol 3x with a residence time of 1 hour at each concentration.
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III. This was followed by washes in xylene (BDH, UK) 3x each with a residence 
time of 1 hour.
IV. The tissues were then flooded with molten wax at 56°C over night before 
embedding into wax and allowing to cool to room temperature.
V. Wax blocks were kept at room temperature until use when sections of 5mm 
were cut using a sledge microtome.
VI. Sections were adhered to polished glass slides following the incubation of
the slides in poly-L-lysine (SIGMA, UK) (0.1% MW>35,000 in Ultra pure
water) until air dried.
VII. Sections were attached to slides by baking at 50°C overnight.
VIII. Dewaxing was performed by incubating the slides in xylene 2x 5 minutes
followed by incubating 2x 5 minutes in industrial methylated spirit (IMS, 
BDH, UK)
Tissue staining
Haematoxylin / eosin (H+E) staining of formalin fixed paraffin wax embedded tissue
I. Dewaxed tissue sections were incubated in Harris haematoxylin for 45 
minutes followed by washing in copious amounts of running tap waste.
II. Sections were counter stained in eosin for 30 seconds followed by acid 
alcohol wash 1x5 minutes
III. Sections were dehydrated by incubation in IMS 2x 5 minutes and xylene 2x 
5 minutes after which DPX was added for coverslip mounting
Antibody labelling of tissue
Tissue were fixed and dewaxed as described in tissue fixation above
I. Primary antibody (rabbit anti-bovine XO) was loaded onto dewaxed sections 
at a range of concentrations 1:50 -  1:1000 in PBS/Tween 20/Marvel (MPT) 
and incubated overnight at 4°C in a humidified atmosphere
II. The sections were washed in PBS/Tween 20 (PT) 2x 5 minutes before 
loading of the secondary swine anti-rabbit biotin conjugated antibody, 1:200 
dilution (Dako, Denmark) for 2 hours
III. Sections were washed 2x PT
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IV. Avidin biotin complex ABC (Dako, Denmark) was mixed in PT and allowed
to stand for 30 minutes before being applied to sections for a further 30
minutes
V. Sections were washed 2x PT
VI. Diamino benzidine (DAB) was used as the chromagen from Fast DAB
tablets (SIGMA, UK) by adding to the sections
VII. The reaction was followed until a brown colour was seen, followed by
termination of the reaction with the addition of copious amounts of Ultra
pure water
VIII. Sections were mounted under coverslips in Aquamount and stored at room 
temperature until visualisation
Peroxynitrite generation: chemical method (From Crowe t al (1995))
The following stock solutions were generated
I. 0.6M NaN02, 0.7M H20 2f 0.6M HCI, 1.5M NaOH (SIGMA, UK)
II. NaN02 was made up in Ultra pure H20  and mixed rapidly in equal volume
with H20 2 made up in 0.6M HCI
III. The resultant mixture was then immediately reacted with the NaOH to 
quench the reaction
IV. To remove excess H20 2 the mixture was incubated with Mn02 for 5 minutes 
before removing the Mn02 using a 0.22^m filter.
V. The concentration of ONOO- was measured spectrophotometrically at 
303nm in 0.3M NaOH and the mixture aliquotted into 5ml and frozen at -  
70°C.
VI. One aliquot was allowed to stand at room temperature for 3 days before use 






Sodium-dodecyl-sulphate gels were prepared in the following manner for a 10ml
mini-prep
I. Mix Ultra pure H20  5.384ml, 2ml acrylamide stock (acrylamide 40% w/v, 
bis-acrylamide 2.105% w/v, Anachem, UK), 2.51ml Tris pH8.8 (Tris base, 
SIGMA, UK), 100pl SDS (10% stock, SIGMA, UK)
II. Add 10pl TEMED (N.N.N’.N’-tetramethyethylene diamine, Promega, UK) 
and 150|xl ammonium persulphate (AMPS, 10% w/v in Ultra pure H20  made 
fresh daily, SIGMA, UK) and add to gel apparatus immediately.
III. Add a layer of butan-1-ol saturated water until polymerisation has occurred
5% SDS Stacking gel
Remove butan-1-ol and make up the following mixture for a 3.3ml mini-prep
I. Mix Ultra pure H20  2.464ml, 0.416ml acrylamide stock (acrylamide 40%
w/v, bis-acrylamide 2.105% w/v, Anachem, UK), 0.42ml Tris buffer pH6.8 
(Tris HCI, SIGMA), 33.3^1 SDS (10% stock, SIGMA, UK)
II. Add 17jxl TEMED and 100jil ammonium persulphate (AMPS, 10%w/v in
Ultra pure H20  made fresh daily, SIGMA, UK) and add to gel apparatus 
immediately using a comb to generate the wells
Loading Buffer
For 10ml of 2x loading buffer the following amounts were used
I. 2ml SDS (20%w/v) in Ultra pure H20 , 4ml 50% glycerol, 2ml 1M DTT
(dithiothreitol), 1M Tris buffer pH 6.8 (Tris HCI) and 800ml (0.4% w/v stock) 
bromophenol blue.
Samples were mixed in a 1:1 ratio with bromophenol blue before being incubated at




For 1L of running buffer the following amounts were used
3.06g Tris base (25mM final concentration) pH8.8, 14.4g glycine (190mM) and 1g 
SDS (0.001%) made up to 11 in Ultra pure H20 and stored at room temperature.
Blotting Buffer
As for 1L running buffer with the following additions 
200ml methanol (20% final) made up to 11 with Ultra pure H20
Washing buffer
1x PBS / 0.5% Tween 20 (final concentration)
Blocking Buffer
5% Non fat dried milk Marvel (Cadbury, UK) in 1x PBS / 0.5% Tween 20 
Protein determination: Bradford's assay
The Bio-Rad Protein Assay is based on an observed shift in the absorbance 
maximum when Coomassie Brilliant Blue G-250 reacts with protein. Bradford first 
demonstrated the usefulness of this principle in protein assay. Over a broad range 
of protein concentrations, the dye-binding method gives an accurate, but not 
entirely linear response.
I. Using a standard of 1.4mgml'1 bovine serum albumin, a standard curve was
generated by reacting protein with 200jaI Bradford’s reagent made up to 1 ml 
in Ultra pure H20  and measuring the coloured product at 595nm
II. Unknown protein concentrations were measured by adding a dilution of
protein to 200|xl Bradford’s reagent and diluting to 1ml in ultra pure H20.
The absorbance is read at 595nm and the result related to the known 




Bacteria were assessed for their Gram staining to determine phenotype
Bacteria were grown overnight in nutrient broth
I. Crystal violet - 2g, Ammonium oxalate- 0.8gt 95% alcohol - 20mls, Distilled 
water - 80mls. Dissolve the dye in the alcohol, add the rest, stir for 3 hours 
and filter.
II. Iodine - Ig, potassium iodide- 2g, distilled water - 300ml. Dissolve iodine 
and potassium iodide in a small quantity of the water and then add the 
remainder.
III. A 10p.l aliquot was added on to a polished glass slide and spread to 
generate a smear
IV. The smear was then dried by passing quickly through a yellow Bunsen 
flame to fix the bacteria
V. Cells were Stained with crystal violet -1  minute. Washed off with tap water.
VI. Treated with Iodine solution - 2 minutes. Washed in tap water.
VII. Differentiate in acetone 1-2 seconds. Washed in tap water and checked 
using a microscope. The background should not be purple.





Human Umbilical Vein Endothelial Cell media (HM)
To 500ml M199 media (GIBCO, UK) add
I. 100ml heat inactivated (56°C for 30 minutes) Foetal calf serum (FCS) (final 
concentration 20%) (GlobePharm, UK)
II. 5000IU Heparin (Monoparin, CP Pharmaceuticals, UK) (50IUml'1) 
containing Heparin Sodium (Mucous) BP, water, HCI and NaOH for injection
III. 15mg Endothelial cell growth supplement (ECGS, SIGMA, UK) (30jigmr1)
IV. Penicillin / Streptomycin (Pen / Strep) 10,000IUmr1 / lO.OOO^gml'1 (GIBCO, 
UK) 100IU ml'1 and 100jigml'1 respectively
Synovial Microvascular Endothelial Cell media (SM)
As for HM above with the following additions
To 500ml M199 media (GIBCO, UK)
I. 75ml heat inactivated human serum (SIGMA, UK) (final concentration 15%)
II. 10ngml'1 Epidermal Growth Factor (EGF) (SIGMA)
Reduced serum SMEC media (rSMEC)
As for HM with the following changes and additions
I. 5ml heat inactivated (56°C for 30 minutes) Foetal calf serum (FCS) (final
concentration 1%) (GlobePharm, UK)
Synovial Fibroblast media (SF)
To 500ml Dulbeccos modified eagles media (DMEM) (GIBCO, UK)
I. 50ml FCS heat inactivated (56°C for 30 minutes) (final concentration 10%) 
(GlobePharm, UK)
II. Penicillin / Streptomycin (Pen / Strep) 10,000IUml'1 / 10,000pgml'1 (GIBCO, 




I. Pepstatin A (l^igml'1)
II. Antipain (1|igml‘1)
III. Leupeptin (Ijxgml'1)
IV. Dulbeccos phosphate buffered saline (PBS) (Oxid, UK)
Homogenisation Buffer (HB)
A for HW with the following additions
I. 50mM KP04 pH 7.3
II. ImMEDTA
III. ImMPMSF
IV. * PBS was changed for Ultra Pure H20
Cell count and viability assay
Trypan blue is regarded as a vital dye as it is impermeable to cells with an intact
plasma membranes while non viable cells take up the dye and appear blue in
colour.
I. 100^1 aliquots of call solution were mixed with equal volumes of 0.4% 
Trypan blue solution (SIGMA, UK) and allowed to stand for 5 minutes at 
room temperature.
II. A 10jil aliquot of this solution was added to an improved Neubauer 
haemocytometer by capillary action. Cells were viewed by low power 
transmitted light microscopy and cells within the central 0.1mm3 section of 
the haemocytometer were counted.
III. Total cell counts were calculated by counting all the cells, blue and clear, in 
the central area of the two counting chambers and dividing by two and then 
multiplying by 1x104. This figure represents the original cell number before 
dilution and expressed as cells per ml.
IV. Viable counts were calculated by repeating the above procedure by 
counting only the unstained cells.
V. The percentage viable count was calculated by dividing the clear cell count 
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